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Abstract 
Contraction in skeletal and cardiac muscle is initiated by a cascade of events 
collectively known as excitation-contraction coupling, in which depolarisation of the 
sarcolemma triggers Ca2+ release through ryanodine receptor Ca2+ release channels in 
the sarcoplasmic reticulum. Releasable Ca2+ is loosely bound to, and stored on, a high 
capacity moderate affinity Ca2+ binding glycoprotein- calsequestrin - which is located 
within the sarcoplasmic reticulum lumen. Calsequestrin is tethered to the ryanodine 
receptor by two anchoring proteins, triadin and junctin, although calsequestrin has been 
shown to bind to and regulate ryanodine receptors in the absence of these anchors. 
Calsequestrin has recently been implicated to have a role in cardiac hypertrophy and 
resultant heart disease, although relatively little is known about the role of calsequestrin 
in ryanodine receptor function in vivo. 
The regulation of the skeletal muscle ryanodine receptor by calsequestrin was studied 
using the lipid bilayer technique. This technique allows monitoring of channel 
modulation by measuring current passing through the membrane in response to an 
electrochemical gradient. Currents were recorded using Cs+ as the conducting ion. Once 
incorporated, sarcoplasmic reticulum vesicles orientate in such a way that the cytoplasm 
of the sarcoplasmic reticulum faces the cis chamber, whilst the sarcoplasmic reticulum 
lumen faces the trans chamber. As calsequestrin is found solely in the sarcoplasmic 
reticulum lumen, it may be isolated to the trans chamber. 
This study provides novel evidence that calsequestrin inhibits native ryanodine receptor 
calcium release channel activity. Calsequestrin dissociation from junctional face 
membrane was achieved by increasing luminal (trans) ionic strength from 250 to 500 
mM with CsCl, or by exposing the luminal side of ryanodine receptors to high (13 mM) 
[Ca2+], and dissociation was confirmed with SDS-Page and Western blotting. 
Calsequestrin dissociation caused a 10-fold increase in the duration of ryanodine 
receptor channel opening in lipid bilayers. Adding calsequestrin back to the luminal 
side of the channel after dissociation reversed this activity increase. In addition, a 
polyclonal anti-calsequestrin antibody added to the luminal solution reduced ryanodine 
receptor activity before, but not after, calsequestr~ri dissociation. 
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A population of ryanodine receptors (~35%) may have initially lacked calsequestrin, 
since their activity was high and was unaffected by increasing ionic strength, altering 
luminal [Ca2+], or by anti-calsequestrin antibody: their activity fell when purified 
calsequestrin was added and they then responded to antibody. 
The effects of phosphorylation status on calsequestrin regulation in native ryanodine 
receptors was shown to affect channel regulation quite differently in native ryanodine 
receptors, compared to the effects observed in purified ryanodine receptors. Szegedi et 
al. (l 999) and Herzog et al. (2000) have shown that only dephosphorylated 
calsequestrin activates the ryanodine receptor, and upon phosphorylation, calsequestrin 
is unable to alter ryanodine receptor activity. In native calsequestrin-depleted ryanodine 
receptors, both phosphorylated and dephosphorylated calsequestrin induced significant 
channel inhibition. Therefore, unlike calsequestrin's effect on purified ryanodine 
receptors, channel regulation of native ryanodine receptors (with triadin and junctin 
intact) by calsequestrin is not phosphorylation-dependant. 
In contrast to native ryanodine receptors, purified channels ( deplete of triadin, junctin 
and calsequestrin), were not inhibited by calsequestrin. In fact, calsequestrin had a 
tendency to activate purified ryanodine receptors. This shows that calsequestrin 
regulates the ryanodine receptor by two distinct mechanisms. Firstly, calsequestrin can 
bind directly to the ryanodine receptor and activate the channel in a 
phosphorylation-dependant manner ( as reported by [Szegedi et al, 1999), Secondly, 
calsequestrin can inhibit native ryanodine receptor activity, presumably by associating 
with triadin and junctin and influencing ryanodine receptor activity through this 
interaction. From these results, it is apparent that calsequestrin associates with the 
ryanodine receptor via two binding mechanisms, firstly through anchoring proteins 
triadin and junctin and secondly, by direct association with the luminal domain of the 
ryanodine receptor. The regulation imposed on ryanodine receptors by calsequestrin is 
strikingly different, depende,nt on the presence or absence of triadin or junctin, or the 
phosphorylation status of calsequestrin. 
This is the only detailed study considering the role of calsequestrin on luminal Ca2+ 
regulation of ryanodine receptors· Luminal Ca2+ was originally thought to modulate 
ryanodine receptors solely by binding to Ca2+ activation and inhibition sites on the 
channel. For the first time, luminal [Ca2+]-induced ryanodine receptor activation is 
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shown to be a result of two independent mechanisms. Raising Ca2+ to 5 mM and 
lowering Ca2+ to 100 nM is shown to induce activity due to an initial fast phase, as a 
result of Ca2+ activation, and a slower, secondary phase, due to calsequestrin 
dissociation. As well, results suggest that the presence of calsequestrin alters the 
ryanodine receptors response to luminal Ca2+. In the presence of calsequestrin, 
ryanodine receptors had a tendency to be more active at 1.5 and 2.0 mM trans Ca2+, 
compared with calsequestrin-deplete ryanodine receptors. Calsequestrin may also be 
involved in the communication of small ( and probably physiological) Ca2+ fluxes 
th'ough the channel into the cytoplasm. ,. 
These data suggest that calsequestrin reduces ryanodine receptor activity by binding to a 
co-protein, possibly to the luminal domain of triadin and it is possible that triadin and/or 
junctin forms part of the signalling pathway by which calsequestrin communicates the 
luminal Ca2+ to the ryanodine receptor, an essential step in sarcoplasmic reticulum Ca2+ 
release and muscle contraction. 
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GENERAL INTRODUCTION 
Chapter 1 
1.1 Muscle and excitation-contraction coupling 
Both voluntary movement and respiration rely on the contraction of skeletal muscle. 
Structurally, three distinct membranes found within the muscle cell are involved in the 
regulation of muscle contraction (Fig. 1.1 ). (1) The sarcolemma, a specialized 
plasmalemma membrane, separates the extracellular space from the intracellular 
myoplasm. (2) The transverse tubules (t-tubules) are invaginations of the sarcolemma, 
which embed deep within the muscle cell. They allow the internal transmission of the 
membrane depolarisation induced by an action potential, that is essential in skeletal 
muscle contraction. Embedded within this membrane, are the dihydropyradine receptors 
(DHPRs), an L-type Ca2+ channel. (3) The sarcoplasmic reticulum (SR), a modified 
endoplasmic reticulum and large intracellular Ca2+ store, which forms an internal 
membrane system, and consists of a network of tubules aligned longitudinally. The part 
of the SR membrane facing the t-tubules is known as the terminal cisternae, in which 
the ryanodine receptor (RyR) - a ligand gated ion channel - is embedded. Ca2+ is stored 
in the lumen of the SR. These three membrane systems and the proteins contained 
within them are paramount for muscle contraction. 
The process of muscle contraction begins with an action potential within a motor 
, , 
neuron, if the summation of both excitatory and inhibitory synapses induces a threshold 
depolarisation withrithe soma. The action potential leads to release of acetylcholine into 
the neuromuscular junction, and acetylcholine binding to acetylcholine receptor cation 
channels generates an endplate potential. This in tum, elicits an action potential in all 
muscle cells within the motor unit. A motor unit is defined as an a-motor neuron, its 
axon and the muscle fibres that it innervates. 
This muscle action potential signals the start of a process known as excitation 
contraction coupling (ECC; Fig 1.1 a). In mammalian skeletal muscle, depolarisation 
spreads along the sarcolemma and deep into the muscle fibre (via the t-tubule 
invaginations). The DHPR in the t-tubule acts as the voltage sensor for contraction, and 
in tum inducesRyR opening in the SR, across the junctional gap (see Fig 1.1 a). In 
skeletal muscle, this signal is transmitted via a physical coupling between these two 
2 
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receptors, whereas in cardiac muscle the signal is transmitted via an inward Ca2+ 
current. The activation of RyRs allows Ca2+ stored within the SR to diffuse down its 
electrochemical gradient, into the myoplasm. This Ca2+ is then available for interaction 
with specific sites upon troponin C, enabling actin and myosin filaments to slide past 
each other ( as a result of cross-bridge cycling), and contraction of muscle fibres. 
Ca2+ available for release through the RyR is stored intraluminally in the SR on a Ca2+ 
binding protein, calsequestrin (CSQ). CSQ is tethered to the junctional face membrane 
(JFM; the portion of the SR membrane facing the junction of the triad and the SR) by 
two membrane spanning proteins, triadin and junctin (Fig 1.1 b ), allowing localization of 
Ca2+ close to the RyR. CSQ, the RyR, triadin and junctin form what is referred to here 
as the RyR/T/J/CSQ complex. 
1.2 Ryanodine receptor 
RyRs are ligand-gated Ca2+ release channels, so named because they bind the neutral 
plant alkaloid ryanodine, localized in the root and stem of Ryania speciosa. The planar 
- or black - lipid bilayer technique for observing current flow through ion channels 
helped identify RyRs in skeletal muscle. Smith et al. (1985) were the first to report the 
presence of a large conductance ion channel, regulated by both adenine nucleotides and 
ruthenium red (refer to Sections 1.2.6.4 and 1.2.6.6), and thought to be the Ca2+ release 
channel within the SR of skeletal muscle. 
1.2.1 Gene/isoforms 
RyRs have been found in species as diverse as mammals, amphibians, avian and insects, 
but it is the mammalian isoforms that have been extensively studied. Three mammalian 
genes for the RyR have been sequenced, RyRl, RyR2 and RyR3 (Takeshima et al., 
1989; McPherson and Campbell, 1993; Sutko and Airey, 1996). In adult skeletal 
muscle, RyRl is the predominant isoform. RyRl encodes for between 5032-5037 amino 
acids, dependant on species. The presence ofRyRl is essential for skeletal muscle 
ECC; in transgenic ( dyspedic) mice where the RyR gene is not expressed, ECC is 
totally lost and animals die at or before birth (Takekura et al., 1994). There are many 
3 
Fig. 1.1. (A). Schematic representation of the interactions of essential 
proteins involved in excitation contraction coupling. The SR junction is 
is circled in red (B). The RyR/triadin/junctin/CSQ protein complex, 
circled in A - showing the proposed binding between CSQ, the RyR, 
triadin and junctin. The interactions of these proteins are in part, 
responsible for modulating RyR Ca2+ release. Residues involved in the 
interaction between CSQ and Triadin ( circled in black) are listed below 
the diagram. Adapted from Wang et al, 1998 and Sakowska, 2000. 
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conserved regions throughout all three isoforms, with an overall homology of 66 - 70%. 
The inositol 1,4,5-triphosphate (IP3) receptor is a receptor for IP3, a second messenger 
found in m:uscle sarcolemmal membranes (and other cell types). The IP3 receptor is the 
only protein known to be homologous with the RyR, the carboxyl terminal (C-terminal) 
region being a prime example (Furuichi et al., 1989; Berridge, 1993). 
RyR2 is prevalent in cardiac muscle. RyR3, the so-called 'brain isoform', is found only 
sparingly in brain and is in fact more extensively expressed in smooth muscle and 
non-muscle tissue (Ogawa et al., 2000). Interestingly in neonates, up to 30% ofRyRs 
found in skeletal muscle are RyR3, these levels fall to below 1 % after birth 
(Bertocchini et al., 1997). The presence of RyR3 is seemingly non-essential for adult 
skeletal muscle ECC, and is unable to restore ECC in dyspedic mice which lack RyRl 
(Flucher et al., 1999). RyR3 is thought to play a role in normal morphogenesis of 
skeletal muscle (Ikemoto et al., 1997). 
Non-mammalian RyRs have been sequenced; a-RyR and P-RyR have been identified in 
avian, amphibian and fish muscle (Rubtsov and Batrukova, 1997; and references 
therein), with birds also expressing a mammalian cardiac isoform. The a and p RyRs 
differ both biochemically and immunologically from their mammalian counterparts. 
Takeshima et al. (1994) first isolated and characterized a RyR gene in Drosophila 
melanogaster, which has a 45% amino acid homology with the skeletal-type RyR. 
1.2.2 Alternative splicing 
Futatsugi et al. (1995) first described an alternate splicing of the skeletal muscle RyR 
mRNA. Two alternate spliced regions, encompassing several modulatory sequences 
were localized, characterized by the presence or absence of 15 hp and 18 hp exons, 
know as ASI and ASII respectively. The absence of ASI resulted in the exclusion of 
Ala 3481 - Gln 3485 , whilst the lack of ASII resulted in the omission of Val 
3865 
-Asn 3870 
(Futatsugi et al., 1995). Both these regions are located within the modulatory region of 
the RyR and are situated downstream of the proposed Ca
2
+ and ATP binding sites, and 
upstream of the phosphorylated residue, Ser 
2843 (Zorzato et al., 1990; Chen et al., 1992; 
Suko et al., 1993) . . Distribution and abundance of each splice variant in skeletal muscle 
is dependant on the stage of muscle development; the expression of the variant lacking 
ASII increases between embryonic day 18 and birth. This is followed by a gradual 
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increase in the isoforms containing both ASI and ASII, which are thought to be 
essential for muscle development (Futatsugi et al., 1995). Whilst the appearance of 
splice variants may account for observed RyR channel variability, no functional 
significance has been determined (Sutko and Airey, 1996). 
1.2.3 Structural 
In skeletal muscle, RyRs form hetrotetramers, each subunit having a molecular weight 
of ~ 560 kDa (Takeshima et al., 1989; Zorzato et al., 1990). Hydropathy profiles 
suggest that the majority of the protein ( ~80%) exists in the cytoplasm ( which forms 
'foot-like' projections extending from the SR junctional membrane to the triadic-SR 
junction, close to where the DHPR is located). The remaining 20% forrnsa compact 
membrane-spanning structure (Radermacher et al., 1994; Samso and Wagenknecht, 
1998). The number of transmembrane helices and residues in the transmembrane 
domain remains controversial. Reports suggest the existence of four, ten or twelve 
putative membrane-spanning regions (Takeshima et al., 1989; Zorzato et al., 1990; 
Radermacher et al., 1994). Reconstructions from cryoelectronmicroscopy (resolution of 
25 - 30 A 0 ) gives a picture of the overall profile of the protein, but does not allow 
identification of residues. The cytoplasmic domain is relatively unstructured, with up to 
50% of the volume being unoccupied by protein material (Radermacher et al., 1994 ). 
Four electron dense columns appear to provide the scaffolding for this domain, leaving 
a central channel of 2-3 nm in diameter (See Fig 1.2). Radermacher et al. (1994) show 
ten cytoplasmic domains in each of the four RyR subunits, which form a prism-like 
structure. Domains 5-6, 7-8 and 9-10 are referred to as clamp structures, thought to 
form the prism corners. Domain 3 forms one side of the prism, whilst domain 1 
provides a connection to the transmembrane segment. 
Cardiac and skeletal muscle RyRs are strikingly similar in sequence, although three 
regions of divergence exist - namely D1, D2 and D3. The largest area of low sequence 
homology, DI, is found between residues Pro4254 - Phe4631 in the skeletal RyR, and 
- encompasses residues Ser 4210 - Val4562 in the cardiac isoform (Sorrentino and Volpe, 
1993 ). This region includes the predicted intraluminal loop between transmembrane 
domain three (M3) and transmembrane domain four (M4) and is thought to include part 
of the pore forming region (based on the RyR transmembrane segment model proposed 
by Zorzato et al. (1990). Region D2, from amino acids Try1342 - Pro 1403 in skeletal 
7 
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Samso et al., 1999). 
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(cardiac: Asp 1353 -Tyr1397) and D3, from residues Thr1872 - Glu1923 (skeletal) which 
d . .d L 18s2 L 1890 . h d. - ~ -correspon s to amino ac1 s ys - ys 1n t e car 1ac 1so1orm, may contain 
different regulatory domains , responsible for the different properties of cardiac and 
skeletal Ry Rs (Sorrentino and Volpe, I 993 ). In particular, skeletal D3 is much more 
acidic than its cardiac equivalent and is thought to fonn the low affinity divalent 
binding site (Zorzato et al., 1990; see Section 1.2.6.1 ), responsible for inhibition by 
2+ 2+ Ca and Mg . 
1.2.4 Pore-forming segment 
In K+ channels of Streptomyces lividans ( one of only two cation channels whose crystal 
structure has been detennined with high resolution (2.3A0 )), a region between two 
membrane-spanning domains, extends into the membrane and forms part of the ion 
conduction pathway (Doyle et al., 1998). A potential pore forming segment of the RyR 
(located in the M3/M4 loop) is thought to be analogous to that in voltage-dependent K+ 
channels. A Gly-Gly-Iso-Gly motif in RyRs is similar to a motif, found in the K+ 
channel (Val-Gly- Try-Gly), which forms part of the selectivity filter (Gao et al., 2000 
and references therein). 
Sequence analysis of IP3 receptors suggests that a similar region 
(Gly-X-Arg-X-Gly-Gly-Gly-X-Gly-Asp), is the pore-forming segment of the lP3 
receptor (Michikawa et al., 1994 ). A corresponding region is found in rabbit skeletal 
RyRs, between 4890 Gly - Glu 4900. Mutations of amino acids located in the highly 
conserved Gly4822 - Glu 4831 region in rabbit cardiac RyRs resulted a loss of channel 
conductivity and ion selectivity (Du et al., 2001 ). Site directed mutagenesis of the 
skeletal muscle RyR of an isoleucine to a threonine (14898T) resulted in undetectable 
Ca2+ release induced by caffeine and in 3HRy binding (an assay which indicates the 
open state of a RyR channel; Lynch et al., 1999). In fact, this occurs in human central 
core disease, which results in hypotonia and muscle weakness (Lynch et al., 1999). 
Mutations G4894A and D4899N resulted in a reduction in both K+ and Ca2+ 
conductance (Gao et al., 2000). In mouse cardiac muscle, a point mutation (G4824A) 
within this stretch of conserved residues (Gly4822 - Glu 4831 ) resulted in a significant 
decrease in caffeine-induced Ca2+ release, and a greatly reduced 3HRy binding (Zhao et 
al., 1999). These data led to the hypothesis that the residues found within the luminal 
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loop between M3/M4 contribute to the RyR pore, particularly because single mutations 
in the region had such an extreme effect on conductance (Gao et al., 2000). 
1.2.5 Ion conductance 
RyRs are cation selective ion channels, exhibiting an unusually high conductance for 
monovalent and divalent ions. For example, in 250 mM symmetric K\ conductance is 
770 pS, whilst in symmetric 250 mM Na+, conductance is 580 pS. Unitary Ca
2+ 
conductance (50 mM trans Ca2+) is 120 + 30 pS and Cs+ conductance (250 mM 
symmetrical Cs+) is~ 525pS; Smith et al., 1986; Smith et al., 1988b; Tinker and 
Williams, 1992). The ability of the RyR to conduct both choline and TRIS (26 and 22 
pS respectively) illustrates that the ion conduction pathway has a selectivity filter which 
has a known radius of 3.5A and a length of 10.4 A (Smith et al., 1988b; Tinker and 
Williams, 1993; Tinker and Williams, 1995) 
With Ca2+ as the current carrier, four conductance states have been shown, occurring at 
equal intervals of¼ of the maximal conductance state. These substates are also 
promoted by FKBP12 removal (Ahem et al., 1997a) or pH inhibition, (the later 
occurring when RyRs are ryanodine modified; Ma and Zhao, 1994). Whether these are 
due to some form of interaction between each of the four monomers within the RyR, or 
whether each subunit contains its own ion selective pore is unknown (Meissner, 1994). 
1.2.6 RyR regulation 
The RyR is regulated by a wide variety of agents, both endogenous and exogenous. The 
majority of modulation is on the cytoplasmic side, with adenine nucleotides, caffeine, 
histidine-containing dipeptides, ions ( such as cytoplasmic Ca2+ and Mg
2+), ionic 
strength changes, lipids and polycationic metabolites, local anaesthetics, oxidizing 
agents, polyamines, pH, ruthenium red, ryanodine and sphingosine all able to modulate 
RyR activity (11eissner, 1994; Rubtsov and Batrukova, 1997 and reference therein). On 
the luminal side, annexin VI (Diaz-Munoz et al., 1990), Ca2+ (Sitsapesan and Williams, 
1995; Tripathy and Meissner, 1996), ruthenium red (Ma, 1993), sulmazol, themerazol 
and other oxidizing agents (Eager, 1997; Haarmann et al., 1999) have been reported to 
affect RyR activity. In addition, on the cytoplasmic side proteins such a calmodulin 
(CaM; Fuentes et al., 1994), CSQ (see Chapter 3-5 and Kawasaki and Kasai, 1994; 
10 
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Ohkura et al., 1994; Ohkura et al. , 1995; Ohkura et al., 1998; Szegedi et al., 1999; 
Beard et al., 2002; Herzog et al., 2000; \Vang et al., 2001 and Beard et al., 2002), 
DHPR, triadin (Ohkura et al. , 1998), the histidine-rich Ca2+ binding protein (HRC) and 
sarcalumenin (SLM; Hadad et al., 1999), have been shown to interact with, and alter the 
channel activity of, the RyR. Only those agents and proteins with some significance to 
this thesis will be considered in greater detail below. 
1.2.6.1 Cytoplasmic Ca2+ 
Cytoplasmic Ca2+ is an important modulator of the RyR. SR vesicle Ca2+ efflux shows 
biphasic regulation by Ca2+. At low and high [Ca2+] (nM and mM), RyRs are inhibited, 
whilst at 10 - 100 µM Ca2\ channel activation occurs (Kiri no et al., 1983; Nagasaki 
and Kasai, 1983; Smith et al., 1986; Meissner, 1986b; Ma et al., 1988; Moutin and 
Dupont, 1988; Smith et al., 1988a; Fili et al., 1990; Knudson et al., 1993b; Coronado et 
al., 1994; Laver et al., 1997). Cardiac RyRs are less sensitive to Ca2+ -induced 
inhibition, with channel inhibition occurring at < 10 nM and > 1 mM, compared with 10 
- 100 uM in skeletal Ry Rs (Rousseau and Meissner, 1989; Laver et al., 1997). In vivo, 
skeletal RyR activation by cytoplasmic Ca2+ is thought by some authors to be 
responsible for triggering SR Ca2+ release from RyRs that are not coupled to DHPRs. 
Every second RyR facing the triadic-SR junction does not form an association with 
DHPRs; these RyRs are thought to be activated by Ca2+-induced Ca2+ release, similar to 
the signal transduction pathway observed between these two receptors in cardiac 
muscle. However, this is controversial, since Ca2+ activation should not occur in the 
2+ presence of Mg (Lamb, 2000). 
Chen et al. ( 1992) first showed in a polyclonal antibody study of Ca2+ release from SR 
vesicles, that the region from Gly4478 - Pro4512 (predicted to be a modulatory region of 
RyR 1 by Takeshima et al., 1989) was involved in Ca2+ -induced Ca2+ release in skeletal 
muscle. Antibody techniques were employed again in single channel experiments, to 
narrow down the region involved in Ca2+ activation (Chen et al., 1993). A series of 
Pro-Glu repeats, found within the sequence Pro4489 - Glu4499 are thought to contribute to 
Ca2+-activation; a polyclonal antibody to this sequence was able to inhibit 
Ca2+-activation of RyRs, without altering modulation by ATP, Mg2\ ruthenium red or 
ryanodine. Th~data suggests that this Pro/Glu rich region has an important role in 
Ca2+-dependant activation. More recently, a single substitution of E3885A (located in 
1 1 
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transmembrane domain two (M2) ofRyR3) produced a decreas~ Ca
2+ sensitivity 
/\ 
without changing modulation of the channel by either ATP or ryanodine (Chen et al., 
1998). Thought to be a high affinity Ca2+ binding site and termed the Ca
2+ sensor, it is 
believed that Glu3885 of each monomer (located in close proximity) would form a 
coordinated region responsible for Ca
2+ binding and activation of the RyR. 
The role of the D3 region (Thr1872 - Glu 1923) of the RyR is controversial. D3 was first 
proposed to be the stretch of residues responsible for low affinity Ca
2+ binding 
(Ca2+ -dependant inactivation; Zorzato et al., 1990). An ~D3 - RyR mutant, lacking the 
D3 region, showed an increased sensitivity to Ca
2+ activation and a decreased 
sensitivity to Ca2+ inhibition (Bhat et al., 1997). These mutant Ry Rs did not show 
alterations in 3HRy binding and have similar pharmacology and single channel 
behaviour to their wild type counterparts, with greater resistance to inhibition by Mg
2+ 
(at activating Ca2+). However, studies using a RyRl/RyR2 chimera, (skeletal RyRl with 
the cardiac D3 region), failed to show any change in Ca2+ -inactivation of 
3HRy binding 
compared with wild type RyRs (Du and MacLennan, 1999). Ca2+ -dependent 
inactivation was reduced in chimeras where the skeletal C-terminus was exchanged for 
the corresponding cardiac region. With these studies in mind, Du and MacLennan 
(1999) suggest that Ca2+-dependent inactivation is multifaceted, with inactivation site(s) 
located within residues Ala3726 - Ser5037 (encompassing both D3 and C-terminal regions) 
and decreased sensitivity to inhibition by Ca
2+ and Mg2+ (Owen et al., 1997). 
The importance of Ca2+ regulation in RyR function is highlighted by the myopathies 
arising from improper regulation of the RyR. In particular, malignant hyperthermia, 
which is an autosomally inherited skeletal muscle disorder, characterized by 
uncontrolled skeletal muscle hypercontraction upon anaesthetic exposure as a result of 
abnormal Ca2+ handling, and is due to a defect in the RyRl (McCarthy et al., 1990; 
MacLennan and Phillips, 1992; MacLennan et al., 1992). A mutation of an A614C in 
the skeletal muscle RyR increased sensitivity of the RyR to Ca
2
+ (Fujii et al., 1991; 
Laver et al., 1997) and Mg2+ (Laver et al., 1997) shifted to the right. 
12 
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1.2.6.2 Luminal Ca2+ 
The level of Ca2+ loading of the SR is important in regulating Ca2+ release from the SR. 
Increasing or decreasing SR Ca2+ load increases or decreases (respectively) the Ca2+ 
release in response to depolarisation (Bassani et al., 199 5; Lamb et al., 2001 a) , 
cytoplasmic Ca2+ ( Copello et al., 1997), caffeine (Lamb et al. , 2001 a), ATP (Donoso et 
al., 1995) and polylysine (Saiki et al., 1999). Moreover, Lamb et al. (2001 a) found that 
endogenous levels of SR Ca2+ loading in fast (EDL) and slow twitch (soleus) muscle is 
the primary factor determining the difference in caffeine sensitivities in the two fibre 
types. However, the mechanism by which Ca2+ load in the SR alters Ca2+ release is not 
clear. 
In terms of RyR regulation, the effects of varying luminal [Ca2+] are controversial. 
Luminal Ca2+ regulates RyRs: some studies show that increasing luminal [Ca2+] 
increases channel activity, whilst other studies report a reduction in channel activity 
after exposure to increasing luminal [Ca2+]. Luminal Ca2+ regulation was first thought 
to act as a single mechanism; Tripathy and Meissner (1996) suggested that luminal Ca2+ 
activated RyRs by passing through the channel and binding to cytoplasmic sites only, 
whilst Sitsapesan and Williams (1995) suggested that luminal Ca2+ activated RyR by 
binding to luminal sites only. Recent evidence suggests that luminal Ca2+ regulates the 
cardiac RyR by binding to both activation and inhibition sites on the luminal face of the 
RyR, as well as flowing through the open channel and interacting with Ca2+ activation 
sites located on the cytoplasmic side of the RyR (Ching et al., 2000; personal 
communication, Rebecca Sitsapesan, National Heart and Lung Institute, Imperial 
College of Science, Technology and Medicine, London, UK). However, the specific 
luminal binding region has not been located, in fact studies completed thus far do not 
rule out the possibility that luminal Ca2+ may be activating the RyR by binding to a 
luminal accessory protein, such as CSQ. 
Whether or not the differences observed in RyR regulation by luminal Ca2+ are due to 
using different RyR preparations, or activating cytoplasmic ATP and Ca2+ vs no 
cytoplasmic ATP or Ca2+ are unknown, and the exact effect of luminal Ca2+ upon RyR 
regulation is controversial. Some difference may be due to the use of SR vesicles or 
native RyRs (receptors with triadin, junctin and CSQ attached) by some investigators, 
13 
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whilst others use purified RyRs, which presumably no longer have these proteins 
attached. 
1.2.6.3 Magnesium 
SR vesicle studies showed that Ca2+ efflux from skeletal SR was inhibited by mM Mg
2
+ 
(with mM Ca2+), and Ca2+ activation was prevented by mM Mg2+ (at µM Ca2+: Kirino et 
al., 1983; Nagasaki and Kasai, 1983; Meissner et al., 1986a), suggesting that two 
distinct mechanisms were responsible for this inhibition. Single channel studies also 
revealed Mg2+ inhibition ofRyRs (Smith et al., 1986; Meissner et al., 1986a; Laver et 
al., 1997). 
Meissner et al. (1986a) and Laver et al. (1997) also proposed (in both cardiac and 
skeletal muscle), a dual mechanism model for inhibition by Mg2+. Mg2+ can compete 
with Ca2+ for the Ca2+ activation site, preventing Ca
2
+ from inducing RyR opening. 
Mg2+ may also bind to low affinity binding sites (thought to be the Ca2+ inhibition site 
found within the D3 region, see Section 1.2.6.1 ), which bind divalent cations 
non-selectively and result in channel inhibition. This second inhibitory mechanism is 
responsible for inhibition by both Ca2+ and Mg2+. The high and low affinity Mg
2
+ 
inhibition mechanisms operate independently. 
1.2.6.4 Adenine nucleotides 
Physiologically, ATP enhances Ca2+ -induced Ca2+ release in both skeletal and cardiac 
muscle ( Kermode et al., 1998; Laver et al., 2001). It is more likely that Mg
2
+ -ATP is 
the physiological regulator of the RyR, as most of the ATP found intracellularly is 
complexed by Mg2+ (Meissner et al., 1986a; Rubtsov and Batrukova, 1997). ATP has 
been shown to increase Ca2+ release from SR vesicles (Meissner, 1984) and activate 
single RyRs, in the presence (Meissner, 1986b; Moutin and Dupont, 1988) or absence 
(Smith et al., 1986) of µM Ca2+. Other adenine nucleotides, such as ADP, adenine 
AMP-PCP, AMP-PNP and cAMP, have been reported to have similar effects in skeletal 
muscle (Morii and Tonomura, 1983; Meissner, 1986b; Laver et al., 2001). These 
compounds are not as effective as ATP at activating the channel. Since RyR activation 
is not specific for ATP, the mechanism by which adenine nucleotides act is not 
phosphorylation, but by ligand binding of adenosine to sites on the RyR. The consensus 
14 
Chapter 1 
sequence for the ATP binding site on the skeletal RyR, which is thought to 
encompasses residues Gly4449 - Gly4454 and Gly4452 - Gly4457 (Zorzato et al., 1990), 
remains to be confirmed by mutagenesis or binding studies. 
1.2.6.5 Ryanodine 
Ryanodine regulates RyRs by binding to the channel preferentially when it is in the 
open state (Meissner, 1986b ). Channel modulation is biphasic, with activation occurring 
at nM concentrations, whilst the channel is inhibited by concentrations greater than 100 
µM (Lai and Meissner, 1989; McGrew et al., 1989; Carroll et al., 1991 ). Callaway et al. 
(1994) suggested that both the high and low affinity binding sites, which are associated 
by either allosteric or steric coupling, are located in the C-terminal region, downstream 
of Arg 4475 , and near or within the membrane spanning region. 
1.2.6.6 Ruthenium red 
Ruthenium red, first shown to block mitochondrial Ca2+ transport (Moore, 1971 ), is a 
widely used RyR channel blocker. Ca2+ efflux from SR vesicles has been shown to be 
all but blocked in the presence of >20 µM cytoplasmic ruthenium red (Ikemoto et al., 
1985; Meissner, 1986b ), whilst Ma (1993) demonstrated that ruthenium red inhibits the 
single channel RyR at sub-µM concentrations (cytoplasmic). 
Initially, a scheme explaining ruthenium red binding predicted that two ruthenium red 
molecules were required to keep the channel in a closed state (Ma, 1993 ), similar to an 
acetylcholine receptor (Katz and Thesleff, 1957). Binding to the first site would induce 
initial closure, whilst the second molecule binding is responsible for long term 
inhibition (Ma, 1993). More recently, Xu et al. (1999) suggested that more than one 
mechanism existed for ruthenium red regulation of the RyR. The premise is that 
ruthenium red can inhibit RyRs (activated by Ca2+) by a non-competitive interaction 
between ruthenium red and the Ca2+_ Secondly, ruthenium red (both cytoplasmic and 
luminal) can induce substate activity, via a voltage dependant mechanism. This model 
dismisses any suggestion that ruthenium red may occlude the pore. 
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1.2.6.7 Phosphorylation 
RyR activity can be altered by phosphorylation of the RyR complex (Wang and Best, 
1992; Herrmann-Frank and Varsanyi, 1993; Hain et al., 1994; Sonnleitner et al., 1998). 
In skeletal RyRs, Ser 2843 has been reported to be phosphorylated in vivo (Suko et al., 
1993; Varsanyi and Meyer, 1995). Dulhunty et al. (2001) report that the enhancement 
of RyR single channel activity upon application of ATP is partially due to channel 
phosphorylation by calmodulin kinase 2 (CaMKII). Besides Ser 2843 , many other 
residues are theoretically able to undergo phosphorylation (Ser, Thr, Tyr). Triadin and 
the histidine rich Ca2+ binding protein (HRC) contain numerous Ser, Thr, Tyr residues, 
are likely candidates for phosphorylation by a membrane bound CaM protein kinase 
(CaM-Pki; refer to Section 1.5.2 and 1.7.2.1). Whilst the presence of this particular 
kinase has not been established, phosphorylation of these associated proteins cannot be 
ruled out as a possible cause of RyR activation by ATP-induced phosphorylation. 
1.3 DHPR 
The DHPR, named for its affinity for a class of compounds known as dihydropyridines, 
is found embedded in the t-tubule membrane of muscle. As previously mentioned, the 
DHPR is an L-type Ca2+ channel (Tanabe et al., 1987), which is a voltage dependent 
cation channel. Only a small percentage ofDHPRs in skeletal muscle actually function 
as Ca2+ channels (Dulhunty, 1992 and references therein), and as voltage sensors. 
1.3.1 Structural 
The skeletal muscle DHPR, having a molecular mass of~ 390 kDa, consists of four 
subunits, a 1, a 2-8, y and~ (Dulhunty, 1992 and references therein). Functionally, al is 
most important, containing the Ca2+ binding motif, the voltage sensor and the central 
ion channel (Tanabe et al., 1987; Tanabe et al., 1988; Adams et al., 1990; Tanabe et al., 
1990). There is significant sequence homology between the a 1 subunit and the voltage 
dependent sodium channel (Takahashi et al., 1987). Containing extensive hydrophobic 
do1nains, a1 also houses the sites for dihydropyridine binding, and a consensus 
sequence for the phosphorylation site for cAMP-dependent protein kinase (Takahashi et 
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al., 1987)_ The cx 1 subunit contains approximately 2000 residues that are organized into 
four domains, each containing six transmembrane segments (S 1-S6; Catterall , 2000 and 
references therein) _ The a 2 subunit, which has a limited membrane domain, binds 
lectins and forms a disulfide-linked dimer with the 8 subunit (whose role in DHPR 
assembly or channel function is not \Yell understood; Takahashi et al_, 1987)_ The µ 
subunit contains another cAMP-dependant protein kinase consensus sequence and is 
thought not to be embedded in the membrane, but linked intracellularly to a 1 _ The ~ 
subunit, along with the a 1, contributes to a functional coupling between the DHPR and 
the RyR (Beurg et al_, 1999)_ They subunit, which also interacts with cx 1, contains four 
transmembrane domains (Takahashi et al_, 1987)_ 
1.3.2 Essential regions of DHPR for skeletal ECC 
S5 and S6, the fifth and sixth a 1 intramembrane segments of each of the four repeats of 
the membrane spanning domain, and the membrane-associated loop formed between 
them, line the pore of the DHPR Ca2+ channel, whilst the voltage sensor is contained 
within S4 (the fourth intramembrane segment; Catterall, 2000 and references therein)_ 
The cytoplasmic loop between the second and third domain, termed the II-III loop 
( encompassing Lys 720 - Glu 765 ), has been reported to be essential for both skeletal-type 
ECC and responsible for retrograde signal transduction - whereby an interaction 
between the RyR and the DHPR increases the Ca2+ current through the DHPR (Nakai et 
a/_, 1998; Grabner et al_, 1999)_ The application of synthetic peptides in single channel 
and 3HRy binding studies has led to hypotheses about the interactions between the RyR 
and the DHPR, particularly the II - III loop. Peptide A - DHPR residues 
Thr 671 - Leu 690 - has been shown to both activate and inhibit RyR activity ( dependent 
on voltage), with channel activation thought to represent a physiological binding of the 
II-III loop ( el Hayek et al_, 1995; Dulhunty et a/_, 1999)_ Further downstream, peptide C 
(Glu 724 - Pro 760) has been reported to inhibit peptide A-induced RyR activity (Saiki et 
a/_, 1999; Haarman et a/_, 2000), and inhibit depolarisation - induced tension in skinned 
fibres (Lamb et al., 200 I b ). Applied alone, peptide C was able to activate and inhibit 
channel activity at low and high concentrations respectively (Haannan et al., 2000) _ 
Physiologically, interactions of DHPR ll-III loop regions corresponding to these two 
peptide sequences may regulate the RyR Ca2+ channeL Initi all y, it was proposed that at 
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rest, the II-III loop site corresponding to peptide C is bound, rendering the RyR 
relatively inactive (Saiki et al., 1999). Upon depolarisation, this interaction is removed, 
allowing the residues of the II-III loop corresponding to peptide A to interact, resulting 
in SR Ca2+ release. More recently, the Ca
2
+ concentration-dependant activation and 
inhibition of the RyR by peptide C (Haarman et al., 2000) has led to the proposal of two 
alternate hypotheses (Yamamoto et al., 2002). Firstly, peptide A has no functional role 
in ECC in vivo, and upon depolarisation ( at low Ca2+) peptide C activates the RyR, and 
inhibits ECC at higher [Ca2+]. Alternatively, areas of the II-III loop corresponding to 
both peptides A and C contribute to activation at low [Ca
2+] (rest), and hence trigger 
ECC. The inhibitory action elicited by II-III loop peptide C region as [Ca
2+] rises is 
enough to inhibit ECC (Mouton et al., 2001). 
1.4 CSQ 
CSQ is a Ca2+ binding protein, located wholly within the lumen of the SR (Yano and 
Zarain-Herzberg., 1994). CSQ has both a moderate affinity (Kt = 1 mM) and a high 
capacity for Ca2+ (50 mmol/mmol CSQ; MacLennan and Wong, 1971; MacLennan et 
al., 1983). The main role of CSQ is to sequester Ca2+ and to provide a large pool of Ca
2
+ 
for release via the RyR, from the SR into the myoplasm. 
1.4.1 CSQ genes 
CSQ is found in all types of muscle; cardiac, skeletal and smooth (MacLennan and 
Wong, 1971; Ikemoto et al., 1972; Volpe et al., 1994), and has also been isolated in the 
cerebellum (Volpe et al., 1990) and in plant cells (Krause et al., 1989). Limited genetic 
information has been obtained about the smooth muscle and cerebellum isoforms of 
CSQ, but CSQ from both cardiac and fast twitch skeletal muscle ( denoted as skeletal 
CSQ from here on) have been isolated and characterized, and have been found to be 
coded by two different genes. The slow twitch muscle isoform is identical to cardiac 
CSQ (Scott et al., 1988; Fliegel et al., 1989a). 
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1.4.2 Isoform and species homology 
The cardiac isoform of CSQ has been fully sequenced in six species; rabbit , human, 
mouse, chicken, rat and dog (Slupsky et al., 1987; Scott et al., 1988; Park et al. , 1998; 
Rodriguez et al., 1999), and the skeletal isoform has also been sequenced in six species; 
rabbit, human, mouse, chicken, rat and frog, (Fliegel et al., 1987; Yazaki et al., 1990a; 
Yazaki et al., 1990b; Treves et al. , 1992; Park et al., 1998). Table 1.1 shows identity 
between each sequence, presented as % homology. Of particular interest are the most 
extensively studied isoforms (in terms of RyR regulation); rabbit skeletal and canine 
cardiac, and their comparison with the human isoforms (Fig. 1.3 ). Amino acid sequence 
alignment reveals a 95% identity between rabbit and human skeletal CSQ, whilst dog 
cardiac and the human cardiac isoforms are not so highly conserved (83 % identity; see 
Fig 1.3). Rabbit skeletal and dog cardiac also CSQ share an 83% identity (Fig 1.3). 
Such homology allows function inference between species and isoforms. 
1.4.3 Crystal structure 
The crystal structure of CSQ was solved for rabbit skeletal muscle (Wang et al. , 1998). 
Monomeric CSQ has three almost identical domains - domains I, II and III - with each 
domain containing four a - helices, two bordering either side of the core ~-sheet (Wang 
et al., 1998). It is proposed that folding and compaction of CSQ is promoted by 
physiological [Ca2+] and [K+] (Wang et al., 1998). He et al. (1993) first reported the 
requirement of a compact, polymerised CSQ for high capacity Ca2+ binding; 
polymerisation is achieved by two interactions, the back-to-back dimer and the 
front-to-front coupling (Wang et al., 1998). The first interaction (back-to-back) forms a 
dimer, thought to be initiated by a small increase in [Ca2+] (the levels of which have not 
been identified). After formation of the back-to-back dimer, it is proposed that another 
small increase in [Ca2+] induces the second interaction (front-to-front). The front-to-
front interaction involves the coupling of back-to-back dimers , more specifically, an 
interaction between one CSQ molecule from one dimer, with a CSQ molecule from 
another dimer, which results in CSQ polymerisation (Figs. 1.4 and 1.5). 
Several interactions help stabilize and maintain both dimer and polymer formation. The 
back-to-back interaction is stabilized by intermolecular interaction between domain II 
(a-helix 4) and domain I (a-helix 3). Salt bridges between Glu215 and Lys86 , Glu215 and 
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Rat Rat Chicken Dog Frog Mouse Mouse Human Human Rabbit 
cardiac skeletal skeletal/ cardiac skeletal cardiac skeletal cardiac skeletal cardiac 
cardiac* 
Rabbit skeletal 75 82 85 83 86 82 98 86 98 83 
Rabbit cardiac 89 97 94 98 85 96 84 96 82 
Human skeletal 74 80 83 82 85 80 97 84 
Human cardiac 87 94 . 93 83 86 84 87 
Mouse skeletal 76 82 86 86 87 83 
M ouse cardiac 91 98 93 97 86 
Frog skeletal 79 85 86 86 
Dog cardiac 90 97 94 
Chicken skeletal/cardiac* 85 92 
Rat skeletal 91 
T able 1. 1 Amino acid homology(%) between all reported fu ll CSQ sequences (excluding the signal peptide). Homology was calcul ated 
using BioEdit sequence alignment editor (version 5.0.6), using the following published protein sequences (access ion number in italics) ; Rabbit 
skeletal A2587; Rabbit cardiac JQJ 396; Hun1an skeletal XP00J 278, Human cardiac XP0J0544 ; Mouse skeletal NP033943; Fro g skeletal 
S22418; Dog cardiac A2807 l, Chicken skeletal/cardiac A31050; Rat skeletal NP058827, Rat cardiac AAB58746. 
*Chicken skeletal and cardiac CSQ share identical mRNA and protein sequence. 
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Fig. 1.3. Comparison of CSQ amino acid sequence from rabbit skeletal, canine cardiac and human skeletal and cardiac isoforms (excluding the 
signal peptide). Sequence alignment was prepared using Bioedit graphical biological sequence editor. Conserved residues are listed purple, whilst 
resides that are unconserved between species and isoform are in blue. Identical amino acids are in black. Amino acid position is listed below the 
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Lys24, and Glu169 and Lys85 help stabilize this formation (Fig 1.4). In addition, there is 
an interaction between the dihydrobasic sequence (a sequence found in other Ca
2+ 
binding proteins; Blumenthal et al., 1985), and a binding site for the antipsychotic drug, 
trifluroperazine. The interaction was first thought to be involved in intramolecular 
binding and folding. It now is thought to occur between two CSQ molecules. This 
interaction involves salt bridge formation between Lys
85 and Glu223 and Lys86 and 
Glu215 (Fig 1.4). Salt bridges, formed between Glu55 and Lys
49 stabilize the 
front-to-front interaction and involve residues from two a-helices, both from domain I. 
In conjunction with various interaction between domains I and III from different CSQ 
molecules, the final polymer is formed (Fig 1.5; Wang et al., 1998). 
The front-to-front interaction occurs with the insertion of the N-termin>$of CSQ of one 
dimer into the hydrophobic cleft of the second dimer. Wang et al. ( 1998) propose that 
CSQs N-terminus is responsible for anchoring CSQ to triadin and junctin, so when CSQ 
is polymerised ( considered its physiological form), no interaction with the anchoring 
proteins would be possible. Recent evidence suggests that it is the C-terminus 
(Glu354 - Asp367) and not the N-terminus that couples CSQ and triadin, so even if CSQs 
N-terminus has been buried upon polymerisation, a CSQ/triadin interaction may still 
occur (Shin et al., 2001 and see section 1.8.6). 
1.4.4 Conformational changes in CSQ 
Ikemoto et al. (1972) first observed a conformational change in CSQ induced by Ca
2+ 
binding, which has been confirmed by others (MacLennan and Wong, 1971; Ikemoto et 
al., 1972; Cala and Jones, 1983; MacLennan et al., 1983; Cozens and Reithmeier, 1984; 
Slupsky et al., 1987; Wang et al., 1998). When devoid of Ca
2+, CSQ structure is mostly 
random coil, with approx 11 % a-helix. Upon Ca
2+ binding, asymmetry of the protein 
decreases (Cozens and Reithmeier, 1984), whilst a-helical content increases (Ikemoto 
et al., 1972; Ikemoto et al., 1974; Ostwald et al., 1974). Besides Ca
2+, other cations are 
able to bind to and induce conformational changes in CSQ. These include Mg
2+, K+ and 
Zn+ (Ikemoto et al., 1972; Ikemoto et al., 1974; Ostwald et al., 1974; Baksh et al., 
1995). Exposure to 1 M KCl induces a radical change in a-helical content, with a shift 
of up to 19% (Ikemoto et al., 197 4 ). Both Mg2+ and Zn2+ induce minor changes in CSQs 
conformation (Ostwald et al., 1974; Baksh et al., 1995). 
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Fig. 1.IV. Formation of the CSQ aggregate. (A). Dimer formation 
showing the first dimer formed, a back-to-back association and (B) the 
subsequent polymer formation, which induces CSQ aggregation, the 
front-to-front interaction. (C) Ribbon representation of the interaction 
of the dihydrobasic sequence from monomer one (blue) with the 
trifluroperazine binding site for monomer two (green). These 
interactions, stabilized by salt bridge formation, between Lys 85 and 
Glu 223 and Lys 86 and Glu 215 which contribute to the stability of the 
back-to-back dimer (from Wang et al. , 1998). 
Fig. 1.V. Formation of the CSQ aggregate. The formation of front-to-
front interaction, between two CSQ molecules, already in back-to-back 
dimer formation, induces the CSQ polymer. The interaction between 
the CSQ molecules in yellow and red are back-to-back, whilst front-to-
front interactions are depicted between molecules in blue and yellow, 
and red and green (from Wang et al., 1998) 
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Ca2+ binding to cardiac CSQ induced a 2-fold increase in sedimentation coefficient 
(indicative of a more compact protein structure) and a loss of hydrophobicity (Mitchell 
et al. , 1988). Coupled with the inability of several proteases (including trypsin) to digest 
the Ca2+-bound protein, these data suggest a Ca2+ -induced compaction, allowing both 
the sites that are susceptible to proteolysis, as well as the hydrophobic sequence to be 
buried (Mitchell et al., 1988). Presumably, protection of arginine and lysine residues 
(which trypsin cleaves) occurs when these residues are buried, as CSQ becomes more 
a-helical (Cozens and Reithmeier, 1984; Ohnishi and Reithmeier, 1987). 
1.4.5 Binding of Ca2+ and other ions 
The Ca2+ binding properties of rabbit skeletal CSQ have been reported by various 
laboratories. Mac Lennan and Wong ( 1971) reported Ca2+ binding to be 970 nmol/mg 
CSQ, with a KJ of 40 µM~ whilst Meissner et al. (1973) reported a similar binding 
(900-1000 nmol/mg), but a KJ of approximately 4 µM. Extreme differences in KJ in the 
presence of 100 mM KCl have been reported; Ca2+ binding remained constant, whilst 
the KJ was 800 µM (MacLennan, 1974; Ostwald et al., 1974) and 1.3 µM (Ikemoto et 
al., 1972). Similar Ca2+ binding is reported in dog cardiac CSQ (Mitchell et al., 1988) -
between 800 and 900 nmol/mg protein. Ca2+ specificity is quite low, with a number of 
other ions able to compete for the Ca2+ binding site (Ikemoto et al., 1974). Ikemoto et 
al. (1974) reports the order of affinity for various cations binding to CSQ as La3+ > Zn2+ 
Cd2+ M 2+ C 2+ M 2+/S 2+ K+ . h . . (M-1) . fi > > n > a > g r > , wit association constant ranging rom 
3 .3 * 105 (La3+) to 4 (K+). 
Ca2+ binding by CSQ is thought to require only a pair of acidic residues and is driven by 
a gain in entropy (Krause et al., 1991 ). Between 18 and 50 sites for Ca2+ binding per 
CSQ monomer have been predicted (Mac Lennan and Wong, 1971 ; Ikemoto et al. , 
1974; Meissner, 1974; Slupsky et al., 1987), but current opinion is that there are 31 
Ca2+ binding sites for rabbit skeletal muscle CSQ (in the case of rabbit skeletal muscle, 
Ca2+ binding would involve 62 of the proteins 367 amino acids; Krause et al. , 1991 ). 
Rabbit skeletal CSQ is a highly acidic glycoprotein - having between 33 and 46% 
acidic residues ( depending on both isoform and species), and forming no less than 21 
clusters of doublets or triplets (Yano and Zarain-Herzberg. , 1994 and references 
therein). The acidic C-terminus 
(354 Glu-Asp-Asp-Asp-Asp-Glu-Asp-Asp-Asp-Asp-Asp-Asp-Asp-Asp367) is purported 
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to be responsible for 26% of the Ca2+ binding and to be the site for triadin binding in 
rabbit skeletal muscle (Shin et al, 2001). The C-terminus differs in length between 
isoforms. Both the rabbit and human skeletal isoforms have a shorter stretch of acidic 
residues (14 and 9 respectively), compared to dog (38) and human cardiac (26), 
although these differences are not reflected by significant changes in CSQs Ca2+ 
binding capacity. Therefore, the C-terminus may not be the major Ca2+ binding site. 
A peptide corresponding to the C-termintijof rabbit skeletal CSQ (Thr302 -Glu359), 
showed an increased Ca2+ binding capacity (2 µmol/mg peptide), when compared with 
native CSQ (,..., 1 µmol/mg CSQ; Ohnishi and Reithi11eier, 1987). Ca2+ binding sites were 
presumably exposed in this Asp/Glu-rich peptide that were not accessible, or were 
hidden in the intact protein. To account for the reduced Ca
2
+ binding capacity of intact 
CSQ (when compared to that of the C-terminal peptide), the authors suggest that Ca2+ 
binding to the C-terminus signals the conformational change seen in intact CSQ (from 
Thr302 -Glu359), which then buries Ca2+ binding sites. These buried sites remain exposed 
in the truncated C-terminal peptide (Ohnishi and Reithmeier, 1987), and therefore more 
Ca2+ can bind to the peptide. 
CSQ binds Mg2+ with a lower affinity than Ca2+ (Ikemoto et al., 1974). In the presence 
of mM Mg2+, CSQ binds only 23 Ca2+ ( compared with 31 when Mg2+ is absent). The 
shift in heat production obtained experimentally after Ca
2
+ binding in the presence of 3 
mM Mg2+ (AH0 ca2+ (+Mg2+)) is quite different to the theoretical value calculated assuming 
a direct competition between Ca2+ and Mg2+ at a single binding site. The measured 
AHca - AHMg was-15kJ/protein, while the theoretical value was + 11.1 kl/protein 
(Krause et al., 1991 ). The difference between the theoretical and experimentally 
obtained AH0 ca2+ in the presence of Mg2+ suggests two distinct binding sites for Ca
2
+ 
and Mg2+ although this does not account for the loss of Ca
2
+ binding upon Mg2+ 
addition. It may be that there is a direct competition for some binding sites (so the site is 
capable of binding both Ca2+ and Mg2+) and separate binding at other sites. 
Addition of Ca2+ induced an increase in intrinsic fluorescence in CSQ at neutral pH 
(inferring a Ca2+-dependant conformational change in the protein), which WC(,not 
observed at the more acidic pH of 6.0 (Hidalgo et al., 1996). Varying pH from 8 to 6 
resulted in a decreased heat production, and as binding of Ca
2
+ to CSQ is mainly 
entropy driven (Krause et al., 1991 ), these results suggest that a slightly acidic pH 
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abolishes the Ca2+ -induced conformational changes in the protein. A physiological role 
of pH-induced changes in CSQ con:firmation has not yet been established, although it 
has been proposed that a counterflow of protons ( compensating for a loss of Ca2+ during 
SR Ca2+ release during muscle contraction), may lower luminal pH and prevent CSQ 
from binding Ca2+, resulting in CSQ unfolding (Hidalgo et al., 1996 and references 
therein) 
1.4.6 Effects of Ca2+ dependent conformational changes in 
CSQ 
The regulation of the RyR by luminal Ca2+ concentration (see Section 1.2.6.2) is likely 
to be a combination of activation/inhibition of the RyR by luminal Ca2+ binding directly 
to the RyR complex and luminal Ca2+- dependent changes in CSQ, which alter the 
influences of CSQ on RyR activity.(Kawasaki and Kasai, 1994; Donoso et al. , 1995; 
Ohkura et al., 1995). Ikemoto et al. (1989) reported conformational changes within JFM 
proteins (not CSQ) when Ca2+ was raised from <µM to 10 mM. This conformational 
change was not observed in JFM preparations where CSQ was absent. 
The hypothesis that Ca2+ binding to CSQ alters CSQ protein conformation, activating 
Ry Rs and thus inducing RyR Ca2+ release (in contrast to a direct effect of luminal Ca2+ 
on the RyR) was proposed by Donoso et al. (1995). SR Ca 2+ release is most sensitive 
to luminal Ca2+ over the same range of Ca2+ (0.025-2 mM) that induces substantial and 
reversible conformational changes in CSQ (Ikemoto et al., 1989; He et al., 1993; 
Donoso et al., 1995). The precise nature of the transmission ofluminal [Ca2+] to the 
RyR by CSQ is yet to be determined 
1.4.7 CSQ phosphorylation 
Whether or not skeletal CSQ exists in vivo in its phosphorylated form is still debated. 
On one hand, Varsanyi and Heilmeyer (1980) reported the autophosphorylation of CSQ 
and Campbell and Shamoo (1980) found that CSQ was phosphorylated in SR 
preparations, suggesting that it is phosphorylated in vivo. Alternatively, Cala and Jones 
( 1991) found that isolated cardiac CSQ contained no significant endogenous inorganic 
phosphate (Pi), indicating that it is not phosphorylated. 
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The phosphorylation state of CSQ is important in the regulation of purified RyRs by 
CSQ. There was one report that suggests that dephosphorylation of CSQ by as little as 
1 % can increase purified channel activity (Szegedi et al., 1999). This effect was [CSQ] 
dependant; the highest activity observed was after addition of 20 µM dephosphorylated 
CSQ (the highest concentration studied). 
Meggio et al. (1981) first showed that casein kinase II (CK 11) promoted CSQ 
phosphorylation. CK II, a protein kinase present in all eukaryotic cells (Pinna, 1997), 
consists of two p subunits (which are tightly connected) and two a/a' subunits. This 
acidophilic hetrotetramer specifically targets and phosphorylates serine/threonines (but 
preferentially acts on serine; Marin et al., 1986; Kuenzel et al., 1987), although recent 
reports have shown it can also target tyrosines (Marin et al., 1999b ). A higher rate of 
phosphorylation is reported for residues that are flanked by three acidic amino acids on 
either side, compared to those that have such residues located on the C-terminal tail 
(Kuenzel et al., 1987). CK.II phosphorylation of the target protein requires a minimal 
sequence of Ser/Thr-X-X-Asp/Glu, with the negatively charged asparagine/glutamates 
( at position n+ 3, where n is the Ser/Thr) being critical for targeting (Meggio ei al., 
1994). The presence of at least two acidic residues flanking the serine/threonines results 
in a higher rate of phosphorylation (Meggio et al., 1994). 
Whether CK II is found within the SR lumen is not established (Varsanyi and 
Heilmeyer, 1980; Cala and Jones, 1991; Shoshan-Barmatz et al., 1996b), although 
Shoshan-Barmatz et al. (1996b) provide some evidence that CK II might be located on 
the luminal side of the SR. CK II and other kinases are thought to exist in the 
cytoplasm, so that phosphorylation of CSQ, SLM and HRC may · - occur before 
targeting to the SR. The location of CK II or other kinases in the SR, would support the 
hypothesis that RyR activity may be altered by phosphorylation of luminal co-proteins, 
such as CSQ, HRC and sarcalumenin (SLM). 
ATP is essential for CSQ phosphorylation by CK II or any other kinase. At least two 
possible pathways for ATP transport into the SR have been reported. Shoshan-Barmatz 
et al. ( 1996a) illustrated that an SR membrane voltage-dependant anion channel 
(VDAC) may transport ATP into the SR, hence providing the Pi required for CK II 
phosphorylation (if in fact CK II exists in the SR) of the three Ca2+ -sequestering 
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proteins CSQ, HRC and SLM; see also Section 1.7.2). Alternatively, (Laver, 2001) 
propose that a small chloride channel (SCI) channel may transport ATP into the SR. 
Varsanyi and Heilmeyer ( 1979) first suggested that rabbit skeletal CSQ has protein 
kinase properties. Furthermore, CSQ has the ability to autophosphorylate (Varsanyi and 
Heilmeyer, 1980). This was demonstrated by pre-incubating CSQ with protein kinase, 
which resulted in an approximately 10-fold increase in phosphorylation, raising V max 
from 3.7 to 37 pmol.min-1.mg-1. The phosphorylation sites on CSQ have not been 
unambiguously identified. 
After sequencing fast-twitch skeletal rabbit CSQ, Fliegel et al. (1987) proposed two 
potential sites for phosphorylation, Thr189 and Thr229. Neither of these residues has the 
required acidic amino acid at n + 3, and therefore does not contain the minimal 
consensus sequence for phosphorylation by CK II (Fliegel et al., 1987; Meggio et al., 
1994). It may be that in vivo, these two residues are phosphorylated by some other 
kinase, such as casein kinase I (CK I) or £ protein kinase C 1, for which CSQ is also a 
substrate in vitro (Salvatori et al., 1994; Rodriguez et al., 1999) or are involved in 
autocatalytic phosphorylation. Neither CK I f\ef £ protein kinase C 1 have been shown to 
exist within the SR and the role that they may play in CSQ phosphorylation is not 
understood, although it is possible that CSQ may be phosphorylated by CK I and/or£ 
protein kinase C 1 whilst in the ribosomal form (before targeting to the SR lumen; 
Rodriguez et al., 1999 and references therein). The first major study to identify which 
CSQ residues were phosphorylated was by Cala and Jones (1991). Both cardiac 
(canine) and skeletal (rabbit) CSQ contain several repeats of the minimal structure 
required for CK II phophorylation in their C-terminal region. It was found that Ser378, 
Ser382 , Ser 386 (cardiac) and Thr353 ( skeletal) could be phosphorylated by CK II. Cardiac 
CSQ was phosphorylated more rapidly than the skeletal isoform, (V max 240 nmol.min-
1.mg-1 in cardiac, compared with 0.17 nmol.min-1.mg-1 in skeletal), which has been 
attributed to CK IIs preference for serine over threonine, and the position of three acidic 
residues in relation to the phosphorylated residue. In comparison, the calculated · 
V max of rabbit skeletal CSQ is 0.4 nmol.min- 1.mg-1 CSQ (CK II) and 0.9 nmol.min- 1.mg-
1 CSQ (CK I). 
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1.4.8 Targeting of CSQ to lumen 
The luminal retention of endoplasmic reticulum proteins, such as calreticulin and 
protein disulfide isomerase, are dependent on the presence of a C-terminal sequence 
Lys-Asx-Glu-Leu, which allows recycling from pre-Golgi to G-.olgi apparatus (Munro 
and Pelham, 1987; Nori et al., 1999). This motif is absent from all isoforms of CSQ, so 
that the mechanism for CSQ ~ : ~;egregation in the lumen is a mystery. Originally, it 
seemed likely that JSR proteins triadin and junctin may be responsible for the 
segregation of CSQ to the lumen. Both triadin and junctin bind to CSQ and are integral 
luminal proteins. Deletion of the acidic C-terminus, (the probable binding site on CSQ 
for triadin), did not alter CSQ segregation or expression in rabbit skeletal myoblast 
deletion mutants, thus negating the hypothesis that triadin is responsible for luminal 
retention of CSQ (Nori et al., 1999; Nori et al., 2001a). 
Recognition sites within the protein, involving post-translational changes such as 
phosphorylation and glycosylation, are not responsible for CSQ targeting to the lumen. 
Nori et al. (2000) and Nori et al. (2001b) have shown that deletion of the glycosylation 
site and site-directed mutagenesis of the known phosphorylation site and potential site
s 
indicated by Fliegel et al., 1989b of CSQ, did not alter targeting to the SR lumen. 
1.4.9 Overexpression of CSQ 
The development of a cardiac CSQ overexpression mouse model was prompted by the 
observed association between cardiac hypertrophy and an impairment of SR Ca
2
+ 
handling. It was thought that since CSQ is the major Ca
2
+ storage protein found in SR 
(MacLennan et al., 1983; Yano and Zarain-Herzberg., 1994), alterations in CSQ 
expression may be associated with certain cardiomyopathies. Hypertrophy indicates an
 
increase in internal workload (which could occur with inefficient Ca
2
+ handling) and 
which if sustained, may induce heart failure (Sato et al., 1998). 
Mouse hearts overexpressing canine cardiac CSQ developed severe hypertrophy and 
heart failure (Jones et al., 1998; Wang et al., 2000). The RyR, triadin andjunctin were 
all down-regulated and CSQ overexpression resulted in an impairment of Ca
2
+ -induced 
Ca2+ release, and decreased Ca2+ spark frequency (Jones et al. , 1998; Wang et al., 
2000). In contrast, mice overexpressing murine CSQ showed no down regulation of the 
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RyR, triadin or junctin expression, but similar to the model of canine cardiac CSQ 
overexpression, showed both hypertrophy and impaired Ca2+-induced Ca2+ release (Sato 
et al. , 1998). The relevance of altered expression of other proteins with canine CSQ 
over-expression is not known, but it is likely to contribute to changes in Ca2+ signalling. 
These studies illustrates CSQs integral role in establishing Ca2+ homeostasis by 
modulating Ca2+ load and release b7 ~he SR. Whilst in human heart failure , no 
alteration of CSQ expression has been detected, this model may be a valuable tool in the 
study of heart failure prevention by improving Ca2+ homeostasis ( due to an increase in 
Ca2+ storage capacity) and metabolism (Knollmann et al. , 2000). 
1.5 Triadin 
Brandt et al. (1990) first described a unique 95 kDa glycoprotein, later named triadin, 
found embedded in the SR membrane. This was later characterized as an intrinsic 
membrane protein located within the terminal cistemae, capable of forming a disulfide 
linked complex, between triadin monomers (Caswell et al. , 1991). A 94 kDa terminal 
cistemae glycoprotein, also able to form polymer disulfide bonds has also been 
described (Knudson et al., 1993a). Both triadin and the 94 kDa protein are almost 
absent in the t-tubule and non-junctional SR, prompting the authors to suggest that both 
these protei~were identical. 
Skeletal muscle triadin contains 706 amino acids (Knudson et al. , 1993a; Knudson et 
al. , 1993b ). The first 4 7 N-terminal amino acids are cytoplasmic, with the bulk of the 
protein existing within the SR lumen. A single transmembrane a-helix consists of 20 
residues (Knudson et al., 1993a; Knudson et al. , 1993b; Marty et al. , 1995). Two 
cysteine residues , Cys 270 and Cys 671 , are proposed to form a disulfide-linked oligimer, 
whilst two potential glycosylation sites are located within triadins luminal domain 
(Knudson et al. , 1993b ). 
1.5.1 Isoforms 
Two cardiac triadin isoforms have been identified in canine cardiac muscle by SDS 
Page, one migrating at 92 kDa (triadin-3), and an isoforms that forms doublets of 35 
kDa and a doublet of 40 kDa (triadin-1 ; Kobayashi and Jones, 1999) Triadin-2, 
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proposed by Guo at al 1995, was not detected in canine cardiac tissue. Triadin-2 was 
originally proposed to be a form of triadin-1, resolving at 40 kDa, but recently studies 
shown the expression of both a glycosylated and de-glycosylated triadin (with 
mobilities of 40 and 35 kDa respectively), which arise from the same isoform (triadin-3) 
Only one skeletal isoform has been fully sequenced. The three cardiac isoforms arise 
from alternate splicing of one gene. All cardiac triadins are identical for the first 264 
amino acids, so only part of the luminal sequence of the proteins differs. For the first 
663 amino acids, triadin-3 is almost identical to the skeletal muscle isoform (besides 
missing Ala331 ). The major differences occur in the C-terminus, with triadin-3 missing 
the final 39 amino acids (Guo and Campbell, 1995). Cardiac triadin-3 is also missing 
Cys671 and does not forms a disulfide complex like cardiac triadin-1 and triadin-2 (Guo 
and Campbell, 1995), suggesting both disulfide linkages are required for 
oligimerization. 
The most abundant isoform in cardiac muscle is triadin-1, accounting for at least 95 % 
oftriadin isoforms (Kobayashi and Jones, 1999). The reason for the formation of a 
doublet (visible on gel electrophoresis as molecular masses of 35 and 40 kDa) is the 
partial glycosylation status of the protein, and the resultant alteration in mobility of the 
protein. When glycosylated, the 35 kDa protein is converted into the 40kDa protein, 
suggesting that only the 40 kDa protein is glycosylated (Kobayashi and Jones, 1999). 
In mammalian cardiac tissue, triadin-3 is minimally expressed (~%),whilst triadin-2 
was undetectable (Kobayashi and Jones, 1999). Like canine cardiac triadin, in mouse 
cardiac tissue three isoforms (splice variants of the same gene), have been determined, 
namely mouse triadin 1-3, having molecular weights of 35, 35.5 and 40 kDa, 
respectively (Hong et al., 2001). Mouse triadin-3 appears to be the glycosylated form of 
mouse triadin-2. 
1.5.2 Phosphorylation 
Triadin has been shown to undergo phosphorylation by CaM-Pki (Damiani et al., 1995). 
This enzyme was originally thought to phosphorylate the cytoplasmic side of the RyR, 
and RyR activity is altered by phosphorylation ( Wang and Best, 1992; Herrmann-Frank 
and Varsanyi, 1993; Hain et al., 1994; Sonnleitner et al., 1997; Dulhunty et al., 2001). 
It may be that CaM-Pki alters RyR activity via triadin phosphorylation, rather than, or 
in conjunction with, direct RyR phosphorylation. 
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1.5.3 Triadin overexpression 
A cardiac mouse model overexpressing triadin was developed to shed some light on the 
importance of triadin in ECC. Triadin overexpression results in hypertrophy, impaired 
relaxation and reduced contractility at low (i.e. below normal resting heart rate) 
frequency, and the reduced expression of junctin and the RyR (Kirchhefer et al., 2001). 
The authors note that whilst RyR protein expression was significantly reduced, 3HRy 
binding did not alter from wild type, suggesting that each RyR is activated more easily 
to compensate the reduced expression (Kirchhefer et al. , 2001). Unlike the CSQ 
overexpression model, triadin overexpression did not lead to heart failure or premature 
death, possibly due to the down regulation of junctin and the RyR or other 
compensatory mechanisms. The physiological role of triadin is hard to define from an 
overexpression model, due to the altered expression of other proteins. 
1.6 Junctin 
Junctin is an integral membrane protein, found in junctional SR membrane, and is 
proposed to provide a similar role to triadin as a membrane anchor for CSQ. Although 
only characterized in cardiac muscle (Mitchell et al. , 1988; Jones et al. , 1995; Zhang et 
al., 1997; Wetzel et al., 2000), junctin has been identified in skeletal muscle (Mitchell 
et al., 1988). 
Unlike triadin, junctin is not glycosylated and does not form a disulfide linked complex; 
cystine residues are absent in both the canine and human isoforms (Jones et al. , 1998; 
Wetzel et al., 2000). Junctin is a shorter protein than triadin, but has a similar 
membrane topology, with a single membrane spaning domain, a short 21 amino acid 
cytoplasmic terminus and a long, highly charged luminal tail (Jones et al. , 1995). The 
N-terminus, membrane-spanning region and first 58 luminal residues are highly 
conserved between species (Jones et al. , 1995; Zhang et al. , 1997; Dinchuk et al. , 2000; 
Wetzel et al. , 2000). The N-terminus has been hypothesized to contain the sites of 
interaction with triadin, CSQ and the RyR (Zhang et al. , 2001 ). Junctin associates with 
the RyR, triadin and CSQ within the lumen of the SR. No studies thus far have 
determined a regulatory action of junctin on any of these proteins (Zhang et al. , 1997). 
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1.6.1 Junctin overexpression 
Although functional effects of junctin on the RyR, triadin and CSQ have not been 
reported, overexpression of cardiac junctin results in abnormalities in muscle 
contraction, an overall narrowing of the junctional SR, compaction of CSQ and excess 
t-tubule-SR interactions, observed using electron microscopy (Zhang et al., 2001 ). 
These abnormalities might reflect junctins role as an anchor protein for CSQ, and the 
possibility that the short C-terminus has a role in facilitating a SR - t-tubules association 
is currently being evaluated (see Zhang et al., 2001). However, they may also be 
compensatory changes in response to the lack of junctin (for example, changes in 
expression levels of other proteins). 
1.7 Other Ca2+ binding proteins 
1.7.1 Calmodulin 
Ca.Ms role as a Ca2+ senor in most eukaryotic cells has been widely characterized. CaM, 
a 17 kDa protein associating with the RyR, in both a Ca
2+ bound (Ca2+CaM) and Ca2+ 
free (apoCaM) form (Yang et al., 1994; Tripathy et al., 1995), belongs to a family of 
Ca2+ detectors that contain EF hand sequences (Lewit-Bentley and Rety, 2000 and 
references therein). An EF hand binds Ca2+ within a loop structure, created by a 
helix-loop-helix (Lewit-Bentley and Rety, 2000 and references therein). Troponin C is 
an example of another Ca2+ binding protein containing an EF hand structure. Up to nine 
CaM binding sites on the RyR have been predicted (Takeshima et al., 1989; Zorzato et 
al., 1990; Menegazzi et al., 1994; Wagenknecht et al., 1994), although current 
consensus is that there is one CaM binding site per RyR subunit (involving residues 
3630-3637; Moore et al., 1999). Exogenous CaM can activate and inhibit RyR Ca
2+ 
release in a concentration-dependant manner; at nM Ca
2+ CaM increases Ca2+ release, 
whilst CaM inhibits Ca2+ release at mM Ca
2
+ (Tripathy et al., 1995). 
Single channel studies imply that RyR Ca
2
+ release is inhibited by a direct interaction 
with Ca2+ CaM (Fuentes et al., 1994). Apart from directly regulating RyR Ca
2+ release, 
CaM also stimulates Ca2+ uptake. In cardiac muscle, the Ca
2
+ -bound CaM activates 
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phosphorylation of phospholamban, thus increasing the rate of Ca-A TPase activity and 
Ca2+ uptake (Tada and Inui , 1983). 
1.7.2 Histidine-rich Ca2+ binding protein and sarcalumenin 
Other luminal Ca2+ -sequestering proteins have been shown to be substrates for 
phosphorylases. The histidine-rich Ca2+ binding protein (HRC), which is a 165 kDa 
transmembrane protein that shares many similarities with CSQ, and can be 
phosphorylated both on the cytoplasmic and luminal sides (Damiani et al., 1995; Orr 
and Shoshan-Barmatz, 1996). Sarcalumenin (SLM), is a 150 kDa protein, that is also 
involved in the luminal Ca2+ buffering system (Orr and Shoshan-Barmatz, 1996; 
Shoshan-Barmatz et al., 1996b ). Unlike CSQ, which is localized in junctional SR, HRC 
and SLM are distributed throughout the SR (Seiler et al., 1984; Leberer et al., 1990). 
Functionally, the roles of HRC and SLM are not well understood, but it is suggested 
that they may be responsible for non-junctional Ca2+ buffering ( Cal a et al., 1990). Both 
HRC and SLM are thought to modulate RyRs, in a phosphorylation-dependant manner 
( see Section 1. 7 .2.1 ), although no evidence of direct interaction with the RyR exists. 
The 53 kDa protein characterized by Leberer et al. (1989) appears to be a splice variant 
of SLM RNA. This variant is missing the second glycosylation site found in SLM and is 
capable of binding Ca2+. 
The CK II-induced phosphorylation of both SLM and HRC (which is a Ca2+-dependant 
process) inhibits both skeletal and cardiac RyR channel activity and the binding affinity 
for Ca2+ of the RyR (Orr et al., 1991; Shoshan-Barmatz et al., 1996b; Hadad et al., 
1999). Like triadin, the HRC can also be phosphorylated by CaM-Pki on the 
cytoplasmic side of the protein (see Section 1.5.2 and Damiani et al., 1995). 
1.7.3 Calreticulin 
Calreticulin is a member of the reticuloplasm family. It is considered to be a homo log of 
CSQ and is present in the endoplasmic reticulum of many proteins (Fliegel et al., 
1989a). Like CSQ, calreticulin binds Ca2+ with a high capacity; binding 20 - 50 mol 
Ca2+/mol protein (CSQ: 50 mol/mol), with a kDa of 1-4 mM (CSQ: 1 mM; Pozzan et 
al., 1994 and references therein) . Calreticulin has a similar molecular mass to CSQ ( 46 
kDa compared with 43-45 kDa, respectively) and originally the tissue distribution of 
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these two Ca2+ sequestering proteins was difficult to distinguish. Calreticulirls highly 
acidic C-terminus contains multiple doublet and triplets of negatively charged residues 
(Fliegel et al., 1989b ), and presumably is a region of multiple Ca
2
+ binding. Calreticulin 
was first sequenced in liver endoplasmic reticulum (Cala et al., 1990 and references 
therein) and is only found in trace amounts in skeletal muscle (Ostwald et al., 1974). It 
therefore probably plays only a minor role in luminal SR Ca
2
+ sequestering. 
1.7.4 90 and 100 kDa proteins 
The appearance of both a 90 and 100 kDa protein in cardiac muscle, identified as 
probable Ca2+ binding proteins by Stains-ALL (a stain specific for Ca
2
+ binding 
proteins), illustrates the potential of other Ca2+ buffers to playing a part in luminal SR 
Ca2+ homeostasis (Jones et al., 1979b; Jones and Cala, 1981; Cala et al., 1990). Any 
role played by these uncharacterised proteins is yet to be determined. 
1.8 Protein-Protein interactions 
1.8.1 RyRandDHPR 
The RyR and the DHPR are two proteins known to interact in ECC and there is 
particular emphasis at present in determining which residues of the RyR and DHPR 
interact with each other. In 1997, Y amazawa et al. ( 1997) showed that the presence of 
the RyR D2 region (in particular Thr1357-Pro1406), was essential for ECC, but not 
essential for eliciting RyR Ca2+ release (using electrically evoked and caffeine-induced 
[Ca2+]i measurements), although the substitution of the skeletal D2 region for the 
cardiac D2 sequence did not alter channel function. Although D2 is a region of high 
divergence between cardiac and skeletal RyRs, a stretch of four alternate negatively 
charged residues (skeletal Glu 1327 -Glu1333) is conserved in the cardiac D2 domain 
(Y amazawa et al., 1997) This suggests that the D2 region may not be responsible for 
functional differences between cardiac and skeletal ECC, as cardiac ECC requires Ca
2
+ 
influx through the DHPR, rather than a physical DHPR/RyR interaction. RyR3 does not 
contain the D2 region and is unable to mediate skeletal ECC, and does not contain the 
D3 region (Y amazawa et al., 1997). 
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Chimeric constructs of cardiac RyR with various inserts of the corresponding skeletal 
sequence showed two particular areas of the RyR responsible for normal RyR-DHPR 
coupling. The presence of Thr1635 -Phe2636 (found between regions D 1 and D2) in an 
otherwise cardiac sequence restored, and enhanced the retrograde signal (Nakai et al., 
1998; see Section 1.3.2 for the region of DHPR required for retrograde signalling). The 
replacement of cardiac region (Thr2659 -Tyr3720) with the corresponding skeletal region 
enhanced an already present retrograde signal (Nakai et al., 1998). In addition, Proenza 
et al. (2002) have shown that the sequence containing residues Gln1837-Asn2 168 ofRyRl 
help contribute to skeletal-type ECC (although are not essential). These studies 
illustrate. that regions of the RyR that interact with the DHPR are different in 
retrograde and orthograde (DHPR signalling of RyR Ca2+ release) signalling. 
Seemingly, various regions of the RyR are involved in functional coupling with the 
DHPR. 
1.8.2 RyR and triadin 
First shown to interact with the RyR by protein overlay (Brandt et al., 1990; Kim and 
Caswell, 1990), triadirls luminal domain was identified as the critical region required for 
triadin/RyR association (Guo and Campbell, 1995). Since this was published, triadin 
has also been reported to bind to the RyR in a Ca2+-regulated fashion; in the cytoplasm 
the interaction is optimal at< 1 OµM and abolished at higher [Ca2+] (Groh et al., 1999). 
Residues Asp 18 -Ser 46 are essential for binding of triadin to the RyR in the cytoplasm 
(Groh et al., 1999), although the specific binding sequence is not yet known. 
Single channel studies illustrate the role of triadin in RyR activity. Addition of triadin to 
the cytoplasmic side of bilayer-incorporated purified Ry Rs resulted in an almost total 
abolition of channel activity, indicating triadins ability to strongly inhibit RyRs by 
binding to the cytoplasmic domain (Ohkura et al., 1998). Triadin had no such affect on 
RyR activity when added to the luminal chamber (Ohkura et al., 1998), suggesting that 
any interluminal interactions do not regulate the RyR. It seems likely that triadin is 
bound to the RyR on both the cytoplasmic and luminal sides, although how this affects 
overall activity of the RyR is still unclear. 
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1.8.3 RyR and junctin 
A peptide corresponding to the luminal domain of junctin was found to bind to the 
purified RyR, but no interaction was observed with the small cytoplasmic terminus of 
junctin (Zhang et al., 1997). Ry Rs interaction with the luminal domain of junctin does 
not require the presence of Ca2+. Similarly, junctin and triadin can also bind to one 
another in a Ca2+ -independant manner (Zhang et al., 1997). 
1.8.4 RyR and SLM/HRC 
No physical interaction between the RyR and either SLM or HRC has been 
demonstrated. As both the SLM and the HRC are believed to modulate the RyR, this 
raising the possibility that their effects might be exerted through CSQ, triadin or junctin 
(the only other known luminal SR RyR-binding proteins), although such interactions 
have not been shown (Hadad et al., 1999). 
1.8.5 DHPR and Triadin 
Triadin was originally believed to provide a pathway for signal transduction between 
the DHPR and the RyR, since triadin was shown to associate with the DHPR, using an 
overlay assay (Brandt et al., 1990), whilst an antibody to triadin was reported to inhibit 
the slow phase of depolarisation-induced Ca
2
+ release through the RyR (Brandt et al., 
1990). 
Current opinion on membrane topology of triadin is that the relatively small number of 
residues existing in the cytoplasm are not substantial enough to mechanically couple the 
RyR and the DHPR (Knudson et al., 1993b; Marty et al., 1995). Knudson et al. (1993a) 
and Knudson et al. (1993b) suggest that the interaction reported by Brandt et al. (1990) 
was non-specific, and Guo and Campbell (1995) were unable to associate peptides 
corresponding to either the cytoplasmic or luminal triadin domains with the DHPR. Any 
hypothesis involving an interaction between the DHPR and triadin is still controversial 
and relies heavily on the existence of an extended cytoplasmic domain (Fan et al., 
1995), which is in conflict with the accepted membrane topology of triadin (which 
places only a short segment on the cytoplasmic side of the RyR). 
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1.8.6 CSQ and triadin 
The luminal region of skeletal triadin contains 46 basic residues, making it a prime 
target for anchoring the highly acidic CSQ to the SR membrane (Knudson et al. , 1993b; 
Guo and Campbell, 1995; Zhang et al., 1997). Indeed, skeletal CSQ associates with 
triadin in affinity chromatography experiments (Guo and Campbell, 1995), as does 
cardiac CSQ (Zhang et al., 1997). In cardiac triadin-1, the CSQ binding domain has 
been localized to a 25 amino acid Lys-Glu-Lys-Glu, known as the KEKE motif; this 
interaction being most stable at low [Ca2+] (Kobayashi et al. , 2000). Binding to any of 
the abundant charged residues of CSQ would create a so-called 'polar zipper', 
associating these two proteins and, since triadin binds to the RyR, CSQ would be 
tethered close to the channel. The association of skeletal CSQ with triadin is thought to 
be identical to that in cardiac muscle, since skeletal and cardiac triadin have similar 
binding motifs (Arg 210 - Lys 224). 
1.8.7 CSQ and junctin 
CSQ binding to junctin is Ca2+ -dependant to some degree; Zhang et al. ( 1997) found 
optimal interaction in the absence of Ca2+, although a significant interaction occurs even 
at mM Ca2+. It remains to be seen whether or not small fluxes in luminal Ca2+ occurring 
in the contraction/relaxation cycle may alter CSQ-junctin interaction. Although junctin 
has numerous KEKE motifs (the residues of triadin that bind to CSQ), no definitive site 
for CSQ binding has been identified (Kobayashi et al., 2000), and therefore the way in 
which junctin anchors CSQ remains unclear. 
1.8.8 Triadin and HRC 
The HRC ( see Section 1. 7 .2) forms a Ca2+ -dependant association with rabbit skeletal 
triadin (Kim and Caswell, 1990). HRC immunoprecipitation studies show that the 
HRC/triadin interaction is greatest in the absence of Ca2+ and is inhibited by [Ca2+] > 1 
mM (Lee et al. , 2001 ). Lee et al. (2001) have identified nine tandem repeats in the 
HRC, consisting of histidine-rich sequences, capable of aiding an association with 
triadin, whilst HR Cs binding site is found within residues Glu205 -Lys260 of triadin. This 
stretch of amino acids also contains the proposed CSQ binding KEKE motif. 
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1.9 RyR regulation by CSQ and CSQs role in ECC 
The regulation ofRyRs by CSQ is somewhat controversial and unresolved. An initial 
study by Kawasaki and Kasai (1994) showed that addition of CSQ to native RyRs 
(incorporated into lipid bilayers), previously exposed to high [EGTA ], caused a 
marginal increase in channel activity. Ohkura et al. (1995) and Ohkura et al. (1998) 
reported that CSQ significantly increased single channel P 0 • In contrast to other reports, 
Beard et al. (2000), Wang et al. (2001) and Beard et al. (2002) showed that increasing 
luminal [Ca2] to levels believed to disrupt CSQ-triadin-junctin interactions (Zhang et 
al., 1997; Beard et al., 2002), activated RyRs two-fold, suggesting that CSQ is a RyR 
inhibitor. Ohkura et al. ( 1995) conducted native RyR experiments seemingly in the 
absence of any luminal Ca2+ (luminal [Ca2+] was not clear in the report). It is thought 
that for CSQ to be attached to the RyR (via junctin and triadin) [Ca
2+] should be 
between 0.01 - 1 mM (Zhang et al., 1997; Wang et al., 1998). This suggests that the 
reported increase in channel activity seen by Ohkura et al. (1995) after the addition of 
CSQ, may not be due to the tethering of CSQ to the RyR by triadin and junctin. The 
effect may have been due to a direct RyR-CSQ coupling, shown to activate ryanodine 
receptors (Herzog et al., 2000; Szegedi et al., 1999). There had been no systematic 
study of the interaction between CSQ and native RyRs at the time the work for this 
thesis commenced. 
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MATERIALS AND METHODS 
Chapter L 
2.1 Materials 
The polyclonal anti-CSQ antibody was obtained from Swant Chemicals (Switzerland), 
whilst the monoclonal anti-triadin antibody was kindly donated by Professor Kevin 
Campbell, Howard Hughes Medical Institute, University of Iowa College of Medicine, 
Iowa City, Iowa, USA. The anti-sheep, anti-rabbit HRP, and alkaline phosphatase 
antibodies were purchased from Proscitech (Thuringowa, Australia) and Amersham 
(Baulkam Hills, Australia). All Nunc Immunoplates and PVDF membrane were 
obtained from Millipore (Lane Cove, Australia). The high and low molecular weight 
markers, Silver Stain Plus kit, Novex dry ease mini cellophane and Bio-Rad 
O c© protein 
assay kit were from Bio-Rad (North Ryde, Australia) The spectra/par cellulose ester 
membrane was from Edwards Instrument Company (Narellan, Australia), HYPER ECL 
film and ECL reagents from Amersham (Baulkham Hills, Australia), Gelcode© 
phosphoprotein staining kit from Selby-Biolab (Clayton, Australia), centricon 
centrifugal concentrators from Amicon (Fawkner, Australia), chromophores D-16 and 
F-2181 were from Molecular probes (Oregon, USA), and all lipids from Avanti Polar 
Lipids (Alabama, USA). All other chemicals were from Sigma-Aldrich (Castle Hill, 
Australia). 
2.2 Methods 
A number of membrane preparations were isolated throughout this study. Two methods 
were employed to isolate SR vesicles. RyR enriched SR vesicles (termed terminal 
cistemae) were isolated from muscle homogenates, and used in single channel bilayer 
experiments. These vesicles are considered more pure than a heavy SR preparation, 
which would also contain vesicles enriched with t-tubules and longitudinal SR. In brief, 
chopped muscle underwent a low g-force centrifugation step, removing cell debris, 
followed by homogenisation, designed to disrupt the SR structure. The microsomal 
pellet (heavy or crude SR) was collected after centrifugation. The resultant crude SR 
pellet was further purified by sucrose gradient centrifugation (27-45% sucrose), which 
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separated longitudinal SR from terminal cistemae; the latter being the part of the SR 
that faces the t-tubule and contains the RyR. The first fraction ( occurring at the 27-32% 
interface) contains only longitudinal SR, whilst the fraction at the 32/34% interface is 
mainly longitudinal SR, with a small amount of terminal cistemae. The fraction found 
at the 34/38% interface contains terminal cistemae, with some longitudinal SR. The 
final fraction, at the 38-45% interface is highly enriched in terminal cistemae. 
Either SR vesicles or heavy SR were used as a starting preparation in the CSQ isolation 
procedure, depending on the method used for isolation. The terminal cistemae of SR 
contains two membrane components, the JFM and the calcium-pump (Ca2+ -ATPase) 
membrane. Two methods were used to isolate CSQ, using either high [NaCl] or high 
and low [Ca2+] to dissociate CSQ from JFM. Exposure of the terminal cistemae of SR 
tclriton-X 100 (in the presence of Ca2+), results in the formation of an insoluble pellet 
of JFM, leaving Ca2+ -ATPase in the supernatant (Costello et al., 1986). Addition of 500 
mM NaCl to the JFM disrupts ionic interactions (Ikemoto et al., 1989), tethering CSQ 
to the RyR/triadin/junctin (RyR/T/J) complex, allowing select dissociation of CSQ from 
this complex. In the first method (high [NaCl] exposure), CSQ~ ionic binding properties 
have been exploited to successfully dissociate this protein from the JFM. In the second 
method, increasing luminal Ca2+to > 10 mM or addition of Ca2+ chelators such as EGTA 
(which subsequently lowers Ca2+free), promotes CSQ dissociation from the RyR/T/J 
complex (Zhang et al., 1997; Wang et al., 1998), again allowing CSQ's removal. Using 
Ca2+ as a dissociation agent provided a higher yield of CSQ, but sometimes required 
extra purification steps, whereas NaCl dissociation although not providing such a high 
yield, yielded CSQ with few contaminating proteins. 
To determine direct effect of exogenous CSQ on RyR activity, without co-proteins such 
as, triadin and junctin present, RyRs were purified from solubilized RyR enriched SR. 
SR components were separated by fractionation after sucrose gradient centrifugation 
and RyRs isolated. Purified RyRs do not contain any contaminant triadin, junctin or 
CSQ (see Ch. 3, Fig. 3. V and Ch. 5, Fig. 5.I) and this preparation was used in CSQ"'s 
effects on the channel protein itself, rather than effects via interactions with associated 
co-proteins. 
Procedures 2.3.1 - 2.5.2 were carried out at 4 °C unless otherwise stated. 
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2.3 SR vesicle preparation 
2.3.1 RyR enriched SR vesicle preparation 
SR vesicles were prepared according to Chu et al. (1988), with minor modifications 
(Ahem et al., 1994; Ahem et al., 1997b). Mrs S. Pace and Mrs J. Stivala, John Curtin 
School of Medical Research, Australian National University, Canberra, Australia 
undertook this preparation. New Zealand male white rabbit back and leg muscle was 
removed and rinsed in phosphate buffered saline, containing (mM): 137 NaCl, 
7 Na2HPO4, 2.5 NaH2PO4.H2O. Once excess fat was removed, the tissue was cut into 
small pieces and 'snap' frozen in liquid nitrogen and then stored at -70 °C. Fifty gram 
aliquots of tissue was homogenised in a Waring Blendor (Waring, Connecticut, USA) -
2 x 30 sec on high, 2 x 30 s on low - in SR buffer 1, containing (mM): 20 imidazole, 300 
sucrose, pH 7 .4. In all cas,es, pH was adjusted using a TPS digital pH meter (Bacto 
Laboratories; Lane Cove, Australia). The homogenate was centrifuged at 11 000 gin a 
Beckman JA-14 rotor (Beckman Instruments; Gladesville, Australia) for 20 min. The 
resultant pellet was resuspended in SR buffer 1 and then homogenised, washed and 
centrifuged as above. After filtering the supernatant through several layers of cotton 
gauze, the sample was centrifuged at 100 000 g in a Beckman Ti-45 rotor (Beckman 
Instruments; Gladesville, Australia) for 1 - 2 h. The heavy SR pellet was resuspended in 
3 - 4 ml of SR buffer 1 and homogenised in a dounce teflon homogeniser (Edwards 
Instrument Company; N arellan, Australia) with 40 ml of SR buffer 1. The homogenate 
was added to a sucrose density gradient, containing 45%, 38%, 34%, 32% and 27% 
(w/v) sucrose layers (suspended in 20 mM imidazole, pH 7.4, plus a standard protease 
inhibitor solution, (mM): 1 benzamadine, 0.5 PMSF and (µg/ml) 1 leuopeptin, 
pepstatin-A), allowing sub-fractionation of vesicles, after centrifugation at 40 000 gin a 
Beckman SW-28 rotor (Beckman Instruments, Gladesville, Australia) for 16 h. The 
band appearing at the 38 - 45% interface (RyR enriched fraction) was collected and 
diluted with 2 volumes of 20 mM imidazole (pH 7.4). Following centrifugation of the 
diluent at 100 000 gin a Beckman Ti-45 rotor for 1 h, the final pellet was resuspended 
in 1 ml of SR buffer 1 with 2 mM DTT (included in a small number of preparations) and 
standard protease inhibitor solution. Aliquots of 15 µ1 were stored at -70 °C. 
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2.3.2 Heavy SR preparation 
Heavy SR was isolated according to Kim et al. (1983). Briefly, 100 - 200 g of muscle 
tissue was homogenised in a Waring Blendor ( 4 x 30 son high speed) in 4 volumes of 
2.5 mM NaOH, pH 6.8. The muscle homogenate was centrifuged at 10 000 gin a 
Sorval GSA rotor (Kendro Laboratory Products; Lane Cove, Australia) for 3 min (to 
remove residual fat and cell debris) and after a pH adjustment to 6.8, the supernatant 
was filtered through 8 cotton gauze swabs, followed by a final filter through filter paper 
(Whatmans no. 2). The filtrate was centrifuged at 17 000 gin a Sorval GSA rotor for 30 
min. After homogenising the pellet in 4 volumes of a solution containing (mM): 150 
KCl and 20 MES (pH 6.8), the suspension was then centrifuged as above, removing 
muscle contaminants. The above homogenisation and centrifugation step was repeated 
and heavy SR collected. Heavy SR was either stored in <5 ml aliquots at - 70 °C, or 
kept on ice briefly (if further purification was to take place the same day). 
2.4 RyR purification 
RyRs were purified from SR vesicles using methods of Lai et al. (1988). SR vesicles 
were incubated at room temperature for 2 hr in a solubilization medium containing: 25 
mM Pipes, 1 M NaCl , 0.5% (w/v) CHAPS/0.25% (w/v) PC, with RyR specific protease 
inhibitors (mM: 0.8 Benzamadine, 0.1 PMSF and µg/ml: 1 leuopeptin, 0.6 pepstatin A). 
After centrifugation for 15 min at 100 000 g using a Beckman TLA 100.3 rotor 
(Beckman Instruments; Gladesville, Australia), the solubilized muscle proteins were 
applied to a sucrose gradient of between 5 - 25% ( containing: 5-25% (w/v) sucrose, 25 
mM PIPES, IM NaCl, 0.5% (w/v) CHAPS/ 0.25% (w/v) PC and RyR specific protease 
inhibitors) and ultracentrifuged in a Beckman TLA 100.3 rotor at 80 000 g for 16 hr. 
Fractions (2 ml) were collected and RyRs visualised after SDS-Page and Western 
blotting. Those fractions enriched with RyR were concentrated by centrifugation at 
5 000 g for 30 min in a Sorval SS-34 rotor (Kendro Laboratory Products; Lane Cove, 
Australia) using a centricon-30 centrifugal concentrator. The concentrate was then 
dialyzed overnight against (mM): 500 NaCl , 10 NaPipes , 1 DTT, (µM ): 100 EGTA, 200 
CaCh, and 1.5 PMSF, pH 7.4 at 4 °C. Small aliquots(~ 100 µl ) were stored frozen at 
-70 °C. 
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2.5 CSQ preparation 
2.5.1 Dissociation of CSQ from heavy SR 
CSQ was purified as described by Ikemoto et al. (1989). Heavy SR vesicles were 
suspended in a solution of (mM): 20 MES, 300 sucrose, plus standard protease 
inhibitor solution (see section 2.3.1) and solubilized using 0.5% (w/v Triton X-100 (at 
0 °C). After incubation for 20 min on ice (vortexing every 5 min), the suspension was 
then centrifuged at 330 000 g in a Beckman TLA 100.3 rotor for 15 min. The insoluble 
fraction ( containing CSQ attached to JFM) was homogenized in a solution containing 
(mM): 20 MES, 500 NaCl plus standard protease inhibitor solution (pH 6.8), to 
dissociate CSQ. JFM was then removed by centrifugation at 330 000 g using a 
Beckman TLA 100.3 rotor for 15 min, leaving CSQ in the supernatant, which was then 
dialysed twice overnight (see section 2.5.3) against CSQ storage buffer, containing 
(mM): 1 CaCli, 100 KCl, 10 TES (pH 7.4), to remove residualTriton X-100. The final 
pellet was suspended at an approximate concentration of 1 mg/ml in CSQ storage buffer 
and stored in <100 µl aliquots at -70 °C. 
2.5.2 Purification of CSQ from RyR enriched SR. 
CSQ was purified from RyR enriched SR, using the methodology published by Costello 
et al. (1986), with minor changes (personal communication, Professor Cecilia Hidalgo, 
Instituto de Ciencias Biomedicas, Facultad de Medicina, Universidad de Chile, 
Santiago, Chile). SR vesicles were diluted to 3.3 mg/ml with CSQ isolation buffer (mM: 
300 sucrose, 0.4 benzamadine, 20 MOPS-Tris, (pH 6.8) and 1 µg/ml leupeptin), with a 
final [Ca2+] of 1 mM, and incubated on ice for 10 min. Triton X-100 was added to 0.5% 
(w/v), and the resultant suspension incubated on ice for 20 min, vortexing every 5 min. 
The suspension was centrifuged at 110 000 g for 15 min or 48 000 g for 1 hr, using a 
Beckman TLA 100.3 rotor. After resuspending the pellet at lmg/ml in CSQ isolation 
buffer, the insoluble JFM was homogenized in a dounce glass homogeniser. To remove 
CSQ from the JFM, EDT A was added to a final concentration of 2 mM and incubated 
on ice for 20 min. The homogenate was again centrifuged at 110 000 g for 15 min and 
the supernatant, containing CSQ, was collected. Depende:J1t on the level of purity 
obtained after EDTA incubation, in some cases CSQ was exposed to 500 mM NaCl, 
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centrifuged at 100 000 g for 15 min and the supernatant collected, to further purify 
CSQ. 
Following two overnight dialysis steps (see section 2.5.3), the final pellet was 
suspended at an approximate concentration of 0.4 mg/ml in CSQ storage buffer (see 
section 2.5 .1 ), in < l 00 µl aliquots at -70 °C. In a number of preparations, 20 mM CaCh 
(in 10 mM TES, pH 7.4) was substituted for 2 mM EDTA (all other procedures 
remained the same). 
2.5.3 Dialysis 
To remove residuallriton X-100 and EDTA from CSQ, all preparations underwent 
overnight dialysis. Dialysis tubing (MW cut-off: 14 - 15 kDa) was soaked in 10% acetic 
acid (both inside and out) and following a MQ water rinse, was boiled for 10 - 15 min 
in 2% (w/v) NaHCO3 and 0.02% (w/v) EDTA. Tubing was stored in 10 % (w/v) acetic 
acid until required. Dialysis was against CSQ storage buffer (see section 2.5.1 ), or on 
occasion, 10 mM TES and 1 mM CaCh. Less frequently, dialysis was undertaken using 
spectra/por cellulose ester membrane pre-prepared dialysis tubing (MW cut-off: 
500 Da). In the chromophore study (see section 2.8.2), dialysis tubing with a MW 
cut-off of 10 kDa was used. 
2.6 Electrophoresis and Western Blot 
2.6.1 SOS-Page 
Electrophoresis of SR vesicles, heavy SR and CSQ isolates on either 3-12%, 5-17% or 
12% SDS polyacrylamide gels, was performed following methods of Laemmli ( 1970). 
Running gels were prepared, containing(%, w/v): 12, 3-12 or 5-17 bis-acrylamide, 
0.025 ammonium persulphate, 0.1 SDS, 0.2 terned and 0.375 M Tris-HCl (pH 8.8). 
Once set, 2 ml of a stacking gel, containing(%, w/v): 3 or 4 acrylamide, 0.05 
ammonium persulphate, 0.1 SDS, 0.2 terned and 0.125 M Tris-HCl (pH 6.8), was 
placed above the running gel. After diluting high and low molecular weight markers, 
SR vesicles, heavy SR and CSQ (protein diluted to ~ 1 mg/ml , equi volume with a 
buffer containing(%, w/v): 2.5 SDS, 10 glycerol, 5 mercaptoethanol , 0.02 bromophenol 
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blue and 62.5 mM Tris-HCL, pH 6.8), standards and protein were loaded onto the gel. 
Typically 10 µl of standard and between 5 - 25 µl of protein were loaded into each 
well. High molecular weight standards contained; Myosin (200 kDa), B-galactosidase 
(116.25 kDa), Phosphorylase B (97.4 kDa), Serum albumin (66.2 kDa) and Ovalbumin 
( 45 kDa), whilst lo\v molecular weight standards contained; Phosphorylase B (97 .4 
kDa), Serum albumin (66.2 kDa), Ovalbumin (45 kDa), Trypsin inhibitor (21.5 kDa) 
and Lysozyme (14.4 kDa). The gel underwent electrophoresis at 35 mA for,___, 1 h, in a 
buffer containing (mM): 25 Tris, 191 glycine and 0.1 % (w/v) SDS. 
2.6.1.1 Protein stain 
Gels were stained in a Coomassie stain, containing(%, v/w): 0.1 Coomassie Brilliant 
Blue, 40 ethanol and 10 glacial acetic acid, for at least 30 min with gentle agitation. 
Excess stain was removed with a destaining solution, containing(%, w/v): 5 acetic acid 
and 20 ethanol (usually overnight, with one solution change). 
2.6.1.2 Silver stain 
Silver staining was carried out in accordance with manufacturers of the Silver Stain 
Plus kit (Bio-Rad; North Ryde, Australia). A silver stain is approximately 50 times 
more sensitive than a Coomassie stain, and was used when only small quantities of ( or 
dilute) samples were available, or to determine the presence or absence of contaminant 
protein(s) in a protein isolate- for example, the presence of junctin in a purified CSQ 
sample (see Chapter 3, section 3.2.3 and Fig. 3.V). In brief, after washing in MQ water 
for at least 20 min, the gels were placed in a fixative enhancer solution containing 50 % 
(w/v) ethanol, 10 % (v/v) acetic acid and 10 % (v/v) fixative enhancer concentrate for 
20 min, with gentle agitation. The gel was fixed to minimize diffusions of molecules 
into the gel and remove substances that may interfere with the oxidation/reduction step. 
The fixed gel was washed twice in MQ water (10 min each wash with gentle agitation) 
and placed in staining solution, containing(%, v/v): 5 silver complex solution, 5 
reduction moderator solution, 5 image development reagent, and immediately before 
use, 2.5 % (w/v) development accelerator solution. In acidic conditions, silver nitrate 
reacts with proteins. Upon addition of formaldehyde (in alkaline conditions) and its 
subsequent oxidization, silver ions are reduced to metallic silver. The reduction of 
silver ions was continued ( aided by the buffering of formic acid produced by 
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formaldehyde oxidization by sodium carbonate) until sufficient band visualization was 
achieved. Amino acids lysine, arginine, methionine and cystine are strongly complexed 
with silver ions. Typically, gels were developed for 10 - 15 min (with gentle agitation) 
before desired protein band visualization. The reaction was stopped by immersing the 
gels immediately in a 5% (w/v) acetic acid solution, for at least 15 min. Gels were 
washed three times in MQ water and then dried (see section 2.6.1.3). Gels were 
processed in a tank using ~ 50 - 100 ml of solution. 
2.6.1.3 Gel drying 
After several washes in MQ water, the gels were dehydrated in ~50 ml of dehydrating 
buffer, containing(%, w/v) 5 glycerol, 10 ethanol, with gentle agitation for at least 30 
min. The gel was then sandwiched between two sheets of Nov ex dry ease mini 
cellophane, which had been exposed to dehydrating buffer for~ 1 min, before pressing 
in a Novex mini gel drying apparatus (Bio-Rad; North Ryde, Australia). After 24 h 
pressing, gels were stored in plastic sleeves, protected from light and moisture. 
2.6.2 Western blot 
As reported by Towbin et al. (1992). All steps were completed at room temperature, 
except where indicated otherwise. Upon completion of electrophoresis, the gel was 
transferred to a transblot cassette (Bio-Rad; North Ryde, Australia) and a PVDF 
membrane was placed over the gel. The cassette was clamped in place in a transblot 
semi-dry cell ( containing an ice pack; Bio-Rad; North Ryde, Australia) and 
electrophoretically transferred at 100 V for 1 hat 4 °C, to ensure sufficient protein 
transfer, in a transfer buffer containing (mM): 25 Tris, 192 glycine (pH 8.3) and 20% 
(w/v) ethanol. 
Once transferred, the membrane was blocked for 1 h in a 5% (w/v) skim milk solution 
in TTBS (containing (mM): 20 Tris, 500 NaCl and 0.5 % (v/v) Tween-20, pH 7.4), by 
rotation on a Glas-Col rotator (Glas-Col; Indiana, USA). Following a standard washing 
step ( once for 15 min, and 3 times for 5 min, using fresh TTBS each wash), the blot was 
then exposed to a primary antibody solution, containing 25 µg/ml anti-CSQ, 25 -50 
µg/ml anti-RyR or 1.75 µg/ml anti-triadin, in primary antibody buffer, containing 1 % 
(w/v) BSA in TBS (20 mM Tris, 500 mM NaCl), for 1 h. After the standard washing 
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step was performed, the blot was incubated overnight at 4 °C (with rotation) in a 
secondary antibody buffer of TTBS, with 1 % (w/v) bovine serum albumin, and 1: 1000 -
1 :4000 (v/v) of either anti-sheep or anti-rabbit horse radish peroxidase (HRP) labelled 
or alkaline phosphatase labelled antibody. After two standard washing steps, the blot 
was ready for visualization. For Western blot of the RyR receptor, the following 
alterations to both the electrophoresis and Western blot procedures were made, (1) a 3-
12% or 5-17 % gradient gel was used and (2) Western blot was at transferred at 150 V 
for the first h, and then decreased to 100 V for the next 2 h. 
Occasionally, the blot was incubated in primary antibody buffer overnight at 4 °C, and 
following standard the washing step, was incubated in secondary antibody buffer for 1 h 
at room temperature (with all other steps as above). Typically, each membrane was 
washed or incubated in between 5 and 10 ml of appropriate solution. 
2.6.3 Visualisation 
Two methods were used to visualise Western blots, dependent on the type of secondary 
antibody available. For all blots published in this thesis, HRP labelled antibodies and 
the ECL development system was used (see section 2.6.3.1 ), due to its enhanced 
sensitivity over the alkaline phosphatase antibody development system. 
2.6.3.1 HRP labelled antibody visualization 
After Western blot, the PVDF membrane blot was placed in an ECL Western blotting 
detection reagent for 1 min. After exposure to autoradiographic HYPER ECL film in an 
x-ray film cassette (Kodak, North Ryde, Australia) for between 10 s to 3 min (to 
achieve visualization of immunoprobed protein bands), HYPER ECL film was 
developed in a Kodak X-Omat M20 film processor (Kodak, North Ryde, Australia). 
2.6.3.2 Alkaline phosphatase antibody visualization 
PDVF membrane blots (after Western blot), were washed a further 2 times in TBS, then 
equilibrated for 15 min in a developer buffer containing (mM): 100 NaCl, 100 
Tris-HCL, pH 9.6. The blot was then rocked, protected from light in developer buffer 
plus (mM): 0.04 mM MgC12, 300 µM nitrotetrazolium blue and 1.15 nM 
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5-Bromo-4-Chloro-3-indoxyl phosphate in dimethylsulphonoxide, until immunoprobed 
bands were distinctly visible (taking between 5 -15 min). 
2.7 Protein Determination 
All protein determinations (besides that determining the concentration of CSQ when 
chromophore was attached) were undertaken using the Lowry technique (Lowry et al. , 
1951), using a Bio-Rad D c protein Assay kit. As chromophore absorbs light at 655 run, 
the Bradford method of CSQ protein determination was used (595 run; Bradford, 1976). 
2.7.1 Lowry method 
Briefly, 5 µ1 of protein standards (BSA, 0 - 1.44 mg/ml), protein sample or sample 
buffer (minus protein) were added to a Nunc-Immunoplate 96 well plate. To each well , 
20 µl of Reagent A (w/v: 95% alkaline copper tartrate, 5% surfactant) was added, with 
the plate shaken for ~20 sec on a titretek plate shaker (Flow laboratories; North Ryde, 
Australia). Two hundred ml of Reagent B (dilute Folins reagent) was then added and 
the assay was left to develop for at least 15 min. The protein assay was measured using 
a Bio-Rad micro-titre plate reader (Model 450; Bio-Rad, North Ryde, Australia) 
detecting light absorbance at 655 run (reference cell: 405 run). Protein concentrations 
were determined from a standard curve generated by Microplate Manager softwear. 
2.7.2 Bradford method of protein determination for 
chromophore-attached CSQ 
The Coomassie Brilliant Blue Reagent was prepared, according to Bradford (1976). 
One hundred mg of Coomassie Brilliant Blue was dissolved in 50 ml of 95% (w/v) 
ethanol and diluted to 1 1 with MQ water. To this mixture, 100 ml of 85% (w/v) 
phosphoric acid was added. The mixture was stirred during the entire procedure. The 
reagent was kept for no more than two weeks at room temperature. 
A standard curve for BSA, (0 - 1.44 mg/ml) was prepared by adding MQ water (where 
necessary) to a total volume of 0.1 ml. Chromophore -attached CSQ was diluted as 
appropriate in CSQ storage buffer (see section 2.5.1 ). Five ml of Coomassie Brilliant 
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Blue Reagent was added to the samples, CSQ storage buffer (sample blank) and the 
standards. The mixtures were vortexed and left to incubate at room temperature for 15 
min. Absorbance of the samples and the standards were determined at 595 nm using a 
Cary 3 spectrophotometer (Varian; Frenchs Forest, Australia), against a protein blank 
(containing no BSA). 
2.8 CSQ phosphorylation/dephosphorylation 
2.8.1 Phosphorylation status determination. 
Two methods were used to determine the phosphorylation status of CSQ. First, the 
Gelcode© Phosphoprotein staining kit was used. There was some uncertainty as to the 
sensitivity of this method, as the levels of detection achieved in house by the supplier 
(Pierce laboratories) were not obtained, and the positive control was labelled for 
phosphorous only very weakly. Secondly, 31 P NMR (section 2.8.1.2) was used 
preferentially because it has high enough sensitivity to determine whether CSQ was 
fully, partially, or not phosphorylated. 
2.8.1.1 Gelcode© Phosphoprotein staining kit 
Phosphoprotiens were detected using the GelCode© Phosphoprotein staining kit, 
following manufacturers instruction (Pierce; Illinois, USA). This kit stains 
phosphorylated proteins directly on SDS-Page gels, specifically serine and threonine 
residues within the protein, as the stain targets these phosphoproteins phosphoester 
linkages. Briefly, after electrophoresis (see section 2.6), the gel was placed in a solution 
of sulfosalicylic acid for 15 min, after which it was transferred to a sulfosalicylic acid 
and CaCii solution, and agitated for 30 min. After a 20 min incubation at 65 °C in 
0.5 M NaOH (and hydrolysis of any phosphoprotein phosphoester linkages and 
subsequent formation of an insoluble Ca2+ -P complex), the gel was treated with an 
ammonium molybdate solution for 10 min. Following a 20 min agitation in an 
ammonium molybdate and nitric acid solution, the resultant insoluble nitrophospho-
molybdate complex (which binds to phosphorylated serines and threonines) stained 
green after incubation in methylene green for 15 min. Excess stain was removed by 
52 
] 
,J 
Chapter 2 
bathing the gel in sulfosalicylic acid for 15 min. All incubations were done at room 
temperature in ~ 25 ml of appropriate solution. 
2.8.1.2 31 P NMR spectroscopy 
This procedure was performed by Dr Marco Casarotto, John Curtin School of Medical 
Research, Australian National University, Canberra, Australia. CSQ phosphorylation 
status was determined using 31 P NMR spectroscopy. All spectra were acquired on 
Varian-Inova 500 spectrometer (Varian; Frenchs Forest, Australia) using a spectral 
width of 15000 Hz, a pulse width of ~15 µs, a spectral frequency of 202.421 MHz, and 
an acquisition time of 0.33 s. Samples were kept at a constant temperature of 5 °C. 
NMR samples were ~0.17 mM in an H2O solution containing 10% D2O/90% H2O. 
2.8.1.3 Dephosphorylation of CSQ 
Acid phosphatase treatment was undertaken as described by Cala and Jones (1991). 
CSQ was diluted to 50 µg/ml in CSQ storage buffer (see section 2.5.1), and 1 mg was 
dephosphorylated at 30 °C for 30 min in (mM): 20 MES (pH 5.8), 3 EGTA, 0.1 % (w/v) 
triton X-100 and 1 unit of acid phosphatase derived from white potato was used with 
100 µg of CSQ . The sample was subject to 31 P NMR to detect phosphorylation status 
of the protein. Small aliquots were frozen in liquid N2 and stored in CSQ storage buffer 
at-70 °C. 
2.9 Fluorescent Labelling of CSQ 
Chromophore attachment was undertaken by Professor David Jans and the Nuclear 
Signalling Laboratory; John Curtin School of Medical Research, Australian National 
University, Canberra, Australia. Pooled fractions of purified CSQ were concentrated in 
(mM): 10 TRIS pH 7 .4, 100 KCl, and 1 Ca Ch, using a centricon-10 centrifugal 
concentrator. Concentrated CSQ was labelled with either fluorescent dye 
5-[ 4,6-dichlorotriazinyl]aminofluorescein (known as D 16) or 
6- fluorescein-5-(and-6)-carboxamido )hexanoic acid, succinimidyl ester (5 (6)-SFX), 
known as F2181. D-16 is a fluoresine dichloratriazine, whilst F-2181 is a succinimidyl 
ester of fluorescein. D-16 preferentially attaches to serines and threonines, and F-2181 
preferentially binds to lysines. 
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CSQ (0.3 - 1 mg) was incubated with D-16 in 45 mM borate buffer (pH 9.5, with 
NaOH) at room temperature for 2 h, protected from light. Chromophore attached CSQ 
was dialysed (see section 2.5.3) in CSQ storage buffer (see section 2.5.1) overnight, to 
remove unbound D-16. The sample was then concentrated using a centricon-10 
centrifugal concentrator, and small aliquots stored on ice for immediate use, or frozen at 
- 70 °C. In the case ofF-2181 attachment to CSQ, the following alterations to the above 
protocol were implemented; the pH of the incubation solution was adjusted to 8.2 with 
NaOH and the incubation time was reduced to 50 min. The concentration of 
chromophore labelled protein was determined using the Bradford assay ( see section 
2.7.2). To detect whether fluorescent labelling altered the RyR regulatory properties of 
CSQ, a standard re-association assay was performed in the bilayer experiments system. 
Refer to Fig. 2.I for probable attachment sites of chromophores. It was presumed that all 
residues targeted by chromophores were labelled by D-16 and F-2181, however this 
was not determined experimentally. 
2.10 Antibody preparation 
A polyclonal antibody to skeletal (predominantly) fast twitch fibre (from rabbit back 
and leg muscle) CSQ was raised in New Zealand male white rabbits. Rabbits were 
inoculated at four-week intervals, and in each inoculation approximately 1 mg of 
purified CSQ was used (which was suspended in an equi volume of adjuvant). Up 
to 200 µl of this suspension was administered to each inoculation site. In the first 
inoculation step, CSQ was mixed with complete adjuvant, whilst all following 
inoculants were suspended in incomplete adjuvant. Rabbits were bled from the portal 
vein in the ear, 9 - 13 days after inoculation, with up to 10 ml collected per rabbit per 
bleed. 
Anti-serum from innoculated rabbits was separated from red blood cells by 
centrifugation for 10 min in a MSE bench top centrifuge at top speed (unknown, RPM, 
RCF or origin) at room temperature, and titrated against CSQ to detect levels of 
antibody present, using an Elissa assay. In brief, a 96 well plate (Nunc Immunoplate) 
was coated with 100 ng of purified CSQ by incubation (with gentle agitation via a 
titretek plate shaker) at room temperature. Following a 1 h incubation in 5% skim milk 
in TTBS (see section 2.6.2) which blocks any non-specific protein binding, all wells 
54 
1 
,! 
Chapter 2 
were washed three times in TTBS and incubated for at least 1 h in anti-serum. Anti-sera 
dilutions (in primary antibody buffer: see section 2.6.2) from 1/ 2 to 1/ 2048 were used. Wells 
were washed as above, and anti-rabbit IgG (1/1000 dilution in secondary antibody 
buffer; see section 2.6.2) was added to each well, for 1 h. Wells were rinsed four times 
in TTBS and incubated, protected from light, in (mM): 100 Na2HP04, 490 citric acid, 
pH 5.0 and 0.01 % H20 2 (w/v) for 15 min before quantification. The reaction was 
stopped by the addition of 500 mM H2S04, and the titre quantified 
spectrophotometrically using a Bio-Rad micro-titre plate reader (Model 450) at 495nm 
(reference 655 nm). On comparison of pre-immune and bleed titres, a change in OD of 
0.5 was considered a significant antibody titre. 
2.11 Planar lipid bilayers 
2.11.1 Lipid bilayers 
In early experiments, bilayer were formed from a lipid mixture containing PE, PS and 
PC (5:3:2, v/v). In later experiments, a mixture containing only PE and PC (8:2 v/v) 
were used. It should be noted that the presence of PS was not required for bilayer 
formation, neither did it appear to alter the integrity of the membrane. In addition, the 
properties ofRyRs and their activation or inhibition by any agents used in this study 
were not altered by the presence or absence of this lipid (N. Beard, unpublished 
observation). Once prepared, the chloroform storage medium was evaporated using a 
stream of N2, and the lipid mixture was resuspended in n-decane, at a concentration of 
45-50 mg/ml. The lipid was 'painted' or applied across an aperture of 150 - 250 µm in 
the wall of a delrin cup, with a glass rod. The lipid thinned spontaneously or via gentle 
manual manipulation, forming a bilayer (Fig. 2.II A). 
The thinning of the lipid film was· monitored visually though 20 x magnification using a 
binocular microscope (Hd Scientific Supplies; Kings Park, Australia), and electrically 
monitored using the current response to a ramp of 1 V/s to measure capacitance. The 
bilayer separated two chambers, denoted cis (cytoplasmic) and trans (luminal; see 
Fig. 2.II B). 
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Fig. 2.1. Position of chromophore attachment sites on CSQ. Amino acid sequence from Fliegel et al, 1987, accession number A25887. The 
probable attachment sites for D-16 (preferentially attaching to serine/threonine) are highlighted in blue, whilst the probable attachment sites 
for F-2181 (a chromophore preferentially attaching to lysine) are shown in red. 
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SR vesicles were added at a concentration of ~ 33 - 100 µg/ml to the cis chamber and 
stirred until vesicles were incorporated into the bilayer (Fig. 2.III). Vesicles fusion was 
promoted by the addition of mannitol (300 mM, cis) and increasing cis CsMS to 250 
mM. Vesicle fusion is also promoted by the high osmotic strength (Niles and Cohen, 
1987) and increasing cis CaCh to 4 mM. More specifically, increasing cis CaCh 
promotes the binding of vesicles to the membrane. Vesicle incorporation was indicated 
by the appearance of step changes in current that indicated channel activity. 
Cis Cs+ was 250 mM in all cases (230 mM CsMS and 20 mM CsCl) whilst 300 mM 
mannitol and 4mM CaCh were present during vesicle fusion only in some instances. 
Mannitol was perfused from the cis chamber prior to experimental recording ( as the 
effects of mannitol on RyR activity are undocumented) by exchange with at least 10 
bath volumes of mannitol free cis solution. 
Once RyRs had incorporated, either cis Ca2+ concentration was lowered to 100 nM, or 
the cis chamber was perfused with~ 10 volumes fresh cis solution, to prevent further 
vesicle incorporation. One hundred nM [Ca2+] is insufficient to activate RyRs (Chu et 
al., 1993; Laver et al., 1995), therefore 2 mM cis ATP was added to induce channel 
opening. 
Miller and Racker (1976) show that in more than 99% of all incorporations, the vesicle 
incorporates such that the cytoplasm of the SR faces the cis chamber, whilst the SR 
lumen faces the trans chamber (Fig. 2.III). In this study, >99 .5 % of channels responded 
in a way that indicated that the cytoplasmic surface faced the cis chamber. To test 
whether the RyR had orientated in this manner, channel response to activating agents 
such as cis Ca2+ and ATP were tested. These agents have very different affects on the 
cytoplasmic and luminal sides of Ry Rs, and can be used to determine channel 
orientation. Only channels responding in a way that indicated that the cytoplasmic side 
faced the cis chamber were analyzed. 
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2.11.2 Solutions 
2.11.2.1 Standard solution 
All solutions were made from analytic grade reagents using MQ water and were pH 
adjusted to 7 .4 with CsOH, using a TPS digital pH meter. Standard incorporating 
solutions which were added to the cis of the chamber contained (mM): 230 CsMS, 20 
CsCl, 1 CaCli and 10 TES (final chamber volume of 1 ml, final pH 7.4) whilst the trans 
chamber contained (mM): 30 CsMS, 20 CsCl, 1 CaC}i and 10 TES (final volume of 1 
ml, final 
pH 7 .4). Free [Ca2+] was measured using an Ion83 ion meter (Radiometer; Copenhagen, 
Denmark). When lowering cis Ca2+ to ~ 100 nM, 4.2 mM BAPTA ( a Ca2+ chelator) was 
added to the cis chamber. 
Cs+ was the chosen current carrier because firstly, Cs+ has a higher conductance (525 pS 
in symmetric 250 mM Cs+ (Laver et al., 1995) than Ca2+ through the channel, therefore 
increasing signal-to-noise ratio. Secondly, Cs+ has also been reported to block SR K+ 
currents (Coronado et al., 1992), ensuring that K+ channels (abundant in muscle), were 
not recorded. CsMS was chosen to minimize the current tl{ough er channels. Twenty 
mM CsCl (cisltrans) was used because the RyR channel is sensitive to anion 
composition (Meissner, 1994). In addition the presence of chloride in the solution 
reduced junction potentials between the solution and the AgCl electrodes. 
2.11.2.2 Drug addition 
Drugs, ions, antibodies and proteins were added to either the cis or trans chamber from 
stock solutions, the compositions of which are listed in Table 2.I. All drugs were stored 
at -20 °C, except for CsMS, ryanodine and ruthenium red, which were all stored at 4 °C. 
Antibodies were stored in a working solution at 4 °C for daily use. SR vesicles and 
CSQ were stored at - 70 °C and thawed immediately before use. As pH changes can 
alter RyR activity (Laver et al., 2000), additions of non-buffered drugs were added to 
bilayer solutions in a test tube, and pH measured. Variations in pH did not exceed 
7 .4 + 0.1; changes in this range would not have any direct effects on RyR activity 
(Laver et al., 2000). 
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Fig 2.11. A. Formation of a black lipid bilayer. After lipid mixture is 
applied across the aperture in a delrin cup, lipid film can be seen 
(deflecting light) in the upper half circle (arrow). Photograph by 
D.R.Laver. B. Depiction of chamber set up, showing delrin cup (which 
constitutes cis chamber), containing the aperture across which the 
bilayer is formed, inserted into the chamber holder, forming the trans 
chamber. Note electrodes (arrow), connecting the solution in the 
chambers with the head stage. Photograph by M.M Sakowska. 
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Fig. 2.111. o,a.<a r~ of RyR orientation. A.After vesicle isolation (section 2.10.2), the SR lumen (where CSQ is located) 
is enclosed within the vesicle. B. Upon fusion of the vesicle with the artificial lipid bilayer, the cytoplasmic side of the 
RyR always faced the cis chamber, whilst the SR lumen faced the trans chamber. Adapted from Sakowska, 2000 
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Solution 
Anti-CSQ 
Anti-triadin 
ATP 
BAPTA 
CaCh 
CsMS 
CSQ 
MgCh 
NaN3 
Ruthenium red 
Ryanodine 
Composition 
25 µg/ml in 1° antibody buffer with 0.02% (w/v) NaN3 
14 µg/ml in 1 ° antibody buffer with 0.02% (w/v) NaN3 
200 mM in 10 mM TES, pH 7.4 
l00mM 
200 mM, in 10 mM TES, pH 7.4 
1.5/2 M, pH 7.4 
0.2 - lmg/ml, in 1 mM CaCh, 100 mM KCL, 10 mM TES, pH 7.4 
200 mM, in 10 mM TES, pH 7.4 
1%, w/v 
lmM 
lmM 
Table 2.1. Components of stock solutions used. All solutions added to the trans or cis 
chamber were done from the above stock solutions. In all cases, pH was adjusted with 
CsOH at room temperature. BAPTA and ruthenium red were stored protected from 
light, due to their light sensitivity. 
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After addition of each drug, ion, antibody or protein, the bath was stirred for at least 
1 O s, to ensure even dispersion through the solution. In the case of CSQ and anti-CSQ 
antibody additions, if it appeared that binding had not occurred (i.e. no change in 
channel activity was observed), stirring was initiated for 15 s every 1 or 2 min, to 
minimize the protein or antibody settling at the bottom of the chamber. 
2.11.2.3 Solution exchange 
A back-to-back perfusion set up allowed solution exchange from either chamber, 
without altering chamber volume. Old solution was simultaneously removed from the 
chamber while fresh solution was added to the chamber. Perfusion of 10 bath volumes 
("" 10 ml) results in a dilution of 1000 (C. Haarmann, unpublished observation). In the 
case of experiments examining Ca2+ regulation ofRyRs, the [Ca2+] is of upmost 
importance. In the most extreme case, where trans solution containing 13 mM Ca2+ was 
replaced with standard trans solution ( containing 1 mM Ca2+), a 10 volume perfusion of 
the trans chamber would result in a [Ca2+] of r---, 1.013 mM. 
2.11.3 Channel recording 
During vesicle addition and incorporation, prior to channel recording, standard cis and 
trans solutions contained (mM): 20 CsCh, 10 TES, 1 CaCh,230/30 CsMS (cis/trans). 
After channel incorporation, control channel activity was recorded, after the addition of 
2 mM ATP and occasionally 3 mM MgCh to the cis chamber and 200mM CsMS added 
to the trans chamber to give symmetrical solutions. All other agents were added to the 
trans chamber, except for ruthenium red, ryanodine and in a small number of channels, 
CSQ. 
To confirm that the recorded channel activity was from RyRs and not from another type 
of ion channel ( such as a K+ or er channel), in addition to selecting Cs+ as the 
conducting ion and MS as the major anion, specific compounds ruthenium red (cis, 10 
µM; Ma, 1993), or ryanodine (cis, 10 µM; Carroll et al., 1991) were routinely added at 
the end of the experiment. 
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The trans chamber was held at virtual ground, and voltage applied to the cis chamber. 
However, in accordance with physiological convention, bilayer potential is expressed 
as: 
V V cytoplasmic - V,u min al [Eq. 2 .1 0-1 ] 
During recording, the voltage was changed from +40 to - 40 mV (and vice versa) at 
each 30 s time interval to determine the possible voltage-dependence of effects on 
channel activity. All recordings were done in symmetrical solutions (with respect to 
Cs+, er and MS), except for ionic dissociation experiments, where trans ionic strength 
was increased to 500 mM. To account for these differences in ionic conditions, V holding 
was always +/- 40 m V from the reversal potential for Cs+. 
Electrical connections with the chambers were made via silver chloride coated silver 
wire electrodes, connected to an amplifier head stage. In some cases, electrodes were 
immersed in salt bridges (2% (w/v) agar in, 1 mM TES, 1 mM CaCli and 250/50 CsCl 
(cis/trans)), which minimized changes in liquid junctio~ potentials arising from a 
change in the composition of the solution. Electrodes were connected to an amplifier 
head stage. Currents were recorded and the voltage was controlled by an Axopatch 
200A amplifier (Axon Instruments; California, USA). 
Data were recorded at a bandwidth of 5 kHz on videotape, using pulse code modulation 
(SDR Clinical Technology; Middle Cove Australia). Prior to analysis, the current signal 
was replayed through a 1 kHz filter, and then sampled at 2 kHz. On fewer occasions, 
data were filtered at 5 kHz, then sampled at 10 kHz and stored directly on computer 
(refer to Fig. 2.N). 
2.12 Data analysis _ 
Channel events were detected using a program developed in house, Channel 2 
(developed by Professor Peter W Gage and Mr Michael Smith, JCSMR). Channel 
openings and closures were detected on a 30 s recording and used to calculate the 
following: 
63 
Open probability (P 0 ) = 
Mean open time (T0 ; ms)= 
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[Eq. 2 .11-1 ] 
[Eq. 2.11-2] 
[Eq. 2.11-3] 
[Eq. 2.11-4] 
In the above equations, Topen is the total channel open time, Tc1osed is the total channel 
closed time, Ttim e is total time ( s) of analysed record, and n is the number of events. The 
threshold detector for events detection was set at either 25 or occasionally 50 % of the 
maximum single channel conductance, with a closed threshold of 12.5 or 25% 
(respectively). Discriminators of 25/12.5% allow detection of subconductance levels 
observed in RyRs. In some cases where indicated, Tc was analysed within bursts. A 
burst is defined as a group of events terminated by > 1 s of closure. Mean current (/, pA), 
was also measured and is the average of all data points in a 30 s recording. 
Channel activity was assessed either from P0 or fractional mean current (I 'F; / '/maximal 
current) and in all cases was measured from > 30 s of continuous data. It is common for 
more than one RyR to incorporate into a bilayer and T0 , Tc and F0 were not analysed for 
multichannel recordings. 
2.13 Statistics 
Average data are presented as mean+ SEM when n>3, or mean+ SD when n=3. 
Individual data are presented where n<3. A paired Students t-test was used to detect 
significance of the difference between control and test values from a single set of 
channels. Where appropriate, the non-parametric sign test was used to assess 
significance. To test for the difference of means of two independent samples, either the 
Mann-Whitney or~t.udents t-test for unpaired data was used. A p value of <0.05 was 
considered significant. 
64 
• I I I I • Filter Filter • I!- It. \ J t t > 
(video•] ~ (3+ ( ] Amplifier 
t 
. 
ClS 
Fig 2.IV. Cartoon diagram of the bilayer setup. Lipids were formed 
across a 150 - 250 µm aperture of a delrin cup, which was viewed 
through a binocular microscope. Silver chloride coated silver wires 
provided the electrical connection to the solution and currents were 
then amplified and recorded onto videotape using PCM, whilst 
simultaneously filtered and displayed on an oscilloscope. Data 
recorded on videotape was filtered and digitized for computer analysis. 
Back to back syringes allow solution exchange from either chamber, 
without altering chamber volume 
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DISSOCIATION OF CSQ USING HIGH IONIC 
STRENGTH SOLUTIONS. 
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3.1 INTRODUCTION 
Miller and Racker (1976) were the first to show that fusing SR vesicles isolated from 
skeletal muscle with artificial ( or black) lipid bilayer 1nembranes allowed incorporation 
of SR ion channels. This technique allows monitoring of channel activity by measuring 
current passing through the membrane in response to an electrochemical gradient. This 
is a powerful tool for studying alterations in both ion channel conductance and gating, 
in response to the addition and removal of ions, pharmacological agents and proteins. 
Of particular interest and importance, is the study of the SR Ca2+ release channel, the 
RyR. 
Using the bilayer technique, the skeletal muscle RyR has been characterized as a cation 
selective ion cham1el, with rapid gating kinetics and high conductance (770 pS in 250 
1nM symmetric K+ and approximately 500 pS in 250 mM symmetric Cs\ Smith et al., 
1986; Tinker and Williams, 1992). In addition to RyRs, the SR also contains K\ er and 
voltage gated anion channels. By using Cs+ as the current carrier, K+ currents are 
blocked (Cukierman et al., 1985), and by conducting experiments at the reversal 
potential of er or by using other impermeant anions, the contribution of currents from 
non-RyR channels can be minimized. Abundant investigation has shown that the RyR is 
activated by µM cytoplasmic Ca2+ (Coronado et al., 1994 and references therein) and 
n1M ATP (Meissner et al. , 1986a; Moutin and Dupont, 1988), and inhibited by mM 
Mg2+ (Smith et al., 1986; Meissner et al., 1986a; Laver et al., 1997) and by 10 µM 
ryanodine and ruthenium red (Meissner, 1986b; Ma, 1993). 
Both the Ca2+ binding properties and kinetics of CSQ, the major Ca2+ binding protein 
found within the SR, have been studied extensively. The role that this protein plays in 
regulation of the RyR, and hence the regulation of SR Ca2+ release, is still not well 
understood. Conflicting evidence shows CSQ to both activate (Kawasaki and Kasai, 
1994; Ohkura et al., 1994; Hidalgo and Donoso, 1995; Ohkura et al., 1995; Szegedi et 
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study and Wang et al., 2001 ). CSQ was reported to be localized near the RyR, through 
interactions with anchoring proteins, triadin and junctin, but not to be directly associated 
with the RyR (Zhang et al., 1997). More recent evidence shows that a close interaction 
between the RyR and CSQ can occur in vitro, suggesting a direct physical coupling 
between these two proteins (Murray and Ohlendieck, 1998). In addition, Szegedi et al. 
(1999) and Herzog et al. (2000) report that in purified RyRs, CSQ induces an increase 
in channel activity and Ca2+ release that is dependent on the phosphorylation state of 
CSQ. No detailed study of the interaction between CSQ and the RyR, or any functional 
or regulatory implications of such an interaction, has been reported thus far. 
In single channel studies using the lipid bilayer technique, the luminal side of the SR 
faces the trans chamber (Laver et al, 1995). As CSQ has no cytoplasmic or 
membrane-spanning domain, it is located wholly in the trans chamber and can be 
dissociated and re-associated by simply altering trans bath conditions, or adding 
exogenous CSQ. An increase in ionic strength (to 500 mM, with NaCl) has been 
reported to dissociate CSQ from junctional face membrane (JFM) in biochemical 
studies (Ikemoto et al., 1989). Exposure of solubilized JFM to high [NaCl] disrupts 
charge-charge interactions, thought to be responsible for tethering CSQ to the JFM), 
allowing the selective removal of this protein. Such an ionic strength change can be 
utilized while using the lipid bilayer technique. This allows channel activity to be 
investigated in detail (in real time), with alterations in channel gating and conductance 
induced by addition or removal of drugs, ligands and proteins, observed in a controlled 
environment. 
The aims of experiments in this chapter were to firstly, confirm the Cs+ current recorded 
in lipid bilayer experiments arose from RyR channel activity, secondly, to selectively 
dissociate CSQ from native RyRs and determine any regulatory effects this protein may 
have on channel activity. Thirdly, to re-associate exogenous CSQ with the RyR, to 
reveal whether any RyR activity changes induced by CSQs removal could be reversed 
by its re-iptrodu_cti(?n. 'Finally, to apply anti-CSQ antibody to the trans chamber, to 
determine whether any effects this antibody had on CSQ conformation were able to 
alter RyR regulation by CSQ. 
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3.2 Results 
3.2.1 Bilayers - general observations 
As a general rule, after formation of a lipid bilayer and addition of SR vesicles, RyR 
incorporation occurred within 15 min, and was usually indicated by a baseline shift in 
the current signal. If incorporation of a RyR had not occurred after 20 min, bilayers 
were broken and reformed in the presence of SR vesicles. 
Due to the sensitivity of the RyR to the isolation procedure and to ensure that the 
protein isolated with the SR was a fully functioning RyR (responding 
pharmacologically in a typical manner), channels from each batch of SR were carefully 
tested after isolation and purification. Responses to Mg2+, ATP, ruthenium red ( or 
ryanodine) and both cytoplasmic and luminal Ca2+ were examined. Any preparation 
not showing typical RyR behaviour was not used. Any experiments involving channels 
that did not show an increase in activity after the addition of 2 mM ATP and an activity 
decrease after lowering Ca2+to 100 nM with BAPTA (and in the case of channels with 
2 mM Mg2+ added, channel inhibition) were terminated, because channels were not 
functioning as normal RyRs, or were incorporated in the incorrect orientation into the 
bilayer. 
On some occasions, single channel multiple subconductance levels were observed 
(Fig. 3.I A). As a general rule, subconductance states of 25%, 50% or 75% were seen. 
Subconductance levels induced by a particular condition or addition of any protein, ion 
or drug used in this study were never observed. Subconductance levels can be further 
seen in the all points histogram in Fig. 3 .I B, with conductances of 90.25 pS 
(corresponding to a 25% conductance state) and 361.5 pS (maximal channel opening; 
which although low, is within the range observed from RyRs). A multitude of 
subconductance levels induced by FKBP 12 removal has been reported by Ahem et al. 
(1997a) and Ahen1 et al. (1997b). Substate activity is more commonly observed in 
purified RyRs (Lai and Meissner, 1989), and might be due to the removal of FKBP12. 
In all bilayer data presented in this chapter, the composition of cis and trans solutions 
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Fig. 3.1. Substate activity observed in native RyRs. (A) Example of 
substate activity in single RyR. The subconductance level (arrow in A) 
was observed at approximately 25 % of the maximum conductance, in 
addition to maximal opening (broken line) and closed ( closed line) 
levels. (B) All points amplitude histogram of activity at +40 m V, 
showing channel closed stated (0 pA), open state (14.46 pA, 361.5 pS) 
and substate (3.61 pA, 90.25 pS). Data was analyzed over a 1 min 
recording. 
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were as follows, unless otherwise specified: cis 100 nM free Ca + (lmM CaC12 plus 4.5 
mM BAPTA), (in mM) 2 ATP, and 250 Cs+ (230 mM CsMS, 20 mM CsCb; trans 
(mM) 250 or 500 Cs+ and 1 Ca2+ (as CaCb). In many instances (57%), more than one 
channel was observed in the bilayer. Up to six channels per bilayer were observed in the 
course of this study (eg. Fig. 3.II), although it was uncommon to observe more than 
two. For purposes of analysis, bilayers with more than two active channels were not 
used. As an interesting aside; when n >2 channels were observed, they were ahnost 
always (84%) from so-called 'high activity' channels (refer to Chapter 4, Section 4.2.1). 
However, since multiple channel activity was identified by summed openings to 
conductance levels that were multiples of the maximum single channel conductance, it 
was possible that multiple channels were not observed if the probability of channel 
opening was low. 
3.2.2 Effect of characterized agents on native channel activity 
3.2.2.1 ATP 
ATP is a physiological enhancer of Ca2+ -induced Ca2+ release and has been shown to 
increase Ca2+ release from RyRs (S1nith et al., 1986). As well as being the physiological 
activator in muscle, ATP has also been proposed to increase RyR activity by 
phosphorylating the RyR or an associated co-protein in lipid bilayers (Dulhunty et al., 
2001). Two mM ATP was added to the cis chamber, evoking a 2.2-fold increase in open 
probability (P0 ; n=5; Figs. 3.IIA & Table 3.I). Open time (T0 ) showed a significant 
increase, whilst closed time (Tc) decreased to 10% of control activity (Table 3 .I). 
Despite increasing in all but one channel, open frequency (F0 ) did not increase 
significantly overall, because of the large variability in frequency between channels 
(Table 3.I). Fig. 3.IIA and Table 3.I contains results obtained with channels at positive 
potentials; it should be noted that at a negative potential, similar effects were observed. 
ATP (2mM) was used as part of the standard cis solution as an activator in all 
experi1nents, as standard cis [Ca2+] of 100 nM is sub-activating, and thus control 
channel activity is difficult to examine quantitatively. Two mM ATP has about the same 
activating effect on bilayer-incorporated RyRs as the 8 mM concentration found in vivo, 
due to so1ne of the ATP being complexed with MgCb (personal communication, Dr 
Derek Laver, University of Newcastle, Newcastle, Australia). 
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Fig. 3.11. Currents observed after incorporation of multiple RyRs into 
the lipid bilayer. Simultaneous activity of at least six RyRs at level 0 6. 
Activity was recorded at +40 m V. Channel openings are indicated by 
upward deflections from the closed line ( c ), indicating the closed state 
of channels. 0 n represents the open state of n channels. 
Table 3.1 
ATP. 
Single channel parameters of RyR response to addition of 2 mM cis 
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Po 0.20 + 0.10 0.44 + 0.66 * 
T0 (ms) 2.32 + 0.48 5.60 + 1.53 * 
Tc (ms) 34.67 + 21.36 3.34 + 1.67 * 
F0 ( events/s) 85.82 + 49.44 90.06 + 15.26 
The addition of2 mM ATP caused significant(*, p<0.05, t-test) increase in Po, To, and 
a significant shortening of Tc. No significant change in F0 was observed. 
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3.2.2.2 Ca+ 
RyR response to both cis Mg2+ and Ca2+ have been well documented and can be used to 
indicate whether the channel has incorporated in the correct orientation (refer to Chapter 
1, Section 1.2.6.1 & 1.2.6.3). Both Mg2+ and Ca2+ are reported to bind at the same 
inhibition and activation sites (Meissner, 1986b; Laver et al., 1997). Fig. 3 .III B 
illustrates the biphasic nature of the effect of cis Ca2+ on RyR activity; with channel 
inhibition in the presence of nM and mM [Ca2+], and activation occurring in the 
presence of µM Ca2+. Each point is the average of between 3 - 10 channels, presented 
as mean+ SEM (Fig. 3.III B). Each channel was exposed to no more than three 
different cis [Ca2+]. The solid line (Fig. 3.III D) is the least square fit of the data to the 
Hill equation; 
[Eq. 3.2-1] 
where P max(CaJ is the open probability at maximally activating Ca2+ in the absence of 
other ligands, na(CaJ and nt(CaJ are the Hill co-efficients for activation (a) and inhibition (i) 
respectively, and Ka(CaJ and Kt(CaJ correspond to the apparent d,uac,q11w1for activation and 
inhibition. 
Channel P0 increased from 0.039 + 0.004 to 0.117 + 0.023 (p<;_0.05, t-test) upon 
increasing cis Ca2+ from 10 nM to 100 nM, further increasing to 0.269 + 0.043 (p"< 0.05, 
t-test) when channels were exposed to 10 µM Ca2+. Channel activity dropped 
dramatically (to 0.052 + 0.009; p·< 0.05, t-test) when cis Ca2+ was subsequently 
increased to 1 mM. These results compare favourably with those reported by Fill et al. 
(1990), although higher act_ivation is reported here (Fig. 3.III) at low cis Ca2+ (pCa 7). 
Because the response to Ca2+ was immediate; channels were either analysed 
immediately after aliquot addition and stirring had ceased, or 30 s after this (depending 
whether at positive or negative potential, as activity was observed for 30 s at each 
potential). After the initial rise or fall in activity, no significant change in the activation 
or inhibition induced at a particular cis Ca2+ was observed up to 5 min after application, 
indicating the Po rise was not due to transient RyR activation. 
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Fig 3.111. Typical RyR response to cis ATP, Ca2+ and Mg2+. V m -Ecs+ 
was +40m V under all conditions. (A) control activity with 250 mM 
trans cs+and 1 mM Ca2+(left panel), and after addition of 2 mM ATP 
(right panel); (B) cis Ca2+ dependence of native Ry Rs in the absence of 
ATP. Each point is the mean PO for 4-10 channels. The so lid line is the 
best least squares fit of the the Hill equation to the data (Eq. 3 .2-1 ), 
with aKa(Ca) of 1.19 * 10-7 and aKi(CaJ of2.25 * 10-4 _ An* indicates 
average values significantly different from those recorded under 
control conditions and a # indicates a significant difference from the 
previous condition (p<0.05, t-test); (C-E) the response of channels to 3 
mM MgC12 (right panels), in the presence of (left panel) 1 mM Ca
2+ 
(C), 1 nM Ca2+ (D) and 1 mM Ca2+ and 2 1nM ATP (E). Channel J'F is 
shown to the right of traces C-E. Single channel opening is upward 
fro1n the zero current level ( continuous line) to the 1naximum open 
conductance (broken line). 
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3.2.2.3 Mg+ 
In earlier experiments, Mg2+ was added to the control cis solution in an attempt to keep 
solutions as 'physiological' as possible. Due to Mg2+ inhibitory actions, its addition 
often reduced channel P0 to close to zero. Therefore Mg2+ was omitted in the majority 
of later experiments in order to obtain meaningful measurements of control activity. 
Fig. 3 .III C-E shows that at different cis Ca2+ and ATP concentrations, 3 mM Mg2\ota1 
(1.26 mM Mg2+free) was able to decrease fractional mean current (J'F), and induce Mg2+ 
inhibition typical of RyR channels. In the presence of 1 mM Ca2+, Mg2+induced a 2.5-
fold decrease in channel activity (Fig. 3.III C). At 1 mM cis Ca2+, Mg2+reduced channel 
J'F in the absence and presence of ATP by 43 and 56%, respectively (Fig. 3.III D-E). At 
1 nM Ca2+, Mg2+free was 2.82 mM in the absence of ATP and 1.2 mM in the presence of 
ATP, due to Mg2+ and Ca2+ complexing with ATP. It is interesting that in the presence 
of 1 nM Ca2+ and 2 mM ATP, Mg2+ could reduce channel activity by a greater amount 
than when ATP was absent (even though ATP significantly lowers Mg2+free). Mg2+-ATP 
has been reported to regulate RyRs (Meissner, 1994), and may be inhibiting RyR 
activity at this very low cis Ca2+ concentration. We cannot rule out that these 
unexpected results may also be due to channel variation, since a detailed study of Mg2+ 
inhibition was not performed. The aim of this limited Mg2+ study was simply to 
determine whether the native RyRs used throughout this study exhibited typical RyR 
behaviour. 
3.2.2.4 Ruthenium red 
Ruthenium red has been shown to block Ca2+ transport in both mitochondria (Moore, 
1971) and RyRs (Ma, 1993). Addition of 10 µM cis ruthenium red reduced native 
channel activity to virtually zero (P0 = 0.007 at+ 40 mV and 0.003 at- 40 mV; Fig. 
3.IV A-D). The channel was blocked within 15 s of addition with only very brief and 
infrequent openings observed. Routinely, ruthenium red was added at the end of an 
experiment, to confirm the channel was a RyR. 
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3.2.2.5 Ryanodine 
Plant alkaloid ryanodine is able to reduce RyR channel to a low (approximately 50%) 
conductance level, and 'locks' the channel into this state (Rousseau and Meissner, 
1989). Ryanodine (3HRy) binding is dependent on the RyR being in a partially or fully 
open state. The use of ryanodine was limited in this study, as in many experiments, 
ligands and proteins (for example exogenous CSQ) induced substantial channel closure, 
with very brief and infrequent openings. In these cases, it was preferential to add 
ruthenium red (which does not require the RyR to be active for binding) to confirm that 
the channel was a RyR. 
Fig. 3.IV E-H shows a channel whose activity upon addition of cis 10 µM ryanodine, 
was reduced to an approximately 50% conductance state, indicated by an arrow to the 
left of traces F &H. No further openings above a 50% conductance level were observed 
within 5 min of addition of ryanodine. The 50% block occurred within 20 s of 
ryanodine addition. 
3.2.3 CSQ purification 
The SR terminal cisternae contains two membrane components, the JFM ( containing the 
RyR, CSQ, triadin and junctin) and the extra junctional membrane containing the 
calcium-pump (Ca2+-ATPase). Exposure of the terminal cisternae of the SR toTriton-X 
100 (in the presence of Ca2+), leads to Ca2+-ATPase extraction and results in the 
formation of an insoluble JFM pellet, leaving Ca2+ -ATPase in the supernatant (Costello 
et al., 1986). Addition of 500 mM NaCl to the JFM disrupts the ionic interactions, 
tethering CSQ to the RyR/triadin/junctin (RyR/T/J) complex, allowing selective 
dissociation of CSQ from this complex (Fig. 3.V). Thus, CS(ls ionic binding properties 
may be exploited to successfully dissociate this protein from solubilized JFM. Such 
treatment allowed partial purification of CSQ, which was contaminated with a protein, 
seen as a faint band at approximately 30 kDa. The 30 kDa protein was removed 
following a second overnight dialysis. The contaminating protein has not been 
positively identified in this study, but it may be the 30 kDa luminal protein reported by 
Yamaguchi et al. (1995). The presence of the 30 kDa protein had no effect on RyR 
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Fig. 3.IV. Response of native RyRs to cis modulators ryanodine and ruthenium red. (A) Control activity with 250/250 mM 
(cisltrans) Cs\ (B) after addition of 10 µM ruthenium red; (C&D) repeat of A&B, at- 40 mV; (E) control activity with 
250/250 mM (cis/trans) Cs+; (F) after addition of 10 µM ryanodine; (G&H) repeat ofE&F, at- 40 mV. V m-Ecs+ was +40mV under 
conditions A,B,E,F and -40m V under conditions C,D,G,H. Single channel opening is upward from the zero current level ( +40 m V) 
and downward from the zero current level (-40 m V; continuous line) to the maximum open conductance (broken line). Open 
probability (P0 ) of the channel is shown to the right of the current traces. The arrow in F&H indicates an,_, 50% reduction in 
maximum conductance of the channels upon exposure to ryanodine. Channel traces in the presence of ryanodine and ruthenium red 
were recorded within 90 s of drug addition. 
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Fig. 3.V. Purification of CSQ. SDS-PAGE (12%) showing a 55 kDa 
band in heavy SR (lane 1) and in supernatant after exposure of JFM to 
500 mM NaCl (lane 2). The band was identified as CSQ by anti-CSQ 
antibody (lane 3), whilst no triadin was detected by anti-triadin 
antibody in the isolated CSQ sample (lane 4) . The position of 
molecular weight markers is shown to the left of lane 1. Proteins were 
transferred onto Immobillon-P PVDF membranes, prior to probing 
with anti-CSQ and anti-triadin antibodies. There was no band 
observed at 26 kDa in the isolated CSQ sample (lane 2) that would 
correspond to junctin ( one of the major CSQ binding protein in the 
lumen). Nott.the appearance of a very faint band (indicated by a red 
arrow), thought to be the 30 kDa protein. 
Chapter 3 
activity and did not alter the RyR response to CSQ (refer to Figs. 3 .XI & 3 .XII and 
Section 3.2.5.3). 
This method of CSQ isolation allows removal of CSQ from solubilized JFM, without 
removing triadin or junctin. From 100 g of tissue, up to 5 mg of CSQ was isolated (see 
Chapter 2, Section 2.5). SDS-Page and subsequent Coomassie stain showed that 
isolated CSQ did not contain protein bands at approximately 95 or 26 kDa (Fig. 3.V, 
lane 2), which would correspond to triadin and junctin respectively. Furthermore, 
immunodetection with anti-triadin antibody showed no visible levels of triadin in the 
isolate (Fig. 3.V lane D). Rabbit skeletal junctin has not been sequenced and antibodies 
to sequenced isoforms (such as canine skeletal and canine cardiac junctin) do not 
cross-react with the rabbit skeletal anti-junctin antibody (personal communication, Prof. 
Larry Jones, Krannert Institute of Cardiology, Indianapolis, IN, USA), therefore junctin 
immunodetection was not performed. It was of paramount importance in this study that 
triadin and junctin remained associated with the RyR and did not contaminate the 
isolated CSQ, for three reasons. Firstly, in single channel studies, luminal (or trans) 
ionic strength was raised to dissociate CSQ from the RyR/T /J complex, and exogenous 
CSQ was re-associated with the channel. Thus, triadin and junctin needed to remain 
associated with the RyR to bind the added CSQ. Secondly, to show any regulation of 
the native RyR by CSQ, it was important that all three proteins proposed to bind CSQ 
(the RyR, triadin and junctin) were present. Finally, to be certain that any modulation of 
the RyR by exogenous CSQ was CSQ-specific, it was important that triadin and junctin 
did not contaminate the CSQ preparation, particularly as triadin has been shown to 
inhibit RyR activity (Ohkura et al., 1998). 
3.2.4 Increasing ionic strength - dissociation of CSQ from SR 
vesicle in lipid bilayers 
The high ionic strength CSQ purification method ( see above and Chapter 2, Section 
2.5.2) was modified to dissociate CSQ from SR vesicles in lipid bilayers. Channel 
activity was analysed at potentials 40 m V positive and negative to the Cs+ reversal 
potential (see Chapter 2, Section 2.11.4). In all the bilayer experiments presented in this 
chapter from here on the composition of cis and trans solutions i.s , as follows, unless 
otherwise specified: cis 100 nM free Ca2+(1 mM CaC12 plus 4.5 mM BAPTA), (in mM) 
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Fig 3.VI. Increasing trans ionic strength activates RyRs. (A) 
Control activity with 250/250 mM Cs+; (B) after raising trans 
ionic strength to 500 mM cs+; (C) fractional mean current (J 'F) 
of average data (n=59 channels), under conditions shown in 
A&B. Cisltrans [Cs+] are shown above the records in A&B. V m 
- Ecs+ was +40m V under all conditions. Single channel opening 
is upwards from zero current level ( continuous line) to 
maximum conductance (broken line) . Asterisks (*) indicate 
average values significantly different from control (p<0.05, t-
test). 
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2 ATP, and 250 Cs+; trans (mM) 250 or 500 Cs+ and 1 Ca2+_ In the case of average data 
presented in this chapter, channels were analyzed for 30 s, unless stated otherwise. After 
incorporating native SR into lipid bilayers, the observed RyR openings were both 
infrequent and brief (Fig. 3.VI A). Addition of250 mM Cs+ to the trans chamber 
(which raises trans Cs+ to 500 mM) induced a 2.3-fold increase in J'F (Fig. 3.VI C). In 
three channels, RyRs were exposed to high trans Cs+ for up to 10 min. In these 
channels, after the initial increase ( occurring at 89 s ± 15 s ), no further significant 
change in activity was observed, indicating that the activation was a sustainable change 
in channel gating and probably not due to random variations in channel gating ( see 
Section 3.2.4.1.2). 
3.2.4.1 Irreversible increase in channel activity 
3.2.4.1.1 5 00mM Cs+ -induced activity 
To determine whether the increase in activity seen after addition of trans Cs+ was due to 
ionic strength increase per se, or whether some irreversible event (such as protein 
dissociation) had occurred, the trans chamber was perfused and the solution replaced 
with 250 mM Cs+ (the solution used for control recording). In these channels, control 
cis solution also contained 3 mM MgC}i. As previously shown in Figs. 3.\1, channel 
activity increased upon Cs+ increase to 500 mM, with both P0 and 10 showing 
significant rises (2.3 and 13-fold, respectively). Activity then remained unchanged 
when Cs+ was restored to control levels (via perfusion) with 250 mM Cs+ (Figs. 3.VII 
B-C & 3.VIII). In fact, P0 and T0 did not change further after subsequent Cs+ additions 
and further perfusion. Although burst Tc fell in 5 out of 8 RyRs with 500 mM Cs+, 
average burst Tc did not change significantly (Fig. 3.VIII), due to channel variability. 
An irreversible increase in channel activity is consistent with CSQ removal. Once 
dissociated, CSQ did not re-associate, because it was diluted enormously in the trans 
chamber solution, and was further diluted following perfusion of the trans bath 
(perfusion of 10 chamber volume results in a dilution of 1000). 
The activation induced by raising [Cs+] was not so pronounced at negative potentials 
(Figs. 3.VII & 3.VIII). An increased in J'F in all channels was seen, from 0.137 + 0.05 
to 0.441 + 0.175 (p < 0.05), a 3.2-fold increase. Following perfusion, there was a small, 
but insignificant drop in J'F, which was still 2.2-fold higher (p < 0.05, sign test) than 
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Fig 3.VII. Increasing trans ionic strength to 500 mM causes an 
irreversible increase in single RyR channel activity. (A) Control 
activity with 250 mM trans cs+in the presence of 3 mM MgC12 ; (B) 
after increasing trans cs+ to 500 mM with CsCl; (C) perfusing the 
trans chamber with 250 mM Cs\ (D&E) repeat ofB&C. F-J 
repeat of A-E, but at--40mV. V m-Ecs+ was +40mV for A-E and -
40mV for F-J. Single channel opening is upward from the zero 
current level (+40 mV) and downward from the zero current level 
(-40 mM; continuous line) to the maximum open conductance 
(broken line). Cisltrans [Cs+] is shown above each record. 
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activity recorded pre-Cs+ increase (Fig. 3. VIII). Due to the number of multiple channel 
recordings in this data set, T0 , Tc and F0 were not analysed. In two bilayers with single 
channels, the Cs+-induced T0 increase was 9.6 and 4.0-fold. Neither Tc nor F0 changed 
significantly (the Cs +-induced F 0 increase was <1.2-fold from control, whilst Tc 
decreased <1.4-fold from control). 
3.2.4.1.2 Time-dependence of RyR activation 
Both Sakowska (2000) and Gallant et al. (2001) reported a time-dependent RyR 
activation in channels recorded for 10 min - 1 h. There is no apparent experimental 
basis for this; recordings were done without the addition of activators. Even without 
standard cis activators µM Ca2+ and mM ATP, distinct activity increases were observed 
in some cases (Sakowska, 2000), but not always (Gallant et al., 2001). In light of these 
observations, all efforts were made to show reversal of activation by either removal of 
the ligands inducing activity rise, or replacement of an inhibitory protein ( e.g. CSQ). 
However, it should be noted that the average time a channel was recorded was 15 min, 
and spontaneous PO changes over this time frame when reported were ~ 10% (Sakowska, 
2000). In all experiments presented here, increasing trans ionic strength resulted in a Po 
or J'F increase to two to four times higher than control, so even if part of this increase 
was due to an intrinsic increase in channel activity, a substantial proportion of RyR 
activation is a direct result of the application of high Cs+. It will be shown later (see 
Section 3 .2.5) that subsequent addition of CSQ reduced activity to within 95% of the 
original control activity. This indicates that intrinsic activation was less than 6% in the 
present experiments. 
3.2.4.1.3 ATP phosphorylation 
To discount possible effects of ATP phosphorylation, bilayers were formed in both the 
presence and absence of 2 mM ATP. Dulhunty et al. (2001) have shown that ATP can 
irreversibly phosphorylate approximately 60% of RyRs and this results in activation 
becoming irreversible after 5 and 10 min exposure to ATP. This time frame is the 
approximate time after ATP exposure that a rise in activity was observed following an 
increase in Cs+ concentration to 500 mM. Five channels were incorporated into bilayers 
and-were incubated with ATP for at least 15 min before channel incorporation, which 
was at least 20 min before activity was recorded in the presence of 500 mM trans Cs+ 
(Fig 3 .IX). These channels responded to 500 mM Cs+ in a similar fashion to channels 
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Table 3.11. Comparison of I' /l'c of activity after exposure to 500 mM Cs+. The 
effects of phosphorylation of Ry Rs by ATP addition on observed activity. 
ATP added,.._, 5 min before exposure to 500 mM Cs+ 2.54 ± 0.242 
ATP added >20 min before exposure to 500 mM Cs+ 2.34 ± 0.25 *1 
RyR phosphorylation in the presence of ATP does not account for the increase in RyR 
activity observed after addition of 500 mM Cs+. A marginally smaller (* 1, p < 0.15) 
relative mean current, J'/I'c was observed 20 min after ATP addition, when ATP had 
presumably phosphorylated the ~hannel before the experiment commenced 
(phosphorylation of the RyR has been shown to occur within 10 min of addition of 
ATP; Dulhunty et al, 2001). 
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which were exposed to 2 mM ATP approximately 2 min before increasing [Cs+] (and 
therefore may have undergone ATP phosphorylation during the CSQ dissociation 
period; compare Figs. 3.VIII & 3.IX). Fig. 3.IX shows a typical increase in relative 
mean current, test relative to control (/'//'c, representing a change in J 'F from 0.054 + 
0.01 to 0.135 + 0.04) observed after exposure to 500 mM Cs+ shown at least 22 min 
after addition of ATP to the cis chamber. Presumably if ATP phosphorylation were 
occurring, phosphorylation-dependent effects would have induced a rise '"~">'~activity 
well before this stage. 
The activity of channels after prolonged exposure to ATP (Fig. 3.IX) did not look very 
different from that after brief exposure to ATP (Fig 3.VIII above). This was not 
surprising because ATP-induced phosphorylation simultaneously causes an irreversible 
activation of RyRs and reduces the activation of the channel by ligand binding of ATP. 
Therefore phosphorylation is not necessarily reflected in an increase in activity during 
response to ATP; it is seen as a failure to reverse the activation by ATP removal 
(Dulhunty et al., 2001). 
Table 3.II illustrates that the change in /'//'c for those channels thought to have 
undergone ATP phosphorylation well before Cs+ was increased to 500 mM, was not 
different from channels exposed to ATP approximately 5 min before [Cs+] increase ( and 
the subsequent channel activity rise induced by CSQ dissociation). These data suggest 
that ATP phosphorylation is not responsible for the activation induced when trans Cs+ 
is increased to 500 mM. 
3.2.5 
3.2.5.1 
Re-association of CSQ 
The effect of trans CSQ on the single channel parameters of 
channels previously exposed to 500 mM Cs+ 
At +40 mV, /'//'c (which initially increased 3-fold from control levels upon [Cs+] 
increase, and was not altered by subsequent reduction of Cs+ from 500 to 250 mM) was 
reduced 2.3-fold by the addition of 20 µg CSQ (Fig. 3.X). Whilst marginally higher 
than control levels, J '/l'c recorded upon re-association of CSQ did not differ 
significantly from control (Fig. 3.X E). At -40 m V, the drop induced by CSQ addition 
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Fig. 3.IX. Response of potentially phosphorylated Ry Rs to an 
increase in [Cs+] (250 to 500 mM trans Cs+). (A) Control activity, 15 
min after the addition of ATP to the chamber ( approximately 20 mins 
before channel activity rise was observed); (B) at least 3 min after 
trans increase to 500 mM cs+, cis/trans Cs+ is shown above A&B; (C) 
average data (n = 5) for relative mean current (test relative to control; 
I'/I'c) under conditions shown in A&B. V m-Ecs+ was +40111V under all 
conditions. Single channel opening is upward from the zero current 
level ( continuous line) to the maximum open conductance ( o, o1 and o2; 
broken line). Asterisks (*) indicate average values significantly 
different from control (p<0.05, t-test). 
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Fig. 3.X. The effect of increasing trans ionic strength to 500 mM can 
be reversed by the addition of 20 µg CSQ. (A) Control activity with 
250 mM trans cs+; (B) after increasing trans cs+ to 500 mM with 
CsCl; (C) perfusing the trans chamber with 250 mM Cs+; (D) addition 
of 20 µg trans CSQ. Cis/trans Cs+ is shown above records A-D; (E) 
Average data (n = 5) showing relative mean current - test relative to 
control (I'/J'c) under conditions shown in A-D at both +40 and -40 
mV. V rn-Ecs+ was +40mV under all conditions shown in A-D. Single 
channel opening is upward from the zero current level ( continuous 
line) to the maximum open conductance (broken line) . Asterisks (*) 
indicate average values significantly different from control, ** 
indicates activity significantly different from the previous conditions 
(p<0.05, t-test). 
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was less pronounced. The initial 1.9-fold increase in J'/I 'c due to ionic strength increase 
was only reversed 1.4-fold by CSQ addition. Despite this, channel activity was still not 
significantly different from control levels (P > 0.06, t-test; Fig. 3 .XE). It 1nay be that 
phosphorylation upon ATP addition, thought to be responsible for a small proportion of 
RyR activation (see Section 3.2.4.1.3), could be responsible for an irreversible 
component of the activation of Ry Rs during exposure to high ionic strength, and may 
explain CSQs inability to fully restore control activity of RyRs. Intrinsic RyR activation 
( discussed above) may also contribute to this irreversible increase in activity. 
As it appears that CSQ-induced changes in RyR activity are not voltage-dependent, data 
obtained only at positive potentials is reported in subsequent experiments. The only 
exception to this is when a new RyR or CSQ preparation was used, and in Chapter 5, 
when investigation the role of luminal Ca2+ on RyR activity. 
3.2.5.2 Channel-CSQ dose response curve 
The irreversible increase in channel activity resulting from the increase in [Cs+] was 
reversed by the addition of 20 µg CSQ to the trans chamber. Fig 3 .XI is a dose response 
curve, illustrating the response of CSQ-depleted RyRs (after exposure to 500 mM Cs+ 
and subsequent perfusion with 250 mM Cs+, resulting in a 2.6-fold increase in P0 ) to 
various [CSQ], over a 10 min time period. 
There was no significant change in channel activity of RyRs exposed to 0, 1, 2 or 5 µg 
CSQ, but channel PO was significantly lowered upon addition of 20 or 50 µg CSQ. In 
CSQ-responsive channels (those exposed to> 20µg CSQ), activity was recorded for 
15 min after CSQ addition, with no detectable alteration in channel activity observed 
after the initial drop. Presumably, CSQ binds to the RyR/T/J complex with a high 
affinity, as it is able to sustain inhibition for 10 min. Either CSQ associates and remains 
associated, or if CSQ does dissociate, it re-associates quickly, so that the overall 
inhibition on RyR activity is maintained. The latter is unlikely because CSQ remains 
associated with the native RyR channel until dissociation with high ionic strength or 
other 1nanipulations (see Chapter 5), when the [CSQ] in the trans chamber is infinitely 
low. As there was no observable difference in the inhibition shown at 20 µg or 50 µg, 
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Fig. 3.XI. Concentration dependent inhibition of native Ry Rs by 
exogenous CSQ. Data is presented as open probability (P0 ) at various 
[CSQ]. Error bars are SEM, except for data point at 2 µg CSQ, where 
n = 3 and SD is presented. V m -Ecs+ was +40m V. Asterisks * indicates 
a significantly lower P0 than at control (0 µg CSQ; P<0.05, t-test). 
Each point is the mean PO for 3-7 channels. 
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the lower concentration was chosen for further experiments (Figs. 3.X, 3.XII-III). The 
dose response curve is shown for activity obtained at +40 m V. 
3.2.5.3 Effect of the 30 kDa protein on channel activity 
In another set of experiments, the effect of CSQ containing the contaminant 30 kDa 
protein was tested on CSQ-dissociated RyRs. After Cs+ increase to 500 mM and 
subsequent trans perfusion (with expected sustained increase in channel activity), 20 µg 
CSQ + the 30 kDa protein essentially reversed the increase in J'/I'c (Fig. 3.XII). A 
second overnight dialysis of the CSQ preparation containing the 30 kDa protein (refer 
to Chapter 2, Section 2.5.3 for details) was sufficient to remove this protein from the 
CSQ preparation, (Fig. 3.V). In both the absence and presence of the 30 kDa 
contaminating protein, CSQ was able to reverse the ionic strength-induced increase in 
channel activity to levels close to control (CSQ with the 30 kDa protein: J'/J 'c = 1.07 
and 0.102 (n=2); CSQ without the 30 kDa protein: J'/I'c = 1.378 + 0.31 (n=5), showing 
that CSQ and not the 30 kDa protein, induced channel inhibition. 
3.2.5.4 Effect of heat-treated CSQ and CSQ storage buff er 
To ensure that RyR inhibition was CSQ-induced, rather than a non-specific effect of the 
protein or a component of the buffer in which it was stored, both heat-treated CSQ in 
storage buffer and CSQ storage buffer (without CSQ) were added to the trans chamber. 
A volume of 100 µl CSQ buffer minus CSQ was added to the trans chamber, which was 
in excess (by 15 - 50%) of the volume of buffer added to channels, as part of the CSQ 
re-association experiments. It was assumed that boiling CSQ for 10 min would denature 
the protein. Fig. 3.XIII A-C shows that addition of storage buffer minus CSQ, after the 
ionic strength increase to 500 mM (resulting in an 2.1-fold increase in J'/I'c, which was 
maintained after subsequent perfusion with 250 mM Cs+ ( data not shown)), did not 
alter. Neither storage buffer minus CSQ, nor the addition of 20 µg heat-treated CSQ in 
storage buffer (Fig. 3.XIII D-F) reduced channel activity from the high [Cs +]-induced 
increase. In 6 channels, J'Fwas 0.54 ± 0.143 after exposure to high [Cs+] and 
0.57 ± 0.14 after 100 µl CSQ buffer minus CSQ, whilst in another 4 channels, J'F was 
0.35 ± 0.07 after dissociation (500 trans Cs+ and subsequent perfusion with 250 mM 
Cs+) and 0.33 ± 0.06 after addition of trans heat-treated CSQ. Thus, channel inhibition 
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Fig. 3.XII. Increasing trans ionic strength to 500 mM can be reversed 
by the addition of 20 µg CSQ + 30 kDa protein. (A) Control activity 
with 250 mM trans cs+; (B) after increasing trans cs+ to 500 mM with 
CsCl; (C) perfusing the trans chamber with 250 mM cs+; (D) Addition 
of 20 µg CSQ + contaminating 30 kDa protein. Cis/trans Cs+ is shown 
above A-D; (E) Average data (bar graph, n = 2) showing fractional 
mean current (J'F) under conditions shown in A-D. Nested line graph 
shows data from each of the two individual channels. V m -Ecs+ was 
+40m V under all conditions. Single channel opening is upward from 
the zero current level (continuous line) to the maximum open 
conductance (broken line) . 
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Fig 3.XIII. Neither CSQ storage buffer (without CSQJ nor heat 
treated CSQ in storage buffer reversed activity induced by CSQ 
dissociation in single channel RyRs. (A) Control activity with 
250 rnM trans cs+, after increasing cs+ to 500 rnM (to dissociate CSQ) 
and trans perfusion with 250 rnM Cs+; (B) after addition of 100 µl CSQ 
storage buffer (without CSQ): (mM) 1 CaC12, 10 TES, 100 KCl; (C) 
average data (n = 6) for relative mean current, I'/I'c (test relative to 
control conditions shown in A) for A&B; (D) control activity with 
250 rnM trans cs+, after increasing Cs+ to 500 rnM (to dissociate, CSQ) 
and trans perfusion with 250 rnM cs+; (E) after addition of 20 µg heat 
treated CSQ. (F) average data (n = 4) for , I'/I'c (test relative to control 
conditions shown in D) for C&D. No significant differences in activity 
from control was observed for either heat-treated CSQ or CSQ buffer. 
V m -Ecs+ was +40m V under all conditions. Single channel opening is 
upward from the zero current level ( continuous line) to the maximum 
open conductance (broken line). 
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by buffered CSQ can be attributed to CSQ alone, and not a non-specific effect due to 
the presence of protein or a component of the buffering system. Ms Magda Sakowska 
undertook the study involving the addition of heat-treated CSQ under my supervision. 
3.2.6 Anti-CSQ antibody inhibits RyR single channel activity 
3.2.6.1 Specificity of anti-CSQ antibody to CSQ 
Polyclonal antibodies display a variety of affinities and activity to the antigen in 
question. Provided that there is no cross-reactivity with other antigens, polyclonal 
antibodies are a more effective way of identifying antigens than monoclonal antibodies. 
A polyclonal anti-CSQ antibody was tested for specificity to CSQ using SDS-Page and 
Western blot. The potential for non-specific antibody interactions were examined. 
Fig. 3.XIV (lane 2) shows anti-CSQ antibody binding specifically to a protein 
resolving at approximately 55 kDa (CSQ) in a SR sample, with no other bands visible in 
the Western blot. Anti-CSQ antibody was used at a concentration of ten times that 
normally used in this laboratory, to optimise the chance of non-specific antibody 
binding. These results indicate that any effects of anti-CSQ antibody on RyR channel 
behaviour were likely to be induced by anti-CSQ antibody binding to CSQ alone. 
The effects of non-specific interaction of IgG with CSQ were also examined in a second 
control experiment. IgG was added to the trans chamber at 0.15 - 1.5 µg and did not 
alter RyR J'F, despite incubation for 10 min, and frequent stirring ( every 30-45 s; Fig. 
3.XV). This confirms the specificity of anti-CSQ antibody for CSQ and shows that the 
effects induced by anti-CSQ antibody addition (below) were not simply due to the 
binding of non-specific IgG. The channels presented as part of Fig. 3.XV were 
undertaken (in part) by Ms Magda Sakowska under my supervision. 
Brandt et al. (1992) first showed that the application of an antibody specific for triadin 
could inhibit the slow phase of depolarisation-induced SR Ca2+ release, but not the fast 
component, demonstrating that an antibody to a luminal RyR regulating protein may 
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Fig. 3.XIV. SDS-Page (12%) and Western blot, showing the 
specificity of the anti-CSQ antibody for CSQ in native SR. The band 
resolving at ,__,5 5 kDa in the SR sample (lane 1) was identified as CSQ 
by anti-CSQ antibody (lane 2). Note that anti-CSQ antibody does not 
detect the presence of any other proteins within the SR isolate. The 
position of molecular weight markers is shown to the left of lane 1. 
Proteins were transferred onto Immobillon-P PVDF membranes, prior 
to probing with anti-CSQ antibody. 
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Fig 3.XV. lgG does notajfect single RyR channel activity. (A) Single 
channel activity under control conditions; (B) after adding 0.5 µg/ml 
IgG to the trans solution; (C) after adding 1.5 µg/ml IgG to the trans 
solution, cisltrans cs+ is shown above record A; (D), dose response 
curve for for average data (n=4) for relative mean current (I'/I'J. All 
I '/J'c were insignificantly different from control (0 µg IgG). V m-Ecs 
was at +40 m V, single channel opening is upward from the zero current 
( continuous line) to the maximum open conductance (broken line). 
Instead of2 mM cis ATP, 2 mM AMP-PCP was used to activate the 
channels. 
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induce regulatory changes on the RyR. Following on from this idea (and to further 
investigate the interaction between the RyR and CSQ), the effects of a polyclonal 
anti-CSQ antibody on RyR activity were investigated. Addition of 0.5 µg anti-CSQ 
antibody (stored in 0.02% NaN3) to the trans chamber significantly inhibited RyRs (Fig. 
3.XVI), at +40 m V (in these channels, control cis solution also contained 3 mM MgCb). 
Inhibition occurred within 30 s of the antibody being added to the trans chamber (and 
subsequent stirring). Anti-CSQ antibody addition resulted in a 5.9-fold reduction in P0 
(Fig. 3.XVI C), due to a 5.1-fold lengthening of burst Tc (Fig. 3.XVI E) causing a 
5.7-fold reduction in channel F0 (Fig. 3.XVI F). No significant change in T0 was 
observed. At negative potentials, 0.5 µg anti-CSQ antibody induced a 3.6-fold fall in P 0 , 
due to a 2.8-fold reduction in F0 (Fig. 3.XVII). 
Anti-CSQ antibody did not alter activity in 10 of 10 RyRs when added to the trans 
solution following treatment with 500 mM trans Cs+, which increased J'/I 'c 2.3-fold 
(Fig. 3.XVIII). Conversely, RyR activity fell in each of 3 experiments in which RyRs 
were exposed to antibody (0.5 µg/ml) after they had been exposed to 500 mM trans 
Cs+, and then to 20 µg purified CSQ. J'F fell from 0.05 + 0.02 (after re-association of 
CSQ) to 0.016 + 0.007 (addition of anti-CSQ antibody; p<-0.05, t-test). Together these 
results suggest that ( a) the antibody inhibited RyRs by binding to CSQ and (b) confirms 
that the high ionic strength solution dissociated CSQ from the RyR complex. Two of 
ten channel presented in this set of experiments contained 3 mM cis MgC}i. 
NaN3, a commonly used laboratory preservative, was used at 0.02% in the anti-CSQ 
antibody solution. In muscle isolation, NaN3 is commonly added to inhibit H+-ATPase 
activity and block mitochondrial ATP-dependent calcium transport. To be certain that 
anti-CSQ antibody and not NaN3 was inhibiting RyR activity, NaN3 was added to the 
trans chamber at the same concentration as that added as part of the anti-CSQ antibody 
solution (60 nM which is approximately 4x10-6 % (w/v)). In 3 channels, no change in 
J 'F was observed upon NaN3 addition (Fig. 3.XIX). In a representative channel, [NaN3] 
was increased to tiC f'M, with no alteration in channel activity observed. Hence, it is 
the anti-CSQ antibody, and not NaN 3, that inhibits the channel. Two of the three 
channels presented in this section were obtained by Ms Magda Sakowska (under my 
supervision). 
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Fig. 3.XVI. Anti-CSQ antibody reduces single RyR channel activity 
at +40 m V. (A) Single channel activity under control conditions; (B) 
after adding 0.5 µg/ml anti-CSQ antibody to the trans chamber. In 
A&B, [Cs+]s cisltrans are shown above each record; (C-F) average 
data for P 0 (C), T0 (D), F 0 (E) and burst Tc (F), under control 
conditions (A) and after adding anti-CSQ antibody (B). Average data 
represent each of 6 individual channels, which are means, with SE 
error bars. Nested line graph shows data from each of 6 channels. V m-
Ecs was at +40 mV, single channel opening is upward from the zero 
current ( continuous line) to the maximum open conductance (broken 
line). An * indicates average values significantly different from 
control (p<0.05, t-test). 
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Fig. 3.XVII. At -40 m V, anti-CSQ antibody reduces 
single RyR channel activity. (A) Single channel activity 
under control conditions; (B) after adding 0.5 µg/ml 
anti-CSQ antibody to the trans solution. In A&B, 
cis/trans [ cs+] are shown above each record; ( C-F) 
average data (n = 6) for P0 (C), T0 (D), F0 (E) and burst 
Tc (F), under control conditions (A) and after adding 
anti-CSQ antibody (B). V m-Ecs was at -40 mV, single 
channel opening is upward from the zero current 
( continuous line) to the maximum open conductance 
(broken line). An * indicates average values 
significantly different from control conditions (p<0.05, 
t-test). 
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Fig. 3.XVIII. Anti-CSQ antibody does not alter activity in 
CSQ-depleted single RyRs. (A) Control channel activity; (B) after 
increasing trans Cs+ to 500 mM; (C) after adding 0.5 µg/ml anti-CSQ 
antibody to the trans chamber. Cis/trans cs+ are shown above traces A-
B;(D) Average mean c_urrent (test relative to control ; J '/J 'c; n = 9) 
under control conditions control (A), after increasing trans Cs+ to 500 
mM (B) and after addition of anti-CSQ (C). V m-Ecs was +40 mV, 
single channel opening is upward from zero current ( continuous line) to 
the maximum open conductance (broken line). In 2 of the 10 channels, 
3 mM MgC12 cis was used. The * indicates that there is a significant 
increase in J'/J 'c above after increasing trans ionic strength to 500 mM 
(p<0.05, t-test). 
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3.2.6.2 Response of Ry Rs to an in-house anti-CSQ antibody 
The results in the previous section show that anti-CSQ antibody can be used as a tool in 
determining whether or not RyR channels are associated with CSQ, i.e. whether the 
RyR/T/J complex has CSQ attached (see Chapter 4, Section 4.2.1.). The predominantly 
fast twitch rabbit CSQ anti-CSQ antibody used in this study was purchased from Swant 
chemicals (Switzerland), and the epitope of CSQ this antibody is raised against was 
unknown. An in-house polyclonal anti-CSQ antibody was generated (see Chapter 2, 
Section 2.10), because the commercial preparation of anti-CSQ antibody was no longer 
available. The in-house antibody was made against the whole CSQ protein. To 
determine whether the in-house anti-CSQ antibody induced similar RyR activity 
responses to commercially available anti-CSQ antibody, both the serum containing anti-
CSQ antibody and the first bleed serum (rabbit serum obtained before CSQ inoculation) 
were added to RyRs incorporated in bilayers. 
3. 2. 6. 2.1 Single channels response to pre-inoculation bleed serum 
Addition ofup to 0.43 mg/ml pre-inoculation bleed serum was added to the trans 
chamber in 3 channels, stirring every min for 10 min, and as expected, the 
pre-inoculation bleed serum did not alter channel activity from levels recorded under 
standard control conditions (see Section 3.2.1 for control conditions; Fig. 3.XX A-C). 
3.2.6.2.2 Single channels response to final bleed serum 
Between 1 and 800 µg final bleed serum was added to the trans chamber, and similar to 
the results observed upon addition of the pre-inoculation bleed serum to the trans 
chamber, in-house anti-CSQ antibody did not alter RyR activity. J'Fwas 0.066 + 0.014 
under control conditions and 0.062 + 0.015 after addition of serum containing anti-CSQ 
antibody (Fig. 3.XX D-E). After addition, the channels were recorded for up to 10 min, 
stirring every minute, to optimise anti-CSQ antibody binding, with no change in J'F· 
Unlike the commercially available anti-CSQ antibody, the in-house anti-CSQ antibody 
did not induce any observable alterations in RyR activity. 
It is of interest to compare the vastly different action of the commercially available and 
the in-house anti-CSQ antibodies, and their abilities to modulate RyR activity. The 
commercially available anti-CSQ antibody was able to significantly reduce RyR 
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Fig. 3.XIX. NaN3 does not inhibit single RyR channel activity. (A) 
Single channel activity under control conditions; (B) after adding 60 
nmol NaN3 to the trans solution. Cis/trans cs+ is shown above record 
A; (C) average data (n=3) for fractional mean current (J'F), for control 
{A) and after addition of NaN3 (B). There is no significant difference in 
J'F between control and NaN3. V m-Ecs was at +40 mV, single channel 
opening is upward from the zero current ( continuous line) to the 
maximum open conductance (broken line). 
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channel activity, whilst the in-house anti-CSQ antibody was unable to modulate RyR 
activity. The in-house anti-CSQ antibody was generated against the whole CSQ protein, 
but it is not known whether the commercially available anti-CSQ antibody was 
generated against the whole protein, or a small CSQ peptide. Immunodetection data 
.illustrates that the in-house anti-CSQ antibody binds to CSQ (see Fig.3 .XIX). It is 
possible that both the commercially available and the in-house anti-CSQ antibodies 
bind to different epitopes, with the commercially available binding influencing CSQ 
conformation, in a manner that allowed it to alter RyR activity. The in-house antibody 
either did not alter CSQ conformation upon binding, or altered it in a manner that did 
not influence RyR activity. 
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Fig. 3.XX. Neither pre-immune serumJ1or final bleed serum (after CSQ inoculation) inhibit single RyR channel 
activity. (A) Single channel activity under control conditions; (B) after adding 100 nmol pre-immune bleed to the 
trans chamber; (C) fractional mean current (J'F) plot, of two channels, under conditions A&B; (D) repeat of A; (E) 
after adding 100 nmol final bleed serum to the trans solution; (F) average data (n=4) for J'F, for conditions C&D. 
There is no significant difference in J'F between control and either the pre-inoculation or the final bleed serum. V m-
Ecs was at +40 m V, single channel opening is upward from the zero current ( continuous line) to the maximum open 
conductance (broken line, o, o1 & o2). 
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3.3 DISCUSSION 
The results in this section illustrate that associations of CSQ with the native RyR/T/J 
complex in lipid bilayers decreases channel activity in the presence of the cytoplasmic 
Ca2+ and ATP concentrations, and luminal Ca2+ concentrations which are present in 
resting muscle. High luminal ionic strength (500 mM) used to dissociate CSQ from the 
JFM, caused an increase in channel activity which was reversed by the re-association of 
exogenous CSQ. In addition, changes in CSQ induced by the binding of commercially 
available anti-CSQ antibody, further inhibit RyR activity. Finally, one anti-CSQ 
antibody emerged as a useful tool in detecting whether CSQ is associated with RyR/T/J 
complex. 
3.3.1 RyR identification and characterization 
As previously mentioned, RyRs are not the only ion channels found in SR (and in fact 
make up the minority of all channels found within the SR); occasionally small 
conductance ion channels were observed which were not responsive to ryanodine. 
Having said this, in 97% of all channel incorporations under the conditions used here, 
the ion channel was identified as a RyR by its response to various activators and 
inhibitors. For example, incorporated channels exhibited RyR-typical cis Ca2+ 
activation ( at µM Ca2+) and inhibition ( at mM and nM Ca2+). In addition, ATP induced 
channel activation, whilst Mg2+ inhibition was observed in channels under varying Ca2+ 
and ATP concentrations. Also, channel responses to ryanodine and ruthenium red were 
characteristic of RyRs. Ryanodine is a specific -f"\Odu,"i.oy; of RyRs, while ruthenium red 
has been shown to also affect Ca2+ channels in mitochondria, although mitochondrial 
ion channels are highly unlikely to be present in a SR isolate. All channels analysed 
displayed a conductance of approximately 15 0 - 525 pS in symmetric Cs+ (250 mM), 
which falls well within the ranges reported for skeletal muscle RyRs. 
3.3.1.1 Multichannel bilayers and substates 
It is worth noting that although channel activity with an amplitude of 
approximatelyl 5 pA indicated single RyR channel activity, this does not mean that only 
one channel was present in the bilayer. It was more likely ( due to the frequent 
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occurrence of two or more active channels under activating conditions), that more than 
one channel has incorporated into the bilayer, with only one of these channels active. 
Given the geometry of RyRs the JFM (two parallel rows of 30 run RyRs) and the size of 
the vesicles (100 run diameter), it would be surprising if vesicles did not contain several 
RyR, with only one or two active. 
Substate activity is a property of native RyRs. Subconductance levels may be due to 
channel gating events that are improperly resolved by the recording apparatus, or to the 
channel opening to several discrete conductance levels. These conductance levels are 
present in native channel activity and can be enhanced by the removal of a RyR 
associated protein (such as FKBP12), or addition of ryanodine, both of which results in 
functional alterations of RyRs. In the absence of the binding protein, three maintained 
subconductance levels are observed (25, 50 & 75% of maximal conductance; Ahem et 
al., 1997a; Brillantes et al., 1994), although brief openings to some levels were 
observed in the presence ofFKBP12. Studies ofFKBP depleted RyRs suggest that 
RyRs possess four coupled conduction pathways ( Liu and Pessah, 1994). The presence 
of subconductance levels in the present data could be due to FKBP 12 removal, but this 
is unlikely. There is no evidence to suggest that channels used in this study were 
lacking FKBP12. Indeed, Western blots reveal the presence ofFKBP12 in all native SR 
preparations examined by other members of the group. 
Subconductance levels of 25, 50, and 75% were observed in native RyRs (Fig. 3.I and 
Ahem et al., 1997a). The presence of substates corresponding to multiples of¼ of 
maximal activity suggests that at times, the four ion conduction pathways become 
uncoupled. The reason for spontaneous uncoupling remains unclear, but 
subconductance levels are observed in many types of ion channels. 
Subconductance states might be due to the presence of another small conductance 
channel in the bilayer, although this was unlikely, due to the relatively fast switch 
observed between a substate and maximal open state (see Fig. 3.I). 
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3.3.2 Dissociation and Re-association of CSQ from the RyR 
It was first shown by Ikemoto et al. (1989) that CSQ could be dissociated from 
solubilized JFM, simply by increasing surrounding ionic strength. As in the detailed 
lipid bilayer study presented here, a significant proportion of CSQ was selectively 
removed by exposure to 500 mM NaCl. Presumably, ionic bonds attaching CSQ to 
triadin and junctin are broken by the high ionic strength, leaving the protein free and 
easy to isolate. 
3.3.2.1 Re-association of CSQ 
In contrast to the findings of Ikemoto et al. ( 1989), who report CSQ-enhanced SR Ca2+ 
release, several lines of evidence have been presented here which show that CSQ may 
be an inhibitor of the RyR. Firstly, increasing ionic strength dissociated CSQ and 
irreversibly raised channel activity, suggesting that the RyR was inhibted by CSQ. 
Secondly, addition of exogenous CSQ returned RyR activity close to control levels. 
Finally, after increasing Cs+ to 500 mM (dissociating conditions), the RyR could no 
longer respond to the commercially produced anti-CSQ antibody, again suggesting that 
the increase in activity was due to dissociation of CSQ by the increase in ionic strength. 
Re-association of exogenous CSQ did not return channel P0 exactly to control levels, 
although CSQ addition did result in a significant fall from dissociation-induced 
activation. The failure of CSQ to fully reverse the increase in activity may be explained 
by two factors: first, spontaneous long-term RyR channel activation, which is thought to 
contribute to a small rise in J'F and P0 (see Section 3.2.4.1.2) and second, 
phosphorylation of the RyR by ATP (see Section 3.2.4.1.3). Both these phenomena may 
account for a small rise in channel activity from control levels, which could not be 
reversed by CSQ re-association. It seems unlikely that insufficient CSQ was 
re-associated with the RyR/T/J complex to fill all available binding sites, and hence be 
responsible for the inability of exogenous CSQ to totally reverse dissociation-induced 
RyR activation. Although an abundance of CSQ exists in the terminal cistemae 
( approximately 100 mg/ml SR; Williams and Beeler, 1986), the percentage of CSQ 
localized within the terminal cistemae and associated with the RyR/T/J complex is not 
precisely known. The addition of 20 µg CSQ to a bilayer bath with 1 or 2 RyRs 
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incorporated is well in excess of the amount of CSQ that is capable of binding to the 
RyR/T/J complex (as a rule, 33 - 100 µg of SR vesicles were added to the cis chamber 
in lipid bilayer recordings, even if it is assumed that all of this protein incorporated into 
the bilayer, CSQ only represents 7% of vesicle protein, approximately 2.3 - 7 µg). The 
addition of 50 µg CSQ did not alter channel activity any more than 20 µg, again 
suggesting that excess CSQ was available for binding to the RyR/T/J complex. 
Alternatively, lack of complete reversibility could suggest that high ionic strength 
permanently alters the ability of CSQ to interact with triadin and junctin and to alter 
RyR function. As CSQ can still bind to the RyR/T/J complex (Fig. 3.X-XII), believed to 
occur through triadin and junctin (Zhang et al., 1997), 500 mM Cs+ apparently does not 
dissociate triadin or junctin, or substantially alter the binding sites on these proteins for 
CSQ. Since triadin is thought to be linked to the RyR via a disulfide bridge, it is 
unlikely that it would be dissociated by high ionic strength. 
3.3.2.2 CSQ activation vs. inhibition of the RyR 
Several laboratories have reported that CSQ enhances SR Ca2+ release (Ikemoto et al., 
1989; Hidalgo and Donoso, 1995) and raises RyR activity (Kawasaki and Kasai, 1994; 
Ohkura et al., 1994; Ohkura et al., 1995). However, a preliminary report by Wang et al. 
(2001) suggests an inhibition ofRyRs by CSQ, similar to that presented here (Figs 3.III, 
IV & VII). It is interesting to ponder the reasons for the opposite effects of CSQ on RyR 
regulation. Several possibilities come to mind. Firstly, the study presented here used 
2 mM ATP to activate the RyR, added to mimic in vivo conditions. No other study of 
CSQ regulation ofRyRs employing the lipid bilayer techniques used this adenine 
nucleotide as an activator. Could it be that the inhibitory nature of CSQ is potentiated by 
the presence of ATP? The effects of luminal Ca2+ are vastly different in both the 
presence and absence of this ligand (Sitsapesan and Williams, 1995; Tripathy and 
Meissner, 1996). Secondly, it may be that the binding of ATP to the channel has 
long-range effects on the ability of CSQ to regulate Ca2+ release, and therefore alter 
RyR activity. Finally, it may not be the binding of ATP to the channel per se, but rather 
ATP-induced phosphorylation of the RyR that facilitates CSQ inhibition. Protein 
phosphorylation may induce a small conformational shift in the RyR, exposing CSQ 
inhibitory sites, or limiting access to CSQ, triadin or junctin activation sites. Whilst 
these last two proposals are highly speculative, it is possible that · 
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differences in laboratory techniques ( such as the absence or presence of ATP) might be 
responsible for the observed difference in CSQs ability to regulate the RyR. 
A second difference in technique is seen in experiments by Kawasaki and Kasai (1994), 
who used RyRs that had been depeleted of CSQ prior to incorporation into the bilayer, 
to study CSQ regulation of single channels. Kawasaki and Kasai (1994) show a 
minimal increase in RyR activity upon addition of CSQ (immediately after addition of 1 
mM trans Ca2+) , a rise that might not be significant (neither average datar nor statistical 
inference was reported). It was not until bath stirring (which occurred after both Ca2+ 
and CSQ had been added), that activity increased dramatically. Ca2+ was added because 
it has been reported that CSQ both associates with the RyR/T /J complex, and forms a 
polymer (required for high capacity Ca2+ binding) at the physiological Ca2+ 
concentration (1 mM; He et al., 1993). Possibly, RyR activity presumed to be induced 
by CSQ was in fact Ca2+ -induced. Increases in trans Ca2+ (from approximately Oto 10 
mM) are well known to activate native RyRs (Sitsapesan and Williams, 1995; Tripathy 
and Meissner, 1996). Similar effects of luminal Ca2+ on RyR activity are also described 
in Chapter 5 (see Section 5.3 for further discussion). 
The conflicting reports of the action of CSQ on RyR activity are not due simply to the 
incorporation of the RyR/T/J complex into an artificial membrane. This study and 
Wang et al. (2001), which report CSQ as an inhibitor ofRyRs, and Kawasaki and Kasai 
(1994), Ohkura et al. (1994) and Ohkura et al. (1995), who report CSQs ability to 
activate RyRs, all use the lipid bilayer technique. Another possible reason for the 
difference in CSQ regulation ofRyRs is that an essential co-protein may remain 
associated with RyRs after the relatively mild dissociating procedures used here and by 
Wang et al. (2001), but not in other studies. Exposure to 500 mM trans Cs+ (with 1 mM 
trans Ca2+) can disrupt charge-charge interactions between CSQ and junctin/triadin 
(Ikemoto et al., 1989), and thus may dissociate CSQ, while leaving other RyR 
co-proteins in place (Fig. 3.V; Wang et al., 2001 and Chapter 5, Section 5.2.3 and Figs. 
5.I) use ~ 0 mM trans Ca2+ to promote CSQ unfolding and possibly its reversion to the 
monomeric form, rendering CSQ unable to bind to the RyR/T/J complex (Wang et al., 
1998). These two (high ionic strength or high Ca2+) mild dissociating procedures are 
unlikely to result in the removal of triadin and junctin from the RyR, as this association 
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is covalent and therefore not ionic strength or Ca2+ -dependent ( see Chapter 5, Section 
5.2.1). 
On the other hand, it is clear that many proteins in addition to CSQ (including triadin 
and junctin), are dissociated from the SR by incubation with EGT A and CHAPS 
(Kawasaki and Kasai, 1994; Ohkura et al., 1994; Ohkura et al., 1995). In fact, Costello 
et al. (1986), after using EGTA to dissociate CSQ from other JFM proteins, showed a 
contaminant protein resolving around 97 kDa (which may have been triadin - the 
protein was not identified). Dissociation of essential proteins could account for the 
failure of CSQ to inhibit channel activity after incubation with EGTA or solubilization. 
The procedure could remove or modify triadin, a protein proposed here to be essential 
in the signalling pathway for CSQ inhibition of the RyR. As both Kawasaki and Kasai 
(1994) and Ohkura et al. (1998) use EGTA to prepare CSQ-depleted SR vesicles, could 
the activation observed by them be due to a direct CSQ-RyR interaction, as seen by 
Szegedi et al. (1999) and Herzog et al. (2000; see Chapter 4, Section 4.2.2.3 & 4.3 .2 for 
further investigation of this hypothesis)? 
Whilst the possible reasons for the reported differences observed in RyR regulation by 
CSQ are many, it should be noted that this study is the first to show the actions of both 
the removal and re-addition of CSQ from native RyRs incorporated into lipid bilayers. 
Re-association of CSQ restores the RyR activity close to pre-dissociation levels, 
providing the strongest evidence to date for CSQs role as a RyR regulator. 
3.3.2.3 Re-association of CSQ in preparations also containing the 30 kDa 
protein 
CSQ was able to restore activity to close to pre-dissociation levels whether or not a 
contaminant 30 kDa protein was present. If the 30 kDa protein can be partially isolated 
by increasing [NaCl] in a JFM preparation, it may also either fully or partially 
dissociate after [Cs+] increase to 500 mM Cs+ in the lipid bilayer setup. The identity of 
the 30 kDa protein is unknown, but a protein binding to CSQ, termed the 30 kDa 
protein (and thought to be an ADP/ATP translocase) has been reported recently and is 
postulated to have a role in RyR regulation (Yamaguchi and Kasai, 1998). It is 
interesting to note that this protein co-purified with CSQ, whilst other CSQ-binding 
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proteins, triadin and junctin, did not. Possibly, the addition of 500 mM NaCl did not 
raise the ionic strength to a high enough level to release CSQ from the 30 kDa protein, 
assuming that they are associated as suggested by Yamaguchi and Kasai ( 1998). 
Although the preliminary experiments presented here do not suggest a role for the 30 
kDa protein in RyR regulation, Yamaguchi et al. ( 1999) reported that atractyloside 
(ATR), an inhibitor of the _A,.TP/ADP translocase (thought to be the 30 kDa protein, see 
above) reduced choline flux through RyRs in a Ca2+-dependent fashion. At activating 
cis Ca2+ (10-5 M), the number ofRyRs inhibited by ATR was approximately half, whilst 
choline influx rate through the RyR (and hence RyR activation), was maximized at 
lower cis [Ca2+] (10-5 - 10-7 M). According to these findings the 30 kDa protein should 
activate RyRs in the presence of 100 nM cis Ca2+. This did not occur (Fig. 3.VI). The 
single channel studies reported by Yamaguchi et al. ( 1999) were performed in the 
absence of trans Ca2+ and it was probable that CSQ had dissociated from the RyR 
before the addition of ATR, (see Chapter 5, Section 5.2.3 for further evidence of low 
Ca2+ -induced CSQ dissociation). Therefore, these experiments would only show 
regulation by the 30 kDa protein, and not by CSQ. In light of current findings (see Fig. 
3.XII), it seems probable that although the 30 kDa protein may be a RyR activator, its 
modulatory role is suppressed by the presence of CSQ. The mechanism for this is 
unknown, but CSQ may limit access to RyR binding site(s) on the 30 kDa protein, 
(presuming the 30 kDa protein binds to CSQ), and it may no longer be able to associate 
with the RyR. 
3.3.3 Anti-CSQ antibody 
There are several possible explanations for the different actions of the two anti-CSQ 
antibodies. The in-house anti-CSQ antibody may have not been at a high enough 
concentration to bind to CSQ within 10 min of exposure. Up to 800 µg of serum protein 
was added to the trans chamber ( corresponding to up to 500 µl of serum). It was not 
feasible to purify the antibody from the final bleed serum, as only enough anti-CSQ 
antibody for up to six RyR channel experiments (and one specificity characterization 
experiment) would be purified, taking into account that at least I 0% of antibody would 
be lost in the purification process. As neither pre-inoculation bleed serum, nor the 
serum containing antibody had any effect on RyR activity, antibody purification was 
not completed. The reasons for anti-CSQ antibody's inability to modulate RyR activity 
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could not be due to an interference of serum proteins with the antibody, since the 
pre-inoculation bleed serum would contain all potential contaminant proteins that could 
be found in the antibody containing serum. 
It is possible that the commercially available anti-CSQ antibody was generated to a 
small peptide fragment of CSQ and not the whole protein, as was the case with the 
in-house antibody. It is conceivable that binding of anti-CSQ antibody to only part of 
the CSQ molecule (which would be the case with an antibody generated against a 
fragment of CSQ), induced a conformational shift that resulted in inhibition. The 
in-house anti-CSQ antibody that recognized and bound to epitopes over the whole CSQ 
molecule may not (a) bind to the same epitope as the commercially available antibody 
or (b) only a very small fraction of the in-house polyclonal antibody may bind to the 
epitope that allows it to influence RyR activity. The usefulness of the commercially 
produced anti-CSQ antibody lay in its ability to induce substantial RyR inhibition only 
when CSQ was present. The commercial anti-CSQ antibody was therefore used to 
determine whether or not CSQ was tethered to the RyR, in experiments presented in 
Chapter 4 (see Section 4.2.1.1 ). 
3.3.4 Physiological implications of CSQ regulation of Ry Rs 
Whilst gross changes in ionic strength ( enough to dissociate CSQ) within the lumen are 
highly unlikely to occur in vivo, these data provide insight into the mechanisms of CSQ 
regulation of the RyR. Do small changes in the concentration of polyvalent ions occur 
in vivo, which result in CSQ dissociation? This hypothesis is explored further in 
Chapter 5. 
Dissociation of CSQ is not the only way that CSQ can inhibit ryanodine receptors, as a 
conformational change (assumed to occur after binding of anti-CSQ antibody to CSQ) is 
enough to elicit RyR inhibition. It is certainly possible that such a change may be 
induced in vivo, by either alterations in total Ca2+ (the levels of which alter dramatically 
in muscle), K+ or H+ during the SR Ca2+ release/uptake cycle, or induced by structural 
changes in associated proteins upon RyR Ca2+ release. It is important to note that 
regulation ofRyRs within the lumen may well rely on an interplay of proteins such as 
triadin, junctin, CSQ and the 30 kDa protein, with the summation of modulations 
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imposed by these proteins contributing to a highly controlled RyR Ca2+ release. 
Whatever the physiological mechanism may be, the data presented in this chapter are 
the first to systematically study the effect of CSQ dissociation/re-association on RyR 
regulation and the first to show CSQ as an inhibitor of SR Ca2+ release. 
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MODULATORS OF CSQ ACTION ON RYRS: 
MODULATORS OF THE MODULATOR. 
Chapter 4 
4.1 Introduction 
Several different observations (listed below) suggest that the effect of CSQ on RyR 
activity can vary depending on the specific experimental conditions, and indicate that 
the effect of CSQ is subject to modulation by factors such as whether or not CSQ is 
already associated with the RyR, phosphorylation ( of CSQ) and the presence of 
co-proteins. Data presented in Chapter 3 shows that only 68% of Ry Rs responded to 
manipulation intended to alter CSQ association with the RyR/T/J complex. 32 % of 
RyRs did not respond characteristically to increasing [Cs+] or exposure to anti-CSQ 
antibody (those responding were described in Chapter 3). This observation raised the 
possibility that two populations of Ry Rs existed, one having CSQ associated and one 
lacking this association. This possibility is examined in this chapter. 
CSQ may be phosphorylated in vivo V arsanyi and Heilmeyer, 1980; activation of 
purified RyRs by CSQ has been reported to be phosphorylation dependent - only 
dephosphorylated exogenous CSQ modulated purified RyR activity Szegedi et al., 
1999; Herzog et al., 2000. These data were the first to illustrate (a) a direct CSQ-RyR 
interaction and (b) that the phosphorylation status of CSQ is important in RyR 
regulation by CSQ. It is unknown whether the interaction of CSQ with native RyRs 
(those containing RyR co-proteins, such as triadin and junctin), requires CSQ 
dephosphorylation in the same way as the interactions with purified RyRs. Therefore, 
the effect of CSQ phosphorylation is also considered in this chapter. 
As discussed previously, CSQ has been reported to either activate or inhibit RyRs 
Kawasaki and Kasai, 1994; Ohkura et al., 1995; Ohkura et al., 1998; Beard et al., 1999; 
Szegedi et al., 1999; Beard et al., 2000; Wang et al., 2001; Beard et al., 2002. As 
reported in Chapter 3, CSQ dissociation (by increasing trans Cs+ to 500 mM) activated 
native Ry Rs in the presence of cis 100 nM Ca2+ and 2 mM ATP. Re-association of 
exogenous CSQ reduced channel activity to pre-dissociation levels, illustrating CSQs 
ability to inhibit Ry Rs. Wang et al. (2001) reported preliminary data also showing CSQ 
as an inhibitor of cardiac RyRs. In the only other comprehensive lipid bilayer study of 
CSQ modulation of the RyR, Szegedi et al. (1999) reported that purified RyRs were 
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either unaffected or activated by CSQ, depending on the phosphorylation state of CSQ. 
The possibility that the different actions of CSQ depend on the association of 
co-proteins with the RyR is examined here. 
Changes in channel activity thought to reflect CSQ dissociation from the RyR, reported 
in Chapters 3 (above) and 5 (below), were slow taking several minutes to complete. It 
should be possible to independently measure the rate of CSQ dissociation from the RyR 
using fluorescence techniques . Therefore the final question addressed in this chapter is 
the rate of CSQ dissociation from the RyRJT/J complex. In an attempt to examine this , 
two chromophores were attached to CSQ to enable CSQ dissociation to be monitored in 
stopped flow experiments . 
The aims of the experiments in this chapter were as follows; 
(1) to explore the possibility that two discrete populations ofRyRs exist. 
(2) to study the effects of dephosphorylated CSQ on the RyRJT/J complex and compare 
with effects of phosphorylated CSQ ( data presented in Chapter 3), 
(3) to investigate the possibility that CSQ can regulate RyR activity by either binding 
directly to the RyR, or indirectly, by binding to triadin and junctin, 
( 4) to determine accurately the dissociation time of CSQ from native RyRs, using 
stopped flow techniques. 
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4.2 RESULTS 
4.2.1 Two populations of Ry Rs 
4.2.1.1 Non-responsive native RyRs 
In 22 of the 69 native Ry Rs exposed to 500 mM trans Cs+, activity did not increase 
significantly from control following ionic strength increase ( after 5 min exposure to 500 
mM Cs+; Chapter 3). In all the bilayer experiments presented in this chapter the 
composition of cis and trans solutions are as follows, unless otherwise specified: cis 
100 nM free Ca2+(1 mM CaC12 plus 4.5 mM BAPTA), (in mM) 2 ATP, and 250 Cs\ 
trans (mM) 250 or 500 Cs+ and 1 Ca2+_ In the case of average data presented in this 
chapter, channels were analyzed for 30 s, unless stated otherwise. 
Ten of the 22 non-responsive RyRs were exposed to 500 mM trans Cs+ for up to 8 min, 
with no increase in channel activity evident. The control activity in these channels was 
unusually high. The channels did however, respond to addition of 20 µg exogenous 
CSQ to the trans chamber (following trans perfusion with 250 mM Cs+ in 5 out of 5 
channels tested). The control activity in these channels was unusually high. Addition 
of exogenous CSQ resulted in a significant drop in channe_l activity, at both positive and 
negative potentials ( data shown at + 40m V; Fig. 4.1), and there was a further drop in the 
relative mean current (test relative to control, J'/I'c) following RyR incubation with 5 
µg anti-CSQ antibody (n=3, Fig. 4.1). In this set of experiments, 3 mM MgCl2 was 
included as part of the cis solution. 
In addition, in 2 of 9 channels (not previously exposed to high ionic strength), control 
activity in the presence ofMg2+ was also unusually high, and exposure to trans 0.5 µg 
anti-CSQ antibody did not alter fractional mean current (J'F) significantly from control 
(Fig. 4.II). RyRs were incubated in anti-CSQ for up to 8 min, and stirred every min, to 
ensure antibody association. It should be noted that commercial anti-CSQ was used in 
the results presented in Section 4.2.1. In this set of experiments, 3 mM MgCh was 
included as part of the cis solution. 
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Fig. 4.1. Exogenous CSQ inhibited channels which did not respond to 
an increase in trans cs+. (A) Control activity with 250 mM trans Cs+, 
in the presence of 3 mM cis MgC12; (B) after increasing trans Cs+ to 
500 mM with CsCl; (C) perfusing the trans chamber with 250 mM Cs+ 
and subsequent addition of 20 µg CSQ; (D) 0.5 µg commercial anti-
CSQ antibody; (E) Average data (n = 5-10) showing relative mean 
current (test relative to control, I'/I'J under conditions shown in A-D. 
Vm-Ecs+ was +40mV under all conditions. Single channel opening is 
upward from the zero current level ( continuous line) to the maximum 
open conductance (broken line). Error bars are SEM, except in the case 
of CSQ and anti-CSQ antibody (n=3), where SD is presented. Asterisks 
(*) indicate average values significantly different from control, ** 
indicates activity significantly different from the previous condition 
(p<0.05, t-test) 
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Fig. 4.11. High activity RyRs did not respond to trans anti-CSQ 
antibody. (A) Control activity with 250 mM trans Cs+, in the presence 
of 3 mM cis MgC12 ; (B) after adding 0.5 µg trans commercial anti-
CSQ antibody; (C) Individual data (n = 2) showing fractional mean 
current (J'F) under conditions shown in A-B. V m-Ecs+ was +40mV 
under all conditions. Single channel opening is upward from the zero 
cun·ent level ( continuous line) to the maximum open conductance 
(broken line). 
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The umesponsive channels (to high ionic strength or anti-CSQ antibody) had a 
significantly higher control activity (J'F), than channels that responded to 500 mM Cs+ 
(in the presence of cis 2mM ATP and 10-7 M Ca2\ Fig. 4.III). Fig 4.III shows a 
frequency distribution of 69 native channels, of which, 22 did not respond to increased 
[Cs+], whilst 47 showed the expected increase in activity. The plot shows that the vast 
majority of umesponsive channels had a higher control activity than their responsive 
counterparts. Average data shows that those umesponsive to Cs+ had a significantly 
higher control J'F (p<l 0- 13 , t-test) than responsive RyRs, indicating that there were two 
populations of Ry Rs. Conceivably, these high activity channels did not have CSQ 
bound to them originally. The possibility that fractions of Ry Rs may not have CSQ 
associated with them was first reported by Yamaguchi et al. ( 1997). If this explanation 
is correct (see Figs. 4.I-III), it might be that RyRs without tethered CSQ would have a 
higher control activity. Presumably, the inhibition imposed by CSQ had been removed, 
but the channels would respond to CSQ addition, and channel activity should fall. This 
hypothesis is consistent with the initial activity increase upon exposure to 500 mM Cs+ 
(in.47 channels) being due to dissociation of CSQ, as CSQ removal results in RyRs with 
a higher activity ( due to the removal of CSQs inhibition). 
4.2.1.2 Addition of exogenous CSQ to low and high activity channels 
Low activity RyRs (those thought to have CSQ tethered to them), did not show any 
alteration in channel activity after the addition of 20 µg exogenous CSQ (Fig. 4.IV 
A-C), suggesting that these channels already had CSQ associated with them. Channels 
were observed for 10 min, with no evident ( or indeed significant) alteration in RyR J'F· 
In contrast, high activity channels responded to the addition of 20 µg CSQ, with J'/I'c 
falling 2.3-fold (Fig. 4.IV D-F) in 6 channels. These results support the theory that two 
populations of Ry Rs are distinguished by their association with CSQ. 
4.2.1.3 The cause of CSQ depleted Ry Rs 
The existence of a population of Ry Rs lacking CSQ may have been due to higher than 
normal ionic strength in control solutions. In vivo , the ionic strength within the lumen is 
in equilibrium with the cytoplasm, and is approximately 150 mM (Berne and Levy, 
1990). It may be that increasing ionic strength from 50 mM (which is the trans [Cs+] 
used to incorporate Ry Rs, pre-control levels) to 250 mM Cs+ ( control levels), 
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dissociated CSQ from a number of RyRs, while the whole RyR population was stripped 
of CSQ after exposure to 500 mM Cs+_ To test this possibility, ionic strength was 
increased from 50 mM to 250 mM (Fig 4.V). Average J'/I'c (in 29 channels) did not 
increase (Fig. 4.V). It is interesting to note that one channel showed a ~2.4-fold rise in 
J'/I'c, as a result of raising [Cs+] to 250 mM. It seems that the increase in channel 
activity in this case may have been due to CSQ dissociation, as this channel did not 
respond to subsequent addition of anti-CSQ antibody. This dissociation may have been 
due to uneven stirring, resulting in a local high [Cs+], close to the CSQ-RyR/T/J 
interaction site(s); high enough to dissociate CSQ (i.e. close to 500 mM Cs+, as 
additions were made from a I .SM stock). None-the-less, the results in Fig. 4.V suggest 
that it is unlikely that the dissociation of CSQ occurs with the pre-control Cs+ increase 
(from 50 - 250 mM Cs+). If CSQ removal were the cause of channel unresponsiveness, 
then the dissociation must have occurred sometime before lipid bilayer channel 
incorporation of Ry Rs. 
It appeared that some batches of SR contained channels that exhibited low activity, and 
therefore may have contained RyRs with tethered CSQ (Table 4.I). In particular, in 
batch 11 a/98, 8 channels were incorporated into lipid bilayers, all of which had low 
control activity (in the presence of cis 2mM ATP and I 0-7 M Ca2+). Conversely in batch 
07 /99, all 16 channels incorporated had high control channel activity, whilst in batch 
number 03a/0l, 41/46 incorporations exhibited high activity. A pattern emerged, 
showing that certain batches of vesicles had either a high proportion of Ry Rs with high 
activity ( channels without CSQ attached), whilst other batches contained channels with 
low control activity. Of course, the number of channels used from certain batches was 
low (less than IO channels were recorded from 5 of the 20 batches) and a few batches 
showed both RyR populations. Taken together, these data indicate that CSQ-depleted 
RyRs existed prior to SR vesicle isolation ( or were depleted during SR vesicle isolation) 
and prior to reconstitution with bilayers. The mechanism of CSQ depletion warrants 
further investigation. Indeed RyRs without tethered CSQ may occur in vivo as 
suggested by Yamaguchi et al. (1997), or CSQ may have been phosphorylated in some 
cases and not others (see Section 4.2.2 for further investigation of this possibility). 
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Fig 4.III. Control activity of single RyR channels that respond to procedures that influence CSQ was lower than control activity 
of responsive channels. Control 1nean current as a fraction of 1naxi1nu1n current (I' F) is shown. Chaiu1els whose activity increased 
with 500 n1M trans Cs+ (CSQ dissociation) or decreased with trans anti-CSQ antibody are indicated by the black bars; channels 
which showed no consistent change in J 'F after either exposure to 500 n1M trans cs+ or 0.5 µg/ml trans anti-CSQ are indicated by the shaded bars. The Student's t-test indicates that there are two populations of RyR channel (see Results). 
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Fig. 4.IV. CSQ was able to reduce channel activity only in RyRs with 
high initial activity. (A) Control activity of high activity channel; (B) 
after addition of 20 µg CSQ; (C) average data (n=4) for relative mean 
current; I/ Jc under conditions shown in A&B; (D) control activity of 
low activity channel; (E) after addition of 20 µg CSQ; (F) average data 
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chan1ber, with no alteration in cham1el activity observed ( data not 
shown). V m-Ecs+ was +40mV under all conditions. Channel opening is 
upward from the zero current level ( continuous line) to the maximum 
open conductance (broken line, o1 & o2). Asterisks(*) indicate average 
values significantly different from control (p<0.05, t-test). 
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data (n = 21) of A&B, nested line graph represents each of 21 single 
channel J'/J 'c· V m-Ecs+ was +40mV under all conditions. Single 
channel opening is upward from the zero current level ( continuous line) 
to the maximum open conductance (broken line) . 
Table 4.1. Batch specificity of responsive and non-responsive (to 
500 mM Cs+ or anti-CSQ antibody) RyR channel be.~v tour 
05/98 4 4 (100) 0 
06/98 1 1 (100) 0 
11 a/98 8 0 8 (100) 
11 b/98 6 5 (83) 1 (17) 
12/98 2 2 (100) 0 
07/99 16 16 (100) 0 
08/99 1 1 (100) 0 
09/99 2 2 (100) 0 
10/99 3 3 (100) 0 
12/99 8 4 (50) 4 (50) 
12/99 15 11 (73) 4 (27) 
05/00 2 2 (100) 0 
12/00 2 2 (100) 0 
03a/01 46 41 (89) 5 (11) 
03b/01 3 3 (100) 0 
04/01 3 3 (100) 0 
06/01 8 6 (75) 2 (25) 
Channels were either exposed to 500 Cs+, or 0.5 µg anti-CSQ. 
Channels were termed unresponsive if activity did not increase or 
decrease (as expected) after 5 min of exposure. Percentages of 
channels exhibiting responsive or non- responsive are given in 
parenthes~~-.. 
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4.2.2 Phosphoryiation and dephosphorylation of CSQ 
To determine what effects the phosphorylation status of CSQ had upon CSQ regulation 
of native Ry Rs, the phosphorylation status of the CSQ isolated for use in the present 
experiments was determined by 31 P nuclear magnetic resonance {3 1P NMR) analysis. 
4.2.2.1 Determination of the degree of phosphorylation of purified CSQ 
Fig 4. VI compares 31 P NMR spectra indicating phosphorous levels in the CSQ sample, 
before and after dephosphorylation. The horizontal axis (ppm) corresponds to a 
chemical shift, reflecting the environment the phosphorous atoms are in. The original 
CSQ sample displays a resonance peak at approximately 0.2 ppm, ( expected for 
phosphorous), indicating that CSQ is at least in part, phosphorylated. The appearance of 
a broad resonance peak, at between -1.5 to -2.8 (red arrow, top trace) observed in the 
phosphorylated sample, may indicate phosphorous atoms in aggregated protein (see 
Section 4.2.2.2). Protein precipitation was observed after NMR analysis, suggesting that 
some of the CSQ aggregated during the 24 hr testing period. From this NMR data, it 
was not possible to determine how many residues were phosphorylated. 
4.2.2.2 Dephosphorylation of CSQ 
CSQ was dephosphorylated according to the methods of Cala and Jones (1991; see also 
Chapter 2, Section 2.8.1.3). Once dephosphorylated, 2-4 mg of dephosphorylated CSQ 
was subjected to 31 P NMR, to determine that dephosphorylation had in fact occurred. 
The peak observed in the phosphorylated sample of CSQ at approximately 0.2 ppm 
(Fig. 4.VI, red arrow, top trace) disappeared after dephosphorylation. The appearance of 
a small peak ( approximately -1.2 ppm, red arrow, bottom trace), close to the broad peak 
observed in the phosphorylated sample, may again be explained by some phosphorus 
atoms in aggregated protein. It may be that the phosphatase cannot access bound 
phosphate (which may be buried within aggregated protein), and hence dephosphorylate 
residues, when CSQ is aggregated. This would account for the small amount of 
aggregated CSQ still in a phosphorylated form, resulting in the appearance of a small 
resonance at - 1 ppm. In terms of phosphorylation levels, the dephosphorylated CSQ 
sample contained at least three times less phosphorus than the phosphorylated CSQ 
sample (as indicated by the area under each graph). It is important to note that only 
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non-aggregated CSQ was used in the lipid bilayer study using dephosphorylated CSQ 
(see Section 4.2.2.3), to try and optimise the yield of dephosphorylated CSQ. 
4.2.2.3 Regulation of native Ry Rs by dephosphorylated CSQ 
The 31 P NMR data indicates that the exogenous CSQ added to CSQ-depleted RyRs 
(Figs. 3.X-XII & 4.XII) was phosphorylated. The action of dephosphorylated CSQ on 
RyRs was examined. After control recording, native RyRs were exposed to 500 mM 
Cs+ to dissociate endogenous CSQ, which resulted in a 2.2 fold increase in J'F (Fig. 4. 
VII). After subsequent perfusion of the trans chamber with 250 mM Cs+, 20-50 µg of 
dephosphorylated CSQ was added to the trans chamber. Dephosphorylated CSQ 
reduced J'F 1.5-fold at +40 mV, and 1.6-fold at-40 mV (Fig. 4.VII, data not shown at 
-40 mV) in much the same way as the native phosphorylated CSQ (see Chapter 3, Fig 
3.X-3.XII). In additional experiments, up to 100 µg of dephosphorylated CSQ (trans) 
was added to high activity RyRs. Addition of dephosphorylated CSQ induced a 2.1-fold 
reduction in J'/I'c at +40 mV, and a 2.0-fold decrease at-40 mV (Fig. 4.VIII). These 
channels had a control J'F of >0.4; a similarly high control J'F was observed in high 
activity channels not responding to 500 Cs+ or anti-CSQ antibody addition (see Figs. 
4.III-IV), therefore it is likely that these channels did not have CSQ attached. 
It appears that the phosphorylation status of CSQ had no influence on CSQs ability to 
inhibit native RyRs. Table 4.II compares the inhibition of native RyRs, induced by both 
phosphorylated CSQ and dephosphorylated CSQ. There was no significant difference in 
the% inhibition (J'F upon CSQ re-association as a% of dissociation) induced by either 
phosphorylated or dephosphorylated CSQ, on native CSQ-dissociated or high activity 
RyR J'F• Apparently, altering the phosphorylation status of exogenous CSQ did not alter 
the functional interaction of CSQ with the native RyR/T/J complex. 
4.2.3 The response of purified Ry Rs to CSQ 
In 1998, the first evidence that CSQ may directly regulate the RyR was published by 
Szegedi et al. (l 999). Purified RyRs were incorporated into lipid bilayers and trans 
addition of dephosphorylated CSQ enhanced open probability, while phosphorylated 
CSQ had no effect. Presumably, these purified RyRs did not contain either triadin or 
junctin, although evidence for this was not shown. It was therefore important to 
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Fig. 4.VII. Exogenous dephosphorylated-CSQ inhibited CSQ-
dissociated Ry Rs. (A) Control activity with 250 mM trans Cs+; (C) 
Increasing trans cs+ to 500 mM with CsC12; (C) Following trans 
perfusion with 250 mM Cs+, addition of 20 µg dephosphorylated CSQ 
( deP-CSQ), cis/trans cs+ is shown above A-C; (D) Average data 
(n = 4) showing relative mean current (I'/J'c, test relative to control) 
under conditions shown in A-C. V m-Ecs+ was +40mV in all cases 
Single channel opening is upward from the zero current level 
( continuous line) to the maximum open conductance (broken line). 
Asterisks (*) indicate average values significantly different from 
control and ** indicates value significantly different from the previous 
condition. (p<0.05 , t-test). 
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Fig. 4.VIII. Exogenous dephosphorylated-CSQ inhibited high 
activity channels. (A) Control activity with 250 mM trans Cs+; (B) 
addition of 20 µg dephosphorylated CSQ. Vm-Ecs+ was +40mV in A 
(con) & B (deP-CSQ). (C) Average data (n = 4) showing relative mean 
current (I'/I 'c, test relative to control) under conditions shown in 
A&B, at both+ and - 40 mV. V m-Ecs+ was +40mV in A-C and -40mV 
in C. Single channel opening is upward from the zero current level 
( continuous line) to the maximum open conductance (broken line). 
Asterisks (*) indicate average values that are significantly different 
from control. 
Table 4.11. Comparison of RyR inhibition by phosphorylated CSQ and 
dephosphorylated CSQ. 
CSQ-induced inhibition of high activity native RyRs 
Addition of phosphorylated CSQ 57 + 7 
Addition of dephosphorylated CSQ 51 + 16 
CSQ-induced inhibition of low activity native Ry Rs 
Addition of phosphorylated CSQ 59 + 7 
Addition of dephosphorylated CSQ 48 + 8 
Inhibition is shown as a percentage of J'F measured after initial CSQ dissociation. Data 
is presented as mean + SEM. There was no significant difference in inhibition induced 
by either phosphorylated CSQ or dephosphorylated CSQ in either low activity channels 
( after CSQ dissociation by Cs+) or high activity channels. 
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determine whether the decrease in native RyF- activity seen upon CSQ re-association 
reported in Chapter 3 (Figs. 3.X-XII), was due to a direct interaction between CSQ and 
the RyR, or to CSQ affecting RyR activity after associating with triadin and junctin 
(inducing a regulatory effect through either one of these proteins). To ascertain the role 
of triadin and junctin in CSQ inhibition ofRyR activity, both purified skeletal RyRs and 
RyRs expressed in a CHO cell line were studied using single channel experiments. 
4.2.3.1 Purification of the RyR 
The purification of Ry Rs from SR vesicles was achieved after solubilized SR had been 
fractionated on a discontinuous sucrose gradient. SDS-Page (and subsequent silver 
stain) of native SR showed strong bands at approximately 400 kDa (presumably the 
RyR; Fig.4.IX A, lane 1) and at approximately 110 kDa, (presumably Ca2+-ATPase), 
and proteins resolving at approximately 97, 55 and 31 kDa (which presumably are 
triadin, CSQ and junctin, respectively). CHAPS solubilized SR (purified RyRs) showed 
a strong band at approximately 400 kDa, and a weak band at approximately 110 kDa 
(Fig. 4.IX A, lane 2), with no CSQ, triadin or junctin, indicating that the solubilized 
fraction contained mostly RyR, with minimal contaminant Ca2+ -ATPase. 
Immunoprobing the gels with anti-CSQ and anti-triadin antibodies showed that CSQ 
(Fig. 4.IX A, lane 3,) and triadin (Fig. 4. IX A, lane 5) were present in native SR, but 
were removed by RyR purification (Fig. 4.IX A, lanes 4&6 respectively). A faint band 
at 26 kD (which corresponds to junctin) can be seen in the native SR (Fig. 4. IX A, lane 
1 ), but was not present in the solubilized fraction (Fig. 4.IX A, lane 2). It was assumed 
that Ca2+-ATPase does not regulate RyR activity or normally bind to triadin, junctin or 
CSQ, since there was no published evidence suggesting that Ca2+ -ATPase has a role in 
modulation of the RyR. 
4.2.3.2 Characteristics of CHAPS solubilized RyR and RyRs expressed in 
CHO cell to ATP, Ca2+ and ruthenium red. 
Fig. 4.X shows that purified RyRs respond to cis Ca2+ and ATP in a similar manner to 
native channels. A reduction of cis Ca2+ from 1 mM to 100 nM (by the addition of 4.5 
mM BAPT A) reduced channel activity 9-fold (Fig. 4.X A, panel 2). Trans Ca2+ was 
held at 1 mM throughout the experiments. As with native RyRs, purified channels that 
were partially inhibited by 1 rnM Ca2+ had a higher activity than channels at sub-
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Fig. 4.IX. Purification of the RyR. Silver stain of SDS-PAGE (5%-
17%) showing a ~ 110 k.Da and ~400 k.Da protein in native SR (lane 1 ), 
after purification of Ry Rs (lane 2). The resolution of the silver stain in 
lane 2 has been enhanced to illustrate the removal of all SR proteins 
(besides Ry Rand Ca2+ -A TPase) following the purification procedure. 
CSQ (lanes 3& 4) and triadin (lanes 5 & 6) were detected in native SR 
membranes (lanes 3 & 5), but not in purified RyR fractions (lanes 4 & 
6), after immunoprobing with anti-CSQ or anti-triadin antibodies. The 
protein located at ~ 110 k.Da is presumed to be Ca2+-ATPase, and the 
400 k.Da protein to be the RyR. The position of molecular weight 
markers is shown next to lane 1. There was no band at 26 kDa in the 
purified RyR sample (lane 2) that would correspond to junctin. Proteins 
were transferred onto Immobilon-P PVDF membranes, prior to probing 
with antibody. 
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channel inhibition upon addition of 10 µM cis ruthenium red (panel 2). 
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of channel traces in A-B. V m-Ecs+ was +40mV under all conditions. 
Single channel opening is upward from the zero current level 
( continuous line) to the maximum open conductance (broken line, o 1 
& 02)-
A 
B 
C 
D 
Control 
0 -------------- - --- --- ------- - -------------- --------------------- ---------
C .,),,_ ,,, 
-'.... '•( . . •11 ~ 
~ 100 nM cis Ca2+ 
II, I (, l ,.. •• .. l,. ~ ~ , l\ •,_ , 
Yf , -..· ' 1 \. 
0.004 
·· ·· ··· ······· . ················· 1 ···· ··· · · ··············· ··· ···· ·· ····· · · 
id ., ... ,. ,, .. !~/\\ t~ , .• 1 .. d I ,•,I , ., .. ~)I, I I ' · • ··•' • ""-''· • • : • .,,_ 0.065 
.... , ... ~, •.. ,;.u j(' 1 ·,\ '1 · \I { \-j lr/~1- - r ·,(.fJ\ f ,t ' •...:;.y=-J.! .. C 'Jf c·'\rf'.,,:WP -• •jl' . I ; u, \ :..:~,u,"ii'<., 
___ __ii lOpA 
1 s 
Fig. 4.XI. Activation and inhibition of RyRs expressed in CHO cells 
by cis modulators ATP and Ca2+. (A) Control activity with 
250/250 mM (cisl trans) cs+, 1 mM cis Ca2+, (B) after addition of 2 
mM ATP; (C) lowering cis Ca2+ to 100 µM (by adding 0.59 mM 
BAPTA); (D) lowering cis Ca2+ to ~ 100 nM ( by adding a further 3_61 
mM BAPT A). Fractional mean current (J 'F) of channel is shown to the 
right of each current trace, measured from 30 s of continuous channel 
recording. V m -Ecs+ was +40m V under conditions_ Single channel 
opening is upward from the zero current level ( continuous line) to the 
maximum open conductance (broken line). 
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activating 100 nM cis Ca2+. Addition of 2 mM cis ATP (using the same bilayer with 
two open channels) induced a 1.5-fold rise in channel J'F (Fig. 4.X A, panel 3). Like 
native RyRs, the calculated Cs+ conductance (250/250 mM) for purified RyRs was close 
to 525 pS, comparable with purified RyR conductance cited in literature (see Chapter 1, 
Section 1.2.5). 
In another bilayer containing two active purified RyRs, the application of 10 µM 
ruthenium red induced channel inhibition; J'F dropped from 0.234 (+ 0.09) to 0.002 
(+0.006; Fig. 4.X B). This drop was almost instantaneous (and occurred within the 15 s 
stirring period) and was sustained for over 5 min. 
The application of 2 mM cis ATP (in the presence of 1 mM cis/trans Ca21 also induced 
an increase in the activity of RyRs expressed in CHO cells, increasing J'F from close to 
zero (0.004) to 0.184 (Fig. 4.XI A-B). A reduction in cis free Ca2+ from the partially 
inhibiting concentration of 1 mM to 100 µM (activating Ca2+ concentration), by 
addition of 0.59 mM BAPTA, induced a further 1.3-fold rise in channel activity (Fig. 
4.XI C), whilst subsequent addition of 3.61 mM BAPTA (reducing cis free Ca2+ to,.., 
100 nM), resulted in significant channel inhibition (Fig. 4.XI D). 
These data (Figs. 4.X-XI) indicate that both purified RyRs and RyRs expressed in a 
CHO cell line display similar ligand-induced modulation to that of native RyRs 
(Figs. 3.1-IV) and that cited in literature Coronado et al., 1994; Meissner, 1994. 
4.2.3.3 Effect of CSQ on purified RyRs 
To test whether the CSQ-induced RyR inhibition was mediated by triadin and junctin, 
purified RyRs were incorporated into bilayers and exposed to either 20 or 50 µg trans 
CSQ (Fig. 4.XII). Fig. 4.XII illustrates that CSQ addition either increased activity (n=3: 
J'/I'c = 3.34 ±1.65, Fig. 4.XII A-C) or caused no significant change in RyR activity (n = 
2: J'/I'c = 0.96 ±0.012, Fig. 4.XII, D-F. The lack of CSQ inhibition of purified RyRs is 
consistent with CSQ requiring anchoring protein( s) to mediate an inhibitory effect, 
since the removal of the only two proteins known to bind to CSQ and the RyR (triadin 
and junctin) prevented inhibition of RyRs by CSQ. 
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4.2.3.4 Effect of CSQ on Ry Rs expressed in CHO cells 
The addition of 20 µg trans CSQ did not induce any change in the activity of Ry Rs 
expressed in CHO cell (Fig. 4.XIII). CSQ was incubated in the trans chamber for up to 
8 min, with no apparent effect upon RyR activity. Up to 150 µg of CSQ was added to 
the trans chamber (with frequent stirring), a high enough [CSQ] to ensure interaction 
with the native RyR (see Ch. 3, section 3.3.2.1 for an estimate of CSQ localized in the 
terminal cistemae and that required for physiological addition in lipid bilayer 
experiments). This particular CHO cell line expresses only RyRs, without muscle 
co-proteins (such as triadin, junctin or CSQ; Bhat et al., 1997).Due to the small sample 
size (n=2; because of a small amount of protein available for these experiments), this 
datawe:insufficient to be conclusive. However, the results are consistent with the effects 
of CSQ on purified Ry Rs presented here (Fig. 4.XIII) and with those of Szegedi et al. 
(1999) and Herzog et al. (2000), and show that phosphorylated CSQ does not inhibit 
RyR activity when co-proteins are absent. Certainly, CSQ regulation of Ry Rs without 
co-proteins such as triadin and junctin present, is far different from regulatory effects on 
the native channel. These data provide further evidence that the anchoring protein(s) are 
necessary for CSQ inhibition of the ryanodine receptor, and this is the first evidence 
from one laboratory showing that CSQ can regulate RyRs by two distinctly different 
mechanisms. 
4.2.4 Attachment of chromophores to CSQ 
As reported in Chapter 3 (Section 3.2.4 and Figs. 3.VI-VIII), CSQ was dissociated from 
RyRs upon increasing Cs+ to 500 mM, after 89 + 15s. This does not give an exact 
measurement of the rate of CSQ dissociation, because time measurements are not 
accurate due to the slow mixing times. To determine the exact time taken to dissociate 
CSQ from the RyRJT/J complex, it was proposed to employ stopped flow experiments, 
to determine the rate of CSQ dissociation more accurately. To achieve this , CSQ had to 
be dissociated from solubilized JFM, and exogenous CSQ (with an attached 
chromophore) re-associated. Once associated, chromophore-attached CSQ could be 
dissociated by either increasing [Cs+] to 500 mM, or raising Ca2+ to 13 mM (see 
Chapter 5, Section 5.2.2.2 for data showing that high Ca2+ dissociation of CSQ). It was 
planned to calculate dissociation time by observing the alterations in fluorescence which 
occur upon CSQ dissociation from the JFM. It was assumed that CSQ would undergo a 
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Fig. 4.XII. Association of 20 µg CSQ either activated or did not alter purified RyR activity. A-C, channels inhibited by CSQ (n = 3), 
D-F, channels non-responsive to CSQ (n=2). C,isltrans Cs+ are shown above traces A-B & D-E. (A) Control activity with 250 mM 
trans Cs+; (B) after addition of20 µg CSQ; (C) bar graph represents average data, fractional mean current (l 'F) of 3 channels under 
conditions shown for A ( con) & B (CSQ), nested line graph represents each of 3 single channel J'F; (D&E) repeat of B&C; (F) bar 
graph represents average data J'F of 2 channels under conditions shown in D (con) & E (buffer), nested line graph represents each of 
2 single channel l'p V m-Ecs+ was +40mV under all conditions. Single channel opening is upward from the zero current level ( continuous line) to the maximum open conductance (broken line). Asterisks (*) indicate average values significantly different from 
control (p<0.05, t-test). 
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Fig 4.XIII. Addition of CSQ to RyRs expressed in CHO cells had no 
effect on single channel activity. (A) Control activity with 250 mM 
trans cs+; (B) after addition of 20 µg trans CSQ; (C) Bar graph 
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conformational change upon dissociation, which would be reflected by an alteration in 
fluorescence. Two chromophores were chosen, the first which binds to threonines and 
serines preferentially ( called D-16) and the second, which attaches to lysines 
preferentially (F-2181 ). The skeletal muscle CSQ sequence contains 24 lysines, 
11 threonines and 14 serines, so that several chromophores should attach to each CSQ 
molecule. Once the chromophores were attached (see Chapter 2, Section 2.8.2 for 
methodology of attachment), it was important to test whether this attachment had some 
how altered the way in which CSQ regulated, or associated with, the RyR/T/J complex . 
4.2.4.1 CSQ-D16 and CSQ-F2181 do not alter RyR activity 
A rise in channel activity was induced by increasing Cs+ to 500 mM, and as expected 
upon perfusion with 250 mM Cs+, activity did not alter further (Figs. 4.XIV & XV 
A&B). Addition of 20 µg CSQ-D 16 or CSQ-F2181 did not then change channel 
activity, despite stirring every 30-45 s for 10 mins, to facilitate binding (Fig. 4.XIV). 
Following perfusion of the trans chamber with 250 mM Cs+, unmodified CSQ (20 µg) 
was able to reduce channel activity to pre-Cs+ J'F (Figs. 4.XIV C-E). In one channel, 
after dissociation and perfusion, 100 µg CSQ-D16 was added to the trans chamber, with 
no alteration in J'F observed. In another experiment, a high activity channel that did not 
respond to 500 mM Cs+, channel activity was not altered by incubation with 50 µg 
CSQ-D16 (Fig. 4.XIV E-G). 
Furthermore, in two channels that did not respond to additions of either CSQ-D16 or 
CSQ-F2181, 20µg of unmodified CSQ was added to the trans chamber (following 
perfusion with 250 mM Cs+, to remove the chromophore-conjugated CSQ). Channel 
activity was reduced to close to control levels. Somehow, chromophore attachment 
alters CSQs ability to bind to the RyR/T/J complex, and hence inhibit CSQs regulation 
of the RyR. 
To ensure that the process of chromophore attachment (i.e. temporary high pH and 
exposure to room temperature at various stages in the process) did not destabilize CSQ, 
and cause its apparent inability to bind to the RyR/T/J complex and inhibit RyRs, 
unmodified CSQ was treated in the same way as CSQ during chromophore attachment. 
Fig 4.XV shows the effect of addition of CSQ, which had been temporarily exposed to 
both the high pH and temperature used in chromophore attachment, i.e. pH 9.5 and 25 
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Fig. 4.XIV. Addition ofCSQ with attached chromophores CSQ-D16 
and CSQ-F2181 did not inhibit channel activity. (A) Low activity 
channel; control activity with 250 mM trans cs+; (B) after increasing 
trans Cs+ to 500 mM with CsCl, and an increase in channel activity 
was observed; (C) after perfusing the trans chamber with 250 mM cs+ 
(not shown) and subsequent addition of 50 µg CSQ-D16; to control 
solution) under conditions shown in A-C, (D) average data (n=2) 
showing fractional mean current (J'F) of channel response to CSQ-D 16 
(n=3) and CSQ-F2181 (n=l), under conditions shown in A-C and E-G. 
(E-G) Repeat of A-C, in high activity channel, not responsive to 500 
cs+. V rn-Ecs+ was +40mV under all conditions. Single channel opening 
is upward from the zero current level ( continuous line) to the 
maximum open conductance (broken line). Individual channel J'F is 
shown next to records E-G. 
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~C for 3 h, before the pH was restored to 7 .4 and the CSQ sample was placed on ice. 
After the expected rise in RyR activity induced by 500 mM Cs+ (and subsequent trans 
perfusion with 250 mM Cs+), addition of 20 µg of the treated CSQ reduced channel 
activity to close to control levels, in the same way as the re-association study presented 
in Chapter 3 (Figs. 3.X-XII and Section 3.2.5). It is apparent that the attachment of 
D-16 and F-2181 (with a resultant functional/structural modification) prevented CSQ 
from inhibiting RyR activity. The failure to inhibit was not a result of extended 
exposure to high temperature or high pH. 
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250/500 cs+ 
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Control 250/500 cs+ CSQ 
Fig. 4.XV. Exposure of CSQ to high pH and temperature (conditions 
used in chromophore attachment) did not alter the ability of CSQ to 
inhibit RyRs. (A) Control activity with 250 mM trans Cs\ (B) after 
increasing trans cs+ to 500 1nM with CsCl; (C) after perfusing the 
trans chamber with 250 mM Cs+ (not shown) and subsequent addition 
of 20 µg CSQ, previously exposed to high pH and temperature, 
cisl trans Cs+ are shown above A-C; (D) average data (n = 4) showing 
mean current (J'F) under conditions shown in A-C. V m-Ecs+ was 
+40m V under all conditions. Single channel opening is upward from 
the zero current level ( continuous line) to the maximum open 
conductance (broken line). Asterisk (*) indicate values significant from 
control, crosshatch(#) indicates value significant from the previous 
condition(p<0.05, t-test) 
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4.3 Discussion 
The primary findings discussed in this section are that: 
(1) There are two populations of RyRs, those with CSQ associated, as well as a 
CSQ-depleted population. 
(2) The phosphorylation status of CSQ did not influence CSQs ability to inhibit native 
RyR activity; in fact both phosphorylated CSQ and dephosphorylated CSQ produced an 
approximately 2.0-fold reduction in J'F in native RyRs. In contrast, only 
dephosphorylated CSQ activated purified RyRs Herzog et al., 2000. 
(3) CSQ modulation was strikingly different in purified and native RyRs. 
Re-association of CSQ inhibited native RyRs, whilst CSQ tended to activate purified 
RyRs. 
(4) Attachment of chromophores D-16 and F-2181, which target lysine, serine and 
threonine residues, abolished CSQs ability to inhibit native RyRs. 
4.3.1 Two populations of Ry Rs 
Firstly, 68% of RyRs observed initially with low control activity, were activated after 
exposure to high ionic strength. The return to control ionic strength did not restore 
activity to pre-dissociation levels, in fact RyR activity fell only upon addition of CSQ. 
The other 32% of channels observed, termed 'high activity' channels (with high initial 
channel activity), did not respond to ionic strength increase. However, these high 
activity channels responded to exogenous CSQ addition, with a significant lowering of 
channel activity. Therefore at the start of the experiments, one population of RyRs has 
CSQ associated, and a second population did not have associated CSQ. 
The absence of CSQ was not due to a lack of the necessary accessory protein(s) (likely 
to be junctin/triadin), because channel activity fell after excess CSQ was added to high 
activity channels, showing that CSQ could bind to and regulate channels. If triadin and 
junctin were absent, it is expected that CSQ re-association would not result in channel 
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inhibition, as was the case in CSQ regulated purified RyRs (where no triadin or junctin 
is present) . 
That high, and not low, activity channels responded to CSQ addition (by inhibiting RyR 
activity), firstly supports the proposal of the existence of two populations of Ry Rs, and 
secondly, supports the notion that a significant number of CSQ binding sites on triadin 
and junctin are occupied by CSQ in low activity channels. If a significant proportion of 
CSQ binding sites on accessory proteins were available, it would be expected that J'F 
would fall in low activity channels due to CSQ eliciting an inhibitory effect. 
These results do not show whether some RyRs lacked CSQ in vivo (suggested by 
Yamaguchi et al., 1997), or whether CSQ was dissociated during preparation of SR 
vesicles. Wang et al. (2000), showed that cardiac myocytes which overexpress CSQ 
have impaired Ca2+ release and a reduction of spontaneous Ca2+ sparks (i.e. reduced 
RyR activity). If Ry Rs are partially depleted of CSQ in vivo (Yamaguchi et al., 1997), 
then the findings of Wang et al. (2000) may be explained. Some RyRs in cardiac 
myocytes that originally lacked CSQ may have been inhibited when CSQ was over 
expressed, because we only observed CSQ-induced inhibition in RyRs that lacked CSQ. 
Of course protein overexpression may also induce other unrelated and non-specific 
changes. 
The role that the degree of CSQ association with Ry Rs in vivo may play in regulating 
SR Ca2+ release would depend on the role CSQ plays in RyR regulation. In native 
RyRs, evidence presented here suggests that CSQ is a powerful RyR inhibitory protein. 
Other accessory proteins, such as triadin, FKBP12, DHPR, HRC and possibly the 30 
kDa protein, have also been shown to modulate RyR activity. Presumably, CSQ forms 
part of a signalling pathway with triadin and possibly other proteins. If CSQ plays a 
major role in RyR regulation by inhibiting SR Ca2+ release, the fact that approximately 
68% of Ry Rs contain associated CSQ may mean that the degree of CSQ association 
with the RyR can be 1nodulated in vivo, and this modulation may influence RyR 
activity. 
The absence of CSQ in some cases provides additional insight into the marked 
heterogeneity cormnonly observed in RyR activity (Laver et al., 1995; Copello et al., 
1997). The observed differences in activity within the CSQ-depleted and CSQ 
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associated groups was less than the variability of the total RyR population, indicating 
that differences in CSQ status may be an important factor in RyR variation. The 
modulatory differences observed within the two RyR groups may stem from RyRs that 
are differently coupled to other accessory proteins known to affect RyR function, such 
as DHPR Melzer et al., 1995, FK506-binding Timerman et al., 1993; AJlem et al., 1994 
and calmodulin Tripathy et al., 1995, or Ry Rs in different oxidation or phosphorylation 
states. 
4.3.2 CSQ regulation of purified Ry Rs 
CSQ decreased the activity of native RyRs incorporated into bilayers (see Chapter 3, 
Figs. 3.X-XII), but had no effect on (or tended to increase) the activity of RyRs that had 
been purified prior to bilayer incorporation (Fig.4.XII). These data indicate that CSQs 
regulatory effect on Ry Rs is dependent on the composition of the native RyR complex. 
Since triadin and junctin bind to both the RyR and CSQ Zhang et al., 1997, and these 
proteins were absent in the CHAPS purified RyRs (Fig.4.X), it is possible that one or 
both of triadin and junctin mediate the CSQ effect. It has already been shown that 
triadin antagonises CSQ-induced changes in RyR activity Ohkura et al., 1998, which 
provides further evidence that triadin forms part of the CSQ signalling pathway for RyR 
regulation. It has also been shown that CSQ binds triadin and junctin (Guo and 
Campbell, 1995, Zhang et al., 1997). Therefore it is most likely that the RyR/T /J 
complex is required for CSQ inhibition ofRyRs. 
Although functional data (see Szegedi et al. (1999) and Herzog et al. (2000)) suggest 
that CSQ binds directly to the RyR when triadin and junctin are absent, there is no 
binding data to support such an interaction. The binding sites for CSQ on the RyR, or 
for the RyR on CSQ have not yet been identified. CSQ was unable to associate with 
peptides to the proposed RyR luminal loops, Ml/2 (4580-4640) and M3/4(4859-4917; 
Herzog et al., 2000); based on the RyRl membrane topology model proposed by 
Zorzato et al. (1990). As the number and location of the RyR luminal loops are still 
controversial: (Zorzato et al. (1990) proposed twelve luminal loops, while Takeshima et 
al. (1989) proposed four luminal loops), it may be that the amino acids corresponding to 
the Ml/2 or M3/4 regions do not exist in the lumen. 
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Although there is no binding data, Kawamoto et al. ( 1986) showed that CSQ is one of 
four proteins that can associate with the RyR (using immunoelectron microscopy) , and 
Murray et al. (1998; using chemical crosslinking and immunoblot analysis), reported a 
close interaction between CSQ and the ryanodine receptor suggesting a physical 
coupling. On the other hand, binding of CSQ to triadin has been shown. Recently it has 
been reported that the Asp-rich region of skeletal CSQ, (Glx354-Asx367), is the site for 
triadin association (Shin et al., 200 I). 
The in vivo action of triadin/junctin on the RyR is not known, although the activity of 
purified Ry Rs was decreased by triadin (Ohkura et al., 1998; Groh et al., 1999). 
Peptides corresponding to the cytoplasmic domain of triadin inhibited purified RyR 
activity, indicating that the functional interaction between triadin and the RyR may 
occur on the cytoplasmic side of the SR membrane (Groh et al., 1999). CSQ binding to 
triadin might somehow influence the interaction between triadiris cytoplasmic domain 
(the proposed site of triadins functional regulation of the RyR) and the RyR, enabling 
triadin to further inhibit RyR activity. On the other hand, Caswell et al. (1999) have 
shown an interaction between the purified skeletal RyR and bacterially expressed 
peptides corresponding to the luminal domain oftriadin (Leu 11 0-Lys280), but reported no 
interaction with a triadin peptide (Thr2 -Pro 49) encompassing the cytoplasmic domain of 
triadin (residues 1-4 7). Therefore some contradiction concerning the location of the 
triadin binding site exists., 
4.3.3 Phosphorylation status of CSQ 
CSQs ability to inhibit native Ry Rs was independent of CSQs phosphorylation status, in 
contrast to CSQ-induced activation of purified RyR activity, which depended so heavily 
on CSQ being dephosphorylated (Szegedi et al., l 999; Herzog et al., 2000). These 
different findings support the suggestion that CSQ modulates RyR activity via two 
mechanisms; (1) by binding directly to the RyR, in a phosphorylation-dependomt 
manner, as shown by Szegedi et al. (1999) and Herzog et al. (2000), and (2) by 
inducing RyR inhibition by interactions with triadin and junctin in a 
phosphorylation-independent manner. Whether or not both mechanisms of CSQ 
regulation are operating in native RyRs is not known. If so , the reported CSQ activation 
induced by a direct RyR-CSQ interaction is overshado\ved by the triadin/junctin 
mediated CSQ regulation, seen as an overall RyR inhibition of the RyR by CSQ. 
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Whether or not phosphorylation and dephosphorylation of CSQ regulates RyRs in vivo 
would depend on whether CSQ is phosphorylated before luminal segregation, or after 
targeting to the lumen. This in tum, would depend on the location of specific kinases 
responsible for CSQ phosphorylation, and whether or not ATP could be transported into 
the lumen of the SR. It is not known which kinase specifically phosphorylates CSQ in 
vivo, or whether such kinases are present in the SR lumen ( or indeed whether CSQ is 
phosphorylated inside the lumen). CK II has been shown to phosphorylate CSQ; it can 
phosphorylate Thr353(Cala and Jones, 1991) To date, the presence of CK II within the 
SR lumen has been intimated, but not proven Shoshan-Barmatz et al., 1996. It is of 
course possible, that either Thr353 or another phosphorylatable residue may be 
phosphorylated by another kinase, which could be present in the lumen. CSQ has also 
been identified as a potentially good substrate for CK I and E protein kinase I, but 
current evidence suggests that within muscle, these kinases exist only in the cytoplasm 
and not in the lumen ~alvatori et al., 1994; Rodriguez et al., l 999) The phosphorylation 
status of isolated CSQ (Fig. 4. VI) suggests that CSQ in the SR lumen is phosphorylated, 
therefore dephosphorylation-depende,nt CSQ activation of the RyR, or indeed regulation 
of the RyR due to phosphorylation changes in CSQ, may not be physiologically 
relevant. 
4.3.4 Attachment of chromophores to CSQ 
It is obvious that chromophore attachment alters CSQ~s ability to bind to the RyR/T/J 
complex, possibly by binding to a residue/residues important in the functional coupling 
of CSQ to the RyR/T/J complex, or to Ca2+ sequestration, or to self-compaction. This 
might somehow alter CSQ"s conformation, or inhibit residues involved in CSQ binding 
to the RyR, triadin or junctin. Whilst stopped flow experiments could not be used to 
examine CSQ dissociation rates, this study has provided insight into the apparent 
importance of threonines/serines, and/or lysines in CSQ°s structural and/or functional 
capacity. 
4.3.5 Physiological Significance 
These results (see Section 4.2.3), coupled with those of Szegedi et al. (1999) and 
Herzog et al. (2000) are intriguing. CSQ can activate the RyR ( dependant on 
phosphorylation status), when triadin and junctin are absent, but not when the anchoring 
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proteins are present; native Ry Rs were inhibited by CSQ (regardl ess of phosphorylati on 
status). One must question the role of both interactions in vivo; certainly the existence of 
two mechanisms adds a new dimension to the rol e that CSQ may pl ay in RyR 
modulation. CSQ may bind to the RyR both directly and via triadin and junctin , with the 
inhibition induced by these two anchor proteins overriding RyR regulation by any direct 
coupling of CSQ to the channel. If this were so, it would explain the overall inhibitory 
effect observed in the native RyRJT/J complex used in this study. The possibility that 
other proteins , such as the 30 kDa protein, binds to and modulates either CSQ or the 
RyR, would only add to the complex nature of RyR regulation by luminal proteins. On 
the other hand, CSQ might have a much higher affinity for triadin than the RyR. When 
triadin is present, CSQ may bind to triadin, causing RyR inhibition, whilst when triadin 
is absent, CSQ may interact with the RyR directly (as no triadin is available to compete 
for CSQ binding), eliciting activation. Another possibility is that upon binding, triadin 
blocks access to RyR binding sites on CSQ. 
Whether or not phosphorylation-dependant changes in CSQ play a role in regulating 
RyR activity depends on two things; (1) whether a CSQ-RyR interaction in vivo occurs, 
and (2) whether or not CSQ can be phosphorylated in vivo. Further investigation in this 
area would help define the role of CSQ in SR Ca2+ release regulation. 
What has emerged from the work in this chapter is that the regulation of RyR activity 
by luminal factors may be as complex as RyR regulation by cytoplasmic factors. 
Almost nothing is known about the effects of RyR regulation by proteins such as 
junctin, the 30 kDa protein, HRC and SLM, and if and how these proteins interact with 
each other, the RyR, and triadin and CSQ (the later two proteins being the only two 
knowl\to regulate the RyR that have been investigated at any length). To understand the 
nature of luminal regulation of the RyR, ( and indeed SR Ca2+ release), further 
investigation into the interaction of such proteins, and their effects on the RyR is 
needed. 
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ROLE OF CSQ IN THE EFFECTS OF 
LUMINAL Ca2+ ON RYR ACTIVITY 
Chapter 5 
5.1 INTRODUCTION 
Maintenance of luminal Ca
2
+ at physiological concentrations is important in stabilizing 
the structural formation of the complex formed between RyR, triadin, junctin and CSQ 
(Wang et al., 1998). In fact, CSQs associations with junctin and triadin are inhibited in 
the presence of >10 mM Ca
2
+ (Zhang et al., 1997). Low [Ca2+]s are thought to 
uncouple the interactions that help stabilize CSQ in a polymer formation, and possibly 
revert CSQ to a random coil structure (Wang et al., 1998). Furthermore, increases in 
[Ca2+] from 0-3 mM have been reported to induce substantial, reversible changes in 
CSQs conformation, leading to the proposal that CSQ is a regulator of SR Ca
2+ release 
(Ikemoto et al., 1989b; Ikemoto et al., 1991; Gilchrist et al., 1992; He et al., 1993). It is 
therefore possible that gross alterations in luminal Ca
2+ may result in reduced RyR 
regulation by CSQ, either by the removal of CSQ, or even by changing CSQ 
conformation. 
The effects of changes in luminal [Ca2+] on RyR activity have been studied extensively, 
although with somewhat conflicting results. Increasing luminal [ Ca
2+] above 
physiological levels has been reported to either increase (Sitsapesan and Williams, 
1995; Herrmann-Frank and Lehmann-Hom, 1996; Tripathy and Meissner, 1996), or 
decrease RyR activity (Ma et al., 1988; Fill et al., 1990; Szegedi et al., 1999). Luminal 
Ca2+ probably binds to luminal Ca
2+ activation sites (located on the RyR or another 
associated luminal proteins), resulting in Ca2+ activation, although regulation via 
diffusion through the pore and interaction with cytoplasmic Ca
2+ activation sites has 
also been proposed (Tripathy and Meissner, 1996). No study thus far has fully 
investigated the possible effects of luminal Ca
2+ on RyR regulation by CSQ. 
In this chapter, the effects of high and low luminal Ca
2+ on RyR activity in the presence 
and absence of CSQ, are presented. The premise that Ca
2+ -induced confonnational 
changes in CSQ effect RyR activity was explored over a physiological luminal Ca
2+ 
range of 1-3 mM. In addition, the Ca
2
+ concentrations tested lie within the range of Ca
2
+ 
(0.05 - 10 mM) that SR Ca2+ release is known to be 1nost sensitive to luminal Ca
2
+ 
concentrations (Donoso et al., 1995). 
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5.2 Results 
5.2.1 Ca2+ dissociation of CSQ 
CSQ binding to triadin and junctin, as well as the polymerisation of CSQ are 
Ca2+ -dependent processes (He et al., 1993; Zhang et al., 1997; Wang et al., 1998). Free 
luminal Ca2+ of 1 mM is required to ensure CSQ/triadin/junctin interactions, and to 
stabilize CSQs polymer structure. As mentioned previously, Zhang et al. ( 1997) have 
shown that luminal Ca2+ of> 10 mM disrupts CSQs interaction with the 
RyR/triadin/junctin (RyR/T/J) complex. The present results show that incubating JFM 
in 13 mM Ca2+ can also dissociate CSQ (Fig. 5.1). A high [Ca2+] wash used during 
purification resulted in a greater yield of CSQ (when followed by an exposure to 500 
mM NaCl, to maximize protein purity), 7-8 mg CSQ/100 g muscle ( 13 mM Ca2+ plus 
high ionic strength dissociation) vs 5 mg CSQ/100 g muscle (ionic strength dissociation 
alone). All isolated protein samples were subjected to SDS-Page, silver staining and 
immunodetection, using anti-CSQ antibody. Exposing SR vesicles (Fig. 5 .I, lane 1) to 
the high Ca2+ CSQ purification protocol (see Chapter 2, Section 2.5.2) successfully 
removed CSQ (Fig. 5.I, lane 2) from the solubilized JFM (Fig. 5.I, lane 3), as shown by 
silver stain and by immunoprobing with anti-CSQ antibody (Fig. 5.I, lanes 4-6). No 
detectable levels of triadin were found in the CSQ isolated by high or low Ca2+, and the 
band at 26 kDa (presumably junctin), seen in the JFM sample (Fig. 5.I, lane 1) has also 
been removed by CSQ purification (Fig 5.I, lane 2). It is unlikely that a significant 
fraction of the CSQ was lost due to proteolytic degradation, since proteolic inhibitors 
were present throughout the isolation procedure (see Chapter 2, Section 2.5). 
5.2.2 Response of RyR to increasing trans [Ca2+] 
5.2.2.1 Luminal Ca2+ dose response curve 
Due to the disparity in the literature regarding the exact nature of luminal Ca2+ 
regulation of Ry Rs (see Chapter 1, Section 1.2.6.2), luminal Ca2+ was raised from 1 to 
20 rnM to determine the effects of raising luminal Ca2+ under standard cis conditions -
activating cis ATP (2 mM) and sub-activating cis Ca2+ (100 nM), in the presence of 
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CSQ. In all bilayer data, the composition of cis and trans solutions ~.$ as follows , 
unless otherwise specified: cis 100 nM free Ca2+(lmM CaC12 plus 4.5 mM BAPTA), (in 
mM) 2 ATP, and 250 Cs+; trans (mM) 250 or 500 Cs+ and 1 Ca2+_ In the case of average 
data presented in this chapter, channels were analyzed for 30 s, unless stated otherwise. 
Fig. 5.II illustrates the biphasic response of RyRs to luminal Ca2+, whereby increasing 
Ca2+ from 1 mM to~ 4.5 mM induces an increase in channel open probability (P0 ) -
whilst further increases in trans Ca2+ to 20 mM resulted in channel inhibition with a P0 
close to that recorded in the presence of 1 mM trans Ca2+_ The curve was fitted with a 
least squares fit to the Hill equation (see Chapter 3. Eq. 3.2-1 for Hill equation), giving 
a Pmax of 0.43, Ca2+ binding affinities of Kacca) = 1.7 mM and Ki(ca) = 13.1 mM, with Hill 
co-efficients for activation (na(ca)) and inhibition (ni(ca)) of 3 .35 and 2.91, respectively. 
Channel activity was analysed within 1 min of changing [Ca2+], to determine effects of 
luminal Ca2+ on RyR activity, presumably when CSQ was present (as CSQ dissociation 
is thought to take longer than 1 min; see Section 5.2.4). Thirteen mM Ca2+ was chosen 
as the concentration used to attempt CSQ dissociation experiments because this [Ca2+] 
results in a significantly higher P 0 than 1 mM trans Ca2+ (see Fig 5.II) and > 10 mM 
trans Ca2+ was previously reported to prevent the interaction between CSQ and triadin 
and junctin (Zhang et al., 1997). 
5.2.2.2 
5.2.2.2.1 
Time dependence and reversibility of raising luminal [Ca2+]. 
C 2+ 13 mMtrans a 
The effects of high luminal [Ca2+] on the RyRJT/J/CSQ complex and RyR activity was 
examined by exposing the trans solution bathing bilayer-incorporated RyRs to 13 mM 
trans Ca2+. As illustrated in Fig. 5.II[ at positive potentials, RyR P 0 increased 
significantly after exposure to 13 mM trans Ca2+. The increase was rapid and occurred 
within 30 s. In addition to this immediate increase in channel activity, the time course of 
the response of Ry Rs showed another distinct slower phase; where Pa increased over 
several minutes (Fig. 5.III C). The secondary increase in activity was characterized by 
significant increases in average P0 and open frequency (F0 ) , and a decline in closed time 
(Tc; Fig. 5.III F,H,I). Open time (T0 ) decreased slightly (but not significantly) from the 
primary increase, although this increase was still significantly higher than control (Fig. 
5.III G). When trans Ca2+ was returned to 1 mM by perfusion of the trans chamber, the 
channel activity fell significantly but did not return to its original ( control) level. 
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However, addition of 20 µg of purified CSQ to the trans chamber did cause a further 
reduction in activity back to control levels. Since addition of exogenous CSQ does not 
alter the activity of channels that are already associated with CSQ (see Ch. 4. Fig. 4.IV), 
the CSQ-induced reduction in activity seen here provides additional evidence that high 
luminal Ca2+ had dissociated CSQ from the RyR complex. At negative potentials (in 4 
out of 7 channels), RyR activity rose immediately upon incubation with 13 mM Ca2+, 
whilst in 3 out of 7 channels, relative mean current (I'/I 'c) initially decreased in 
response to the increase in [Ca2+] (Fig. 5.IV). Tripathy and Meissner (1996) have 
reported a voltage dependence of luminal Ca2+ regulation of purified Ry Rs, with a 
significant decrease in channel Pa observed upon increasing trans Ca2+ from 1 to 10 
mM, in the presence of 2 mM ATP and 45 nM Ca2+ free ( cis) at -40m V. In the present 
experiments, overall average channel activity rose significantly within 30 s of 13 mM 
Ca2+ application, and after 3 min all channels showed an increase in J'/I'c, consistent 
with CSQ dissociation (Fig. 5.IV). Similar to changes observed at +40 m V (see 
previous paragraph and Fig. 5.III), when reducing [Ca2+] from 13 mM to 1 mM, channel 
activity was reduced at -40 m V (P<0.05, sign test), but remained significantly higher 
than control (Fig. 5.IV C&E). Only addition of 20 µg CSQ returned Pa to control levels 
(Fig. 5.IV D-E). 
5.2.2.2.2 The effects of 13 mM Ca2+ on CSQ-depleted RyR activity 
To investigate the role CSQ plays in Ca2+ -dependent activation of Ry Rs, the effect of 
high luminal [Ca2+] was measured in RyRs after CSQ had been removed by exposure to 
500 mM ionic strength. Exposure to high iuminal ionic strength produced a 1.8-fold 
increase in RyR activity, and presumably dissociated CSQ from the RyR/T/J complex 
(See Chapter 3, Section 3.2.4). When trans [Ca2+] was subsequently raised to 13 mM, 
RyRs activity increased during stirring time (Fig. 5.V C). However, in contrast to the 
Ry Rs with associated CSQ (Figs. 5 .III & IV), the time course of activation of 
CSQ-depleted RyRs after an increase in luminal Ca2+ did not show the slow phase (i.e. 
there was no significant increase in activation over the 3 min exposure to 13 mM Ca
2
+; 
Fig. 5.V D). Returning [Ca2+] to 1 mM by either perfusion of the trans chamber or the 
addition of 12 mM BAPTA, restored RyR activity to levels seen prior to the increase in 
luminal [Ca2+], but not to the low levels seen before high Cs+ induced dissociation of 
CSQ (Fig. 5.V E). Only re-association of 20 µg CSQ could return channel activity to 
control levels (Fig. 5.V F). Similar to results obtained in the Cs+ dissociation and CSQ 
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Fig. 5.111. At +40 ,n V, increasing trans Ca2+ from 1 mM to 13 niM caused an increase in single RyR channel activity, which could 
only be fully reversed by addition of exogenous CSQ. (A) Control channel activity, with 1 1nM trans Ca2\ (B) 30 sec after increasing trans Ca2+ to 13 111M; (C) 3 mins after increasing trans to 13 n1M; (D) after perfusing trans chamber with 1 mM Ca2\ (E) Addition of trans 20 µg CSQ. F-1, Average data (n=9) for (F) P0 (G) T0 (H) Tc and (I) F0 for conditions in A-E. V m- Ecs was +40 111 V. Single channel opening is upward from zero current ( continuous line) to 1naxin1un1 open conductance (broken line). An asterisk (*) indicatesaverage values significantly different fro1n control (p<0.05, t-test), whilst ** and## indicate average values are 
signifi cantly di fferent from the previous condition (t-test and sign test respectively). 
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Fig. 5.IV. At-4-0 m V, increasing trans Ca2+ from 1 mM to 13 mM 
caused an increase in single RyR channel activity, which could only 
be fully reversed by addition of exogenous CSQ. (A) Control channel 
activity, with I mM trans Ca2+; (B) 3 mins after increasing trans Ca2+ 
to 13 mM; (C) after perfusing the trans chamber with I mM Ca2+; (D) 
Addition of trans 20 µg CSQ. (E) Average data (n=3-7) for J'/I'c for 
conditions shown in A-D. V rn-Ecs was -40 mV. Single channel opening 
is downward from zero current ( continuous line) to maximum open 
conductance (broken line). (*) indicatesaverage values significantly 
different from control (p<0.05, t-test). 
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re-association experiments, (see Fig. 3.XI), 20 µg CSQ was able to reduce the activity 
of the channels to levelsaot significantly different from the pre-CSQ dissociation levels 
(Fig. 5.V E). Thus , the different effects of luminal Ca2+ on RyRs with and without CSQ 
indicates that 1) luminal Ca2+ activates Ry Rs by both CSQ-dependent and independent 
mechanisms , and 2) that CSQ dissociation underlies the slower component of RyR 
activation. The relatively slow secondary increase in RyR activity seen with high [Ca2+] 
was similar to the slow increase in activity observed after an increase in ionic strength, 
suggesting that in both cases, CSQ dissociation from the RyR complex takes 1.5-3 min. 
5.2.2.2.3 5 mM trans Ca2+ 
Upon increasing trans Ca2+ from 1 mM to 5 mM, an almost immediate and significant 
increase in channel fractional mean current (J'F), from 0.086 + 0.01 to 0.186 + 0.04 was 
observed (Fig. 5.VI). A secondary rise in channel activity was observed after 3 min 
exposure to 5 mM trans Ca2\ with J'F increasing to 0.291 + 0.03. Similar to the results 
observed upon addition of 13 mM trans Ca2\ perfusion of the trans chamber with 1 
mM Ca2+ reduced channel activity somewhat, but not to control levels. In 3 out of 3 
channels tested, addition of CSQ reduced channel activity to a level that was not 
significantly different from control (Fig. 5.VI). Furthermore, in 1 out of 1 channels, 
application of 20 µg trans anti-CSQ antibody after CSQ addition further reduced 
channel activity ( data not shown). These results suggest that 5 mM trans Ca2+ may also 
dissociate CSQ from the RyRJT/J complex. 
5.2.2.2.4 2+ 2 mMtrans Ca 
Exposing RyRs to 2 mM trans Ca2+ (in a similar protocol to that followed in Section 
5.2.2.2.3), did not induce CSQ dissociation from RyRs (Fig 5.VII). Despite incubation 
in 2 mM Ca2+ for up to 15 min, channel J'F was seen to increase almost immediately 
1. 7-fold from control levels ( 1 mM trans Ca2+), with no secondary increase in channel 
activity observed (Fig. 5.VII B&C), despite incubation in 2 mM Ca2+ for up to 15 min. 
Reperfusion of the trans chamber with 1 mM Ca2+ restored RyR J 'F to control levels, 
illustrating the activity increase upon raising [Ca2+] to 2 mM was reversible and not due 
to the re111oval of a RyR-associated protein, such as CSQ. 
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Fig. 5.V. Addition of 13 mM ca+ to the trans bath induced an 
immediate RyR activation, in the absence of CSQ. (A) Control activity 
with 250 mM trans cs+; (B) after increasing trans cs+ to 500 mM; (C) 
[Ca2+] increase fro1n lmM to 13 mM; (D) reducing [Ca2+] back to lmM; 
(E) Addition of trans 20 µg CSQ; (F) Average data (I' /I' c) for A-C (n=4), 
D (n=3) and E (n=l), under conditions shown in A-E, plus after the 
addition of 0.5 µg/ml commercial anti-CSQ (listed as F). V m-Ecs+ was 
+40m V under all conditions. Channel openings are upward fro1n the zero 
current level ( continuous line) to the maximum open conductance (broken 
line) of each of two channels (01 and 0 2). Asterisks(*) indicate average 
values significantly different from control, whilst crosshatch (#) indicates 
significant different fro1n the previous condition (p<0.05, t-test). 
5.2.3 
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Low luminal Ca2+ concentrations may also irreversibly 
increase Ry R activity. 
Wang et al. (1998) illustrated that in the absence of Ca2+, CSQ reverts to an unfolded 
monomeric form, which is unable to associate with anchoring proteins. CSQ has been 
sho¥r'n to associate with junctin and triadin in a Ca2+ -dependent manner (Zhang et al. 
(1997), whilst Costello et al. (1986) used EDTA (a Ca2+ chelator) to isolate CSQ from a 
permeabilized JFM preparation. Therefore, the possibility that low or minimal Ca2+ 
could dissociate CSQ from the RyR complex in lipid bilayers was investigated. 
5.2.3.1 2+ 100 µM trans Ca 
Surprisingly, addition of 900 µM BAPTA, a Ca2+ chelator (who's addition resulted in a 
free [Ca2+] of 100 µM) to the trans chamber actually resulted in an almost immediate 
increase in channel activity, when con1pared with that recorded at 1 mM. In the two 
most comprehensive luminal Ca2+ studies, µM luminal Ca2+ has been shown to reduce 
channel activity below that observed in the presence of 1 mM luminal Ca2+ (Sitsapesan 
and Williams, 1995; Tripathy and Meissner, 1996). Channel activity increased 2.8-fold 
from that recorded in the presence of 1 mM trans Ca2+ (Fig. 5.VIII). No secondary 
increase in channel activity (which would indicate CSQ dissociation) was observed, 
despite frequent chamber stirring ( every minute) and exposure to 100 µM Ca2+ for up to 
10 min. Perfusion of the trans chamber with control solution ( containing 1 mM Ca2+) 
resulted in a complete reversal of channel activation, similar to that recorded under 
control conditions. This indicates that the rise in channel activity was not due to the 
dissociation of CSQ, or of some other protein. 
5.2.3.2 2+ 100 nM trans Ca 
Reducing trans Ca2+ from 1 mM to 100 nM (by the addition of 4.5 mM BAPT A) 
resulted in an immediate 1.7-fold increase in channel J 'F (Fig. 5.IX). A further increase 
in channel activity (raising J 'F 2.8-fold from control) was observed after 3 mins of 
incubation with 100 nM Ca2+. Perfusion of the trans chamber with control solution (1 
mM Ca2+) partially restored control J'F, and like incubation with both 5 and 13 mM 
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Fig. 5.VI. Increasing trans Ca2+ from 1 mM to 5 n1M resulted in two 
distinct stages of RyR activation. (A) Control channel activity, with 1 
mM trans Ca2+; (B) 30 sec after increasing trans Ca2+ to 5 mM; (C) 3 
mins after increasing trans Ca2+ to 5 mM; (D) after perfusing trans 
chamber with 1 mM Ca2+; (E) addition of 20 µg CSQ; (F) average data 
(n=3-6) for fractional mean current (J'F) for conditions shown in A-E. 
V m-Ecs was +40 m V. Single channel opening is upward from zero 
current ( continuous line) to maximum open conductance (broken line). 
Asterisk(*) indicate average values significantly (p<0.05, t-test) 
different from control) and ## double cross hatch indicate average 
values significantly (p<0.05, sign test) different from the previous 
condition. 
A 1 mM Ca2+ 
- -- -- - - - - -- - - -- ---- ---- -- - --- -- -- -- ------------ -- - -- -- ------ --- -- --- ---- - - --------- 0 
B 5 mM Ca2+ - 30 s 
C 
D 
E 
F 
5 mM Ca2+ - 3 min 
1 mM Ca2+ 
~ Q_ µ g -~ ~ _Q --------------------------------------------------------------------
~~-.~IWll!~i"M~fl!"'!f,/liw~ 
___ 1_s __ ---ll1opA 
0.4 
I' F 
0.0 
A B 
* 
C D E 
A 
----------- 0 
B 
C 2 mM Ca2+ - 3 min ~~- - - - ----
D 
1 s I !OpA 
E 
0.3 
* 
I' F 
0.0 A B C D 
Fig. 5.VII. Increasing trans Ca2+ from 1 mM to 2 mM did not result 
in two distinct stages of RyR activation. (A) Control channel activity, 
with 1 mM trans Ca2+; (B) 30 sec after increasing trans Ca2+ to 2 mM; 
(C) 3 mins after increasing trans to 2 mM; (D) after perfusing trans 
chamber with 1 mM Ca2+; (E) Average data (n=4-8) for J'F for 
conditions shown in A-D. V -Ee was +40 mV. Single channel 111 S 
opening is upward from zero current ( continuous line) to maximum 
open conductance (broken line). (*) indicate average values 
significantly different from control and * * indicates values different 
from the previous condition (p<0.05, t-test). 
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Fig. 5.VIII. Decreasing trans Ca2+ from 1 mM to 100 µM did not 
activate RyRs in two stages. (A) Control channel activity, with 1 mM 
trans Ca2+; (B) 30 sec after decreasing trans Ca2+ to 100 µM by 
addition of 900 µM BAPT A; (C) 3 min after decreasing trans Ca2+ to 
100 µM ; (D) after perfusing trans chamber with 1 mM Ca2\ (E) 
Average data (n=3-6) for fractional mean current (J '/J'J for conditions 
shown in A-D. V m- Ecs was +40 mV. Single channel opening is 
upward from zero current ( continuous line) to maximum open 
conductance (broken line). Asterisk (*) indicate average values 
significantly different from control and ** indicates average values 
different from the previous condition (p<0.05 , t-test) . 
Fig. 5.IX. Decreasing trans Ca2+ from 1 mM to 100 nM resulted in activation of RyR in two distinct stages. V m-Ecs was +40 mV. Single channel opening is upward from zero current ( continuous line) to maximum open conductance (broken line). Solutions contained: cis, 100 nM Ca2+, 2 mM ATP and 250 mM cs+; trans, 1 mM or 100 nM Ca2+ and 250 mM cs+. (A) Control channel activity, with 1 mM trans Ca2+; (B) 30 sec after decreasing trans Ca2+ to 100 nM; (C) 3 mins after decreasing trans Ca2+ to 100 nM; (D) after perfusing trans chamber with 1 mM Ca2+; (E) Addition of 20 µg CSQ; (F) Average data (n=3-12) for fractional mean current (J'F) for conditions shown in A-E. Asterisk(*) indicates average values significantly (p<0.05, t-test and sign test respectively) different from control and ## indicates average values significantly (p<0.05, sign-test) different from the previous condition. 
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Ca2+, channel activity was restored upon re-association of 20 µg CSQ (Fig 5.IX). Thus, 
lowering luminal Ca2+ to 100 nM appeared to dissociate CSQ from the RyR/T/J 
complex. 
5.2.4 Comparison of single channel parameters and 
dissociation times induced by 500 mM Cs+, 13 mM and 
100 nM Ca2+. 
The application of 13 mM trans Ca2+ caused a smaller increase in PO due to CSQ 
dissociation, than did 500 mM Cs+ (Table 5.I). The increase due solely to CSQ 
dissociation was calculated from the difference between activities recorded 30 s after 
Ca2+ was increased to 13 mM Ca2+ (which is activity due to Ca2+ binding to Ca2+ 
activation sites), and the secondary increase observed after 3 min exposure to high Ca2+ 
(see Fig 5.III C). Five hundred mM Cs+ increased P0 by increasing the channel T0 
8-fold, with no alteration in either Tc or F0 • On the other hand, CSQ dissociation by high 
luminal Ca2+ induced a P O rise by increasing the F 0 of channels (Table 5 .I). This 
difference could be due to either Cs+ or Ca2+ regulating the RyR by mechanisms after 
CSQ-dissociation (CSQ-independent mechanisms). Alternatively, high Cs+ dissociation 
might result in more CSQ removal (removing more of the inhibitory effect) than that 
induced by raising Ca2+ to 20 mM. However, this is unlikely, as the purification 
procedure using high ionic strength to dissociate1 calsequestrin from soluabilized JFM 
resulted in a lower yield of CSQ than the protocol using high Ca2+ (see Chapter 2, 
section 2.2). 
A comparison of dissociation times for the three dissociation agents - 500 mM Cs+, 13 
mM Ca2+ and 100 nM Ca2+ - revealed that the high [Cs+] may induce CSQ dissociation 
more rapidly than either high or low Ca2+ (Table 5.II). Dissociation time was calculated 
from the second of application of 500 mM Cs+, Ca2+ or BAPT A, until reversible effects 
could be seen. Dissociation took at least 89 s with high [Cs+], supporting the assumption 
that any increase in channel activity immediately after application of 5 mM, 13 mM or 
100 nM Ca2+ was not due to CSQ dissociation. 
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Table 5.1 
J'p 
Po 
To 
Tc 
Fa 
Changes in single channel parameters occurring with the three methods ofCSQ dissociation, 500 mM Cs+, 13 mM and 100 nM Ca2+ 
at +40 m J1. 
2.54* 3.01 * 2.15* 
2.81 * 2.89* na 
8.54* 2.19* na 
0.86 0.07 na 
1.01 2.67* na 
* Represents a significant change from control (p < 0.05). The channel parameter increase due solely to CSQ dissociation was calculated from the 
difference between activity recorded initially (30 s after Ca2+ was increased to 13 mM or decrease tol00 nM Ca2+), and the secondary increase in 
activity which occurred between 30 sec and 3 mins after exposure to high or low Ca2+. Na denotes parameter not analysed. 
Table 5.11 Comparison of time taken in seconds (s) to dissociate CSQ, using 500 mM Cs+, 13 mM and 100 nMmM Ca2+ at +40 m V. 
Mean 89 110 123 
SEM 15 11 18 
N 17 7 5 
5.2.5 
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Effects of the presence and absence of CSQ on changes 
in RyR activity induced by Iuminal Ca2+ between 1-3 
mM 
The response ofRyRs either with or without CSQ to variations in luminal [Ca2+] of 
between 1-3 n1M Ca2+ ( enco1npassing the range of luminal [Ca2+] over which SR Ca2+ 
release was most sensitive to luminal Ca2+ concentrations; Donoso et al., 1995), was 
investigated. Channels were incorporated in the presence of 1 mM luminal Ca2+, and 
Ca2+ was increased to 1.5, 2, 2.5 and 3 mM in a step-wise fashion, and activity observed 
at both positive and negative potentials. 
5.2.5.1 Response of Ry Rs with attached CSQ to small increases in 
luminal Ca2+ 
Channels that were not pre-exposed to 500 mM Cs+ (i.e. channels with CSQ attached) 
showed a small increase in J'/ I'c upon incubation with 1.5 and 2 mM Ca2+ (1.2- and 
1.3-fold increase respectively), compared with control levels in lmM Ca2+. Upon 
exposure to 2.5 and then 3 mM Ca2+, channel J'/ I'c increased 2.9- and 4.6-fold 
(respectively), from control (Fig 5.X). Channels were analysed within 30 s of exposure 
to the increased [ Ca2+]. Increases in [ Ca2+] at this level were presumed not to dissociate 
CSQ (see Section 5.2.2). In fact, two representative channels that were left exposed to 3 
n1M trans Ca2+ for up to 8 min, did not show a secondary increase in channel activity, 
suggesting that 3 mM luminal Ca2+ could not dissociate CSQ. 
5.2.5.2 Response of CSQ-depleted Ry Rs to small increases in luminal 
Ca2+ 
To dissociate CSQ, RyRs were exposed to 500 mM Cs+ until an increase in channel 
activity was observed, indicating CSQ dissociation (see Chapter 3, Section 3.2.4). Once 
the increase in activity occurred and remained stable (for 30s), the trans chamber was 
perfused with control solution ( containing 250 mM Cs+). As seen previously, no 
alteration in channel activity was detected after perfusion. 
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Fig 5.X. Response of RyRs to 1-3 mM Ca2+ in the absence and presence of CSQ. Experimental conditions: cis (1nM) 250 Cs+, 2 
ATP (activating) and 1 nmol Ca2+(sub-activating); trans (mM) 250 Cs+, 1-3 Ca2+. Trans Ca2+was altered by aliquot additions of 200 
n1M stock Ca2+(ca2+ concentration was determined by a calcium electrode). CSQ was dissociated from RyRs prior to increasing [Ca2+] by exposure to 500 1nM Cs+. Each data point is the mean open probability (P
0 ) relative to control (l n1M Ca2+), error bars are SE for n=7-8 in the absence and presence of CSQ. CSQ was dissociated from the RyR/T/J complex by pre-treatment with 500 n1M 
Cs+. The inset shows relative Po in response to a wider range of trans Ca2+ (1.0 - 3.5 mM) than the 1nain figure, in the same 
conditions as listed above. 
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The activity of CSQ-depleted channels increased upon exposure to increasing luminal 
Ca2+ from 1-3 mM (Fig. 5.X). At 2.5 and 3 mM luminal Ca2+, the removal of CSQ did 
not significantly alter the RyRs response to Ca
2
+ activation. At 2.5 mM Ca2+, RyRs 
without CSQ increased 1.2-fold from control ( compared with a 1.3-fold rise in CSQ 
associated channels), whilst at 3 mM, a 4.1-fold rise in channel current was recorded 
(CSQ associated RyRs: 4.9-fold). The presence of CSQ tended to enhance the activation 
ofRyRs by the two lower Ca2+ concentrations. CSQ-depleted RyRs tended to ·be less 
responsive to alterations in luminal Ca
2\ at 1.5 and 2 rnM Ca2+, RyR activity rose 1.2-
and 1.3-fold from control ( compared with an almost 1.5-fold increase at 1.5 mM and a 
1.7-fold rise at 2 mM, from control activity recorded in CSQ associated RyRs). Whilst, 
neither of these increases are significant (P= 0.092 at 1.5 mM and 0.07 at 2 rnM), it 
appears that a conformational change induced by Ca
2
+ exposure might influence the 
way in which CSQ may regulates the RyR . 
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5.3 Discussion 
5.3.1 Regulation of Ry Rs by high luminal [ Ca2+] 
The level of Ca2+ loading of the SR is important in regulating Ca2+ release. Increasing or 
decreasing SR Ca2+ load, increases or decreases (respectively) the sensitivity of Ca2+ 
release to depolarisation (Bassani et al., 1995; Lamb et al., 2001a), cytoplasmic Ca2+ 
(Capello et al., 1997), caffeine (Lamb et al., 2001a), ATP (Donoso et al., 1995) and 
polylysine (Saiki and Ikemoto, 1997). Moreover, Lamb et al. (2001a) found that 
different endogenous levels of SR Ca2+ loading in fast (EDL) and slow twitch (soleus) 
muscle was the primary factor determining the difference in caffeine sensitivities of the 
two fibre types. However, it has not been clear how the Ca2+ load in the SR alters Ca2+ 
release. 
These effects of SR Ca2+ load on Ca2+ release are also reflected in single RyR channel 
studies. Increasing luminal Ca2+ increases channel activity in both purified (Tripathy 
and Meissner, 1996) and native RyRs (Sitsapesan and Williams, 1995). This increase in 
activity has been attributed to Ca2+ flowing from the luminal solution, through the 
channel, and binding to Ca2+ activation sites on the cytoplasmic side of the RyR 
(Tripathy and Meissner, 1996). An alternative hypothesis is that luminal Ca2+ is sensed 
by regulatory sites on the luminal side of the RyR (Sitsapesan and Williams, 1995; 
Ching et al., 2000). Since these bilayer studies were performed under conditions where 
CSQ ( and possibly triadin and junctin) were not likely to have been present, regulation 
by CSQ bound to triadin/junctin can be discounted. Triadin and junctin were not 
present when RyRs were purified using CHAPS solubilization (Tripathy and Meissner, 
1996). It was also likely that CSQ was not present when native RyR were incorporated 
into bilayers in the absence of luminai Ca2+ (Sitsapesan and Williams, 1995; Ching et 
al., 2000). 
It has been proposed in other studies that CSQ is involved in RyR regulation by luminal 
Ca2+ (see review by Donoso et al., 1995). SR Ca 2+ release is most sensitive to luminal 
Ca2+ over the same range of Ca2+ (0-2 mM) that induces substantial, reversible 
conformational changes in CSQ (Ikemoto et al., 1989b; He et al., 1993). Evidence is 
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presented, which suggests that high levels of luminal [Ca2+] can activate RyRs by at 
least two mechanisms; one that is independent of CSQ, and another that involves CSQ 
dissociation from the RyRJT/J complex. Raising Ca2+ from 1 mM to 13 mM dissociates 
CSQ from the JFM (Figs. 5.III-V), inducing a 2.4- fold rise in RyR activity, which could 
be fully reversed only by replacing the CSQ (Fig. 5.V). Wang et al. (2001) also found 
that 10 mM Ca2+ induces a 2.1-fold increase in P O of cardiac Ry Rs in bilayers. Both 
studies are consistent with previous findings that high luminal [Ca2+] disrupts the 
charge-charge interactions binding triadin and junctin to CSQ (Mitchell et al., 1988; 
Zhang et al., 1997). Presumably the CSQ-independent mechanism is due to a direct 
activation of the RyR by luminal Ca2+ seen in single channel studies in the absence of 
CSQ (see above). 
5.3.2 Regulation of Ry Rs at low luminal Ca2+ 
Both Tripathy and Meissner (1996) and Sitsapesan and Williams (1995) report that 
RyRs respond to luminal [Ca2+] increases over the range of nM to mM by increasing 
channel P0 • The most comparable investigation (in terms of the RyR preparation used, 
muscle type and standard cis conditions) to that reported here (see Fig. 5.II), is that of 
Sitsapesan and Williams (1995), who report an increase in channel P 0 when increasing 
luminal Ca2+ from 5 µM to 2 mM. For example, Sitsapesan and Williams (1995) show 
that in ATP activated channels (in the presence of sub-activating cis Ca2+), PO was 
reduced by 100 µM trans Ca2+ when compared with activity recorded at 1 mM (trans), 
whereas Fig. 5 .XI illustrates an increase in channel activity upon lowering luminal Ca2+ 
to this concentration. In both this study and that of Sitsapesan and Williams ( 1995) ATP 
was the only cytoplasmic activating ligand, native skeletal RyRs were used and Cs+ was 
the current carrier. The two differences between the studies are that Sitsapesan and 
Williams (1995) incorporated the RyR in relatively low luminal Ca2+ (5 µM), and the 
RyRs were isolated from sheep, not rabbit. It is possible that 5 µM trans Ca2+ may 
induce CSQ dissociation or a conformational change in CSQ. Thus, the effect of 
luminal Ca2+ on CSQ and RyR activity might be quite different after exposure to 5 µM 
trans Ca2+. Such vastly different RyR regulation by any ligand has not previously been 
reported between species and is not likely to be responsible for the differences between 
the studies. 
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In fact, no other study of the effects luminal Ca + reports both lowering and raising 
luminal Ca2+ from 1 mM results in an increase in channel activity. Whilst both 
Herrmann-Frank and Lehmann-Hom (1996) and Fill et al. (1990) report maximal 
activation occurring at µM Ca
2
+ levels, and a reduction upon increasing luminal Ca
2
+ to 
1 mM, both report channel PO decreasing as [ Ca
2+] is increased from µM to mM. These 
results ( see Fig 5 .XI for dose response curve) warrant further investigation. 
Herrmann-Frank and Lehmann-Hom (1996) incorporate vesicles in the presence of 50 
µM trans Ca2+, whilst Fill et al. (1990) use 10 µM. Is it possible that at such a low Ca
2+, 
CSQ conformation is altered, CSQ is dissociated, or that other RyR regulatory proteins 
are compromised in such a way that the response to luminal [Ca
2+] is altered, when 
compared to the response shown when CSQ is attached, or in a physiological 
conformation? 
Potentially, regulation by luminal Ca
2
+ might be due to the effects of Ca
2
+ on another 
co-protein, such as triadin (Ching et al., 2000). Another possibility is that the RyRs 
response to CSQ may be altered at different [Ca2+], like calmodulin which modifies the 
RyR in a cis Ca2+ -dependent manner (Tripathy et al., 1995). The CSQ status of the 
Ry Rs used was not determined in any of the previous luminal Ca
2
+ investigations. CSQ 
association with the RyR may explain the increases in RyR activity with decreasing 
trans Ca2+ shown in Figs. 5. VIII-IX. 
Another possibility is that BAPTA affects the RyR or an associated luminal protein 
directly, resulting in RyR activation when Ca
2
+ was reduced below 1 mM . Costello et 
al. (1986) show that a 97 kDa protein (presumably triadin) is cleaved from solubilized 
JFM by EDTA (another weaker Ca2+ chelator). Since triadin has been shown to inhibit 
RyRs (Ohkura et al., 1998), its modification or removal may result in enhanced RyR 
activity. 
It is important to note that although the effect of luminal Ca
2
+ at [ Ca2+] lower than 
physiological levels are contradictory, both low and high luminal Ca
2
+ are able to 
dissociate CSQ from the RyR/T/J complex, and the dissociation further illustrates CSQs 
role as a RyR inhibitor. 
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5.3.3 High Cs+ vs high or low Ca2+ as a CSQ dissociation agent 
Mechanistically, the differences in CSQ dissociation time between high Cs+ and high 
Ca2+ exposure (see Section 5.2.4) might be explained by the way in which each agent 
removes CSQ from the RyR/T/J complex. High ionic strength disrupts CSQs ionic 
interaction with triadin and junctin, and hence the RyR. High and low Ca2+ have been 
shown to disrupt CSQs polymer formation and monomeric folding (He et al., 1993; 
Wang et al., 1998). Whether or not the removal of CSQ from the RyR/T/J complex 
requires both the disruption of the polymer complex and reversion to a random coil 
structure, is not known. None-the-less, the formation of a CSQ polymer is a two-step 
process, involving the formation of a front-to-front dimer, followed by a back-to-back 
interaction. It seems possible that the removal of CSQ from the RyR/T/J complex by 
high and low Ca2+ may be more time consuming, simply due to the fact that 
depolymerisation may have to occur prior to CSQ dissociation. 
It is interesting to note that both high Ca2+ and high Cs+ induced an increase in RyR P0 
in very different ways, Ca2+ which increased F0 , while Cs+, which increased T0 • Channel 
activity in both sets of experiments was returned to control levels upon re-association of 
CSQ, indicating that neither of these dissociation agents compromised the CSQ binding 
site on triadin, junctin or the RyR. It is quite possible that high Ca2+, high Cs+ or both of 
these agents dissociate luminal RyR regulating proteins in addition to CSQ. A possible 
contender would be the 30 kDa protein (refer to Chapter 3, Section 3.3.2.3 for further 
information of the possible role of this protein in RyR regulation and Yamaguchi et al., 
1999). A protein resolving at 30 kDa on SDS Page gel appeared after purification of 
CSQ using high ionic strength, but not after Ca2+-induced dissociation. It might be that 
the 30 kDa protein was removed along with CSQ in the lipid bilayer experiments, when 
exposed to 500 niiv1 trans Cs+_ If the removal of the 30 kDa protein explains the 
different RyR gating with high Cs +-induced CSQ dissociation, removal of the 30 kDa 
protein may be increasing T0 but not further increasing PO ( although this is unlikely, 
unless it were due to a compensatory mechanism, where one would expect a drop in F 0 
or an increase in Tc, which was not observed). Although re-association of exogenous 
CSQ with the 30 kDa protein restored control channel activity in CSQ dissociation 
experiments (see Chapter 3, Fig. 3.XII), the effects of the absence and presence of this 
protein on channel To were not investigated ( due to the presence of mainly 
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multi-channel bilayers in this set of experiments). It is also possible that the Ca
2
+ 
binding proteins sarcolumenin and the histadine rich Ca
2
+ binding protein also undergo 
some kind of dissociation, or change in structure in response to the conditions used to 
dissociate CSQ, and that these changes alter the way they regulate the RyR. Both these 
proteins are proposed to regulate the RyR, and any Ca
2
+ -induced effects on these 
proteins may alter R yR gating. 
5.3.4 CSQs role in regulating RyRs at 1-3 mM luminal Ca2+ 
Ikemoto et al. ( 1972) and Ostwald et al. ( 197 4) reported changes in CSQ conformation 
occurring over the range of Ca2+ concentrations tested here, which have been postulated 
to be responsible for an increase in SR Ca2+ release rate constants observed in the _ 
range of 1-3 mM Ca2+ (Donoso et al., 1995). 
No significant difference in luminal [Ca2+] regulation ofRyR activity was observed at 
2.5 or 3 mM Ca2+, whether or not CSQ was associated with the RyR. It should be noted 
however, that at 1.5 and 2 mM Ca2+, RyR activity had a tendency to be higher in RyRs 
with attached CSQ. These results warrant further exploration. It is possible that changes 
in CSQ conformation, induced by altering luminal Ca2+ from 1-3 mM (as suggested by 
Ikemoto et al., 1989 and He et al., 1993) play a role in RyR regulation. Another 
possibility is that direct binding of CSQ to the RyR communicates luminal Ca
2
+ to the 
RyR. This would rely on a direct CSQ-RyR interaction in vivo, which has yet to be 
established. Given that triadin binds to both the RyR and CSQ, and regulates the RyR 
(Zhang et al., 1997; Ohkura et al., 1998), it might be that CSQ and triadin form part of a 
luminal Ca2+ signaling pathway. Indeed it has been suggested that triadin might be 
involved in mediating activation of RyRs by luminal Ca
2
+ (Ching et al., 2000). 
A detailed study, comparing RyR regulation by luminal Ca
2
+ (1-3 mM) in both native 
and purified RyRs would help ascertain the role that CSQ, and in fact all other luminal 
RyR regulating proteins, play in communication of small (and probably physiological) 
Ca2+ fluxes into the cytoplasm, and further our understanding of the complex role that 
luminal proteins play in both Ca2+ signaling and RyR regulation. 
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5.3.5 Physiological Implications 
Taken together, these results show that luminal Ca2+ regulates the RyR via two 
mechanisms. Firstly, Ca2+ can bind to activation sites, found on the RyR or an 
associated proteinr nducing channel activation (when luminal Ca2+ is raised from 1 - 13 
1nM, or reduced to <100 µM). Secondly, changes in luminal Ca2+ concentrations can 
dissociate CSQ, inducing a significant rise in RyR activity. Whether or not luminal Ca2+ 
reaches levels that might induce CSQ dissociation in vivo remains to be determined, 
although Fryer and Stephenson ( 1996) have reported that in the case of severe fatigue, 
Ca2+ forms a Ca-P precipitate, thereby lowering free Ca2+ below 1 mM. This may result 
in some CSQ dissociation and altered RyR regulation. It may also be that local changes 
in [Ca2+], close to CSQ, may be sufficient to induce CSQ dissociation. However, this 
seems unlikely as there is thought to be free Ca2+ diffusion thoughout the terminal 
cistemae. 
The role of CSQ in conveying luminal Ca2+ concentrations to the RyR in vivo is not 
clear. Luminal Ca2+ might regulate RyRs via dissociation of CSQ. Although, it is not 
likely that the dissociation of CSQ from the JFM would be caused by normal 
physiological changes in luminal [Ca2+], and may not be an important mechanism in 
vivo. However, levels of luminal Ca2+ of ~ 10 mM are obtained experimentally when 
loading the SR to above normal levels (Lamb et al., 2001a), and such loading leads to 
enhanced Ca2+ release. Whether this increase occurs due to CSQ dissociation from the 
JFM in the SR or another mechanism ( or a combination of both), remains to be 
investigated. Another possibility is that CSQ is an important co-protein that modifies 
RyR function in response to changes in luminal Ca2+ in a similar manner to calmodulin 
and its association with cytoplasmic Ca2+ (Tripathy and Meissner, 1996). Like 
calmodulin in the cytoplasm, the effect of CSQ on RyR function may depend on the 
Ca2+ binding status of CSQ (and CSQ conformation), which could vary with changes in 
luminal Ca2+. It is also - probable that smaller changes in [Ca2+] might alter CSQ 
conformation and cause subtle changes in RyR activity. Finally, given that triadin binds 
to both CSQ and to the cytoplasmic side of the RyRs (Groh et al., 1999), it is possible 
that CSQ and triadin could form a signalling pathway that communicates the luminal 
Ca2+ concentration to the cytoplasmic side of the RyR. 
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GENERAL CONCLUSIONS 
Chapter 6 
6.1 Introduction 
This study describes the effects that the Ca2+ binding protein CSQ has on RyR activity 
in skeletal 1nuscle. Up until now, little has been know about the role of CSQ in 
regulating Ca2+ release through the RyR, with conflicting reports suggesting CSQ as 
both an activator (Kawasaki and Kasai, 1994; Ohkura et al., 1995; Ohkura et al., 1998; 
Szegedi et al., 1999; Herzog et al., 2000 and an inhibitor (Beard et al., 1999a; Beard et 
al., 2000a; Wang et al., 2001; Beard et al., 2002) of channel activity. 
The novel findings of this report were as follows: 
1) Exposing the luminal side of the SR to high ionic strength (500 mM Cs+), 
resulted in an increase in channel activity, reversible by addition of 
exogenous CSQ. 
2) Application of anti-CSQ antibody to the trans chamber also resulted in 
significant RyR inhibition, presumably by inducing a conformational shift in 
CSQ, which in turn affected the way in which CSQ regulates the RyR. 
3) Two populations of RyRs exist, those with 'high' control activity and those 
with 'low' control activity. The RyR population with high control activity 
did not respond to either 500 mM Cs+ exposure or to trans addition of 
anti-CSQ antibody, suggesting that this population lacked anchored CSQ, a 
hypothesis first suggested by Yamaguchi et al., 1997. 
4) Native RyRs respond in a different manner to CSQ than purified RyRs. 
Addition of trans CSQ had a tendency to activate purified RyRs, suggesting 
that CSQ regulates RyRs in different ways; a direct CSQ-RyR binding 
inducing RyR activation, whilst the presence of known anchoring proteins 
triadin and junctin allowed CSQ to inhibit RyR activity. 
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5) In native RyRs, the phosphorylation status of CSQ does not influence CSQs 
ability to inhibit RyRs. Both phosphorylated and dephosphorylated CSQ 
induce3a significant drop in RyR activity. This is in contrast to the regulation 
shown by CSQ in purified RyRs, where only the addition of 
dephosphorylated CSQ could induce significant change in channel activity, 
an activation of RyRs. Once again, these data illustrate the different 
regulation imposed by CSQ on the RyR when anchoring proteins triadin and 
junctin are present. 
6) Both high ( 2:5 rnM) and low ( :::100 nM) luminal Ca2+ can induce CSQ 
dissociation from the RyR/triadin/junctin complex. Altering luminal Ca2+ to 
these levels resulted in activation via · two independent mechanisms. 
Firstly, an immediate rise in channel activity was seen immediately, due to 
Ca2+ activation of the RyR and was only reversible by replacing control 
luminal [Ca2+] (1 rnM). A secondary phase of channel activity increase was 
also observed, due to CSQ dissociation, occurring approximately 3 min after 
the alteration in luminal [Ca2+] .' This increase in activity could only be 
reversed to control levels upon association of exogenous CSQ. 
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6.2 RyR/T/J/CSQ complex 
6.2.1 The role of triadin and junctin 
Strong evidence suggests that CSQ is an inhibitor of native RyR activity, with three 
methods of CSQ dissociation ( exposure to high ionic strength, and high and low Ca2+) 
all resulting in a significant activation of the channel, which was completely reversible 
by CSQ re-association. It is apparent that luminal proteins are required for CSQ to 
inhibit RyRs, because when RyRs are purified, CSQ strongly activates the channel 
Szegedi et al., 1999; Herzog et al., 2000. Only two proteins residing in the SR lumen 
(triadin and junctin) have been shown to bind both to CSQ and the RyR, although it is 
possible that other luminal proteins (SLM, HRC, 30 kDa) might be responsible for 
co1nmunicating CSQ-imposed RyR regulation (although no direct interaction with the 
ryanodine receptor or CSQ has been shown). Whilst triadin has been shown to inhibit 
RyRs, no effects of junctin on RyR activity have been reported thus far. Although a 
similar protein to triadin - in terms of nu1nber of transmembrane segments, it's role in 
the RyR/T/J/CSQ complex and it's highly charged luminal domain - in terms of 
interacting with CSQ, junctin is a little more complex. Unlike the discrete CSQ binding 
domain, consisting of a KEKE motif, (Arg210-Lys224) found on triadin, seemingly more 
than one site on junctin is required for interaction with CSQ. Kobayashi et al. (2000) 
showed that deletion of any one of three luminal KEKE motifs resulted in inhibition of 
the junctin/CSQ interaction. This suggests that there is not a single binding site on 
junctin for CSQ, that multiple interaction sites exist and that all these sites need to 
interact for the CSQ/junctin interaction to be stable. Certainly, to fully understand the 
co1nplex arrangement and regulation imposed by the RyR/T/J/CSQ complex, it is 
essential to discover if and how junctin influences RyR behaviour. It would be of great 
interest to study which of these KEKE motifs ( or other sites on junctin) are required for 
stability of the protein, and which may be involved in a functional regulation of the RyR 
or CSQ. 
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6.2.2 Direct CSQ-RyR interaction 
To help to understand more about the specific interactions between CSQ and the RyR, 
specific binding sites on CSQ for the RyR, and the RyR and CSQ need to be identified. 
Herzog et al (2000) looked at the binding of CSQ to two segments of the RyR, the Ml /2 
and M3/4 segments, which correspond to residues 4580-4640 and 4859-4917. Neither 
of these two loops interacted with CSQ. The number and location of the RyR luminal 
loops are still controversial - Zorzato et al. , (1990) proposed twelve luminal loops, 
while Takeshima et al (1989) proposed four luminal loops. Therefore the amino acid 
residues thought to correspond to the Ml/2 or M3/4 regions may not in fact be on the 
luminal side of the protein. This aside, identification of a definitive site(s) on the RyR 
for CSQ association would provide more credence to the proposal of a direct CSQ-RyR 
interaction. It is also interesting to ponder a physiological basis for CSQ associating 
with the RyR both directly, and via triadin and junctin. As previously mentioned, these 
interactions result in activation ( direct binding) and inactivation (binding via triadin and 
junctin) of the RyR. This study has shown in native SR, that re-associating CSQ with 
the CSQ-deplete RyR/T /J complex resulted in RyR inhibition. Either, the direct 
CSQ-RyR interaction occurs in vivo, but the resultant channel activation is masked by a 
stronger CSQ-induced inhibition of the RyR/T /J complex. Or, in vivo, a direct 
interaction does not occur. 
6.3 RyR regulation by luminal Ca2+ binding proteins 
SLM and HRC? 
Making the RyR/T/J/CSQ complex much more intriguing, is the existence of Ca2+ 
binding proteins, the HRC and SLM. Knowing that these are believed to modulate the 
RyR (see Chapter 1, section 1.7.2), the question arises; does SLM/HRC exert a RyR 
regulatory effects through its binding to CSQ, which in tum can exerts its effects via a 
signalling pathway through triadin and junctin (see preliminary reports Beard et al., 
1999; Beard et al. , 2000; Wang et al. , 2001) or on CSQ bound directly to the RyR 
Szegedi et al. , 1999; Herzog et al. , 2000? Physiologically, what is the effect of this 
seemingly complex interplay of several modulatory mechanisms; is an inhibition 
induced by SLM/HRC overshadowed by CSQ modulation Kawasaki and Kasai, 1994; 
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Meissner (1996), Gyorke and Gyorke (1998) and Ching et al. (2000) also activated the 
channels with cytoplasmic ATP. It should be noted that Tripathy and Meissner (1996) 
have shown voltage-dependant activation of RyRs by luminal Ca
2
+ in the absence of 
ATP. The observed RyR activity increase is consistent with an increased Ca
2
+ release 
rate from SR observed by Ikemoto et al. (1989) and Donoso et al. (1995). 
6.4 Anti-CSQ 
How the polyclonal anti-CSQ antibody specifically regulates the RyR simply by 
binding with CSQ is still unclear. How CSQs structure is altered by the antibody could 
quite easily be determined using nuclear magnetic resonance, comparing structural 
alteration of CSQ in both the presence and absence of the antibody. It would be of 
interest to determine whether or not anti-CSQ was inducing total channel inhibition by 
binding to CSQ and thus inducing a conformational shift that either exposes a site that 
may bind to the RyR (and induce inhibition). Alternatively such a conformational 
change might alter the way in which CSQ binds to other proteins (such as triadin and 
junctin) and alter the way these proteins interact and regulate the RyR. Such structural 
data would uncover important details such as how conformational changes in CSQ may 
alter RyR activity and possibly give information on changes in the protein conformation 
upon binding ligands, such as Ca2+. 
6.5 Luminal Ca2+ 
In tenns ofRyR regulation, the effects of luminal Ca2+ still remain controversial. Fill et 
al. (1990; using native RyRs) and Ma et al. (1988) and Szegedi et al. (1999) - using 
purified RyRs - showed that increasing luminal Ca2+ decreased RyR activity. In 
contrast, Tripathy and Meissner (1996; using purified RyRs, with ATP to activate) and 
Herrmann-Frank and Lehmann-Hom (1996; using purified RyRs), reported a biphasic 
response to increasing luminal [Ca2+], with Tripathy and Meissner (1996) reporting 
maximal activation occurring at > 5 mM Ca2+ (at +40 mV, or 0.25 mM at - 40 mV). 
Sitsapesan and Williams (1995; using native RyRs, with ATP to activate) , showed an 
increase in channel open probability (P0 ) as lu1ninal Ca2+ was increased, provided 
cytoplasmic ATP and Ca2+ already regulated the channels. Similarly, Gyorke and 
Gycfrke (1998) and Ching et al. (2000) report a Ca2+-dependence of channel activation 
in cardiac RyRs. All researchers, except Tripathy and Meissner (1996) use cytoplasmic 
Ca2+ at activating levels. In addition, Sitsapesan and Williams (1995), Tripathy and 
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Meissner (1996), Gycfrke and Gycfrke (1998) and Ching et al. (2000) also activated the 
channels with cytoplasmic ATP. It should be noted that Tripathy and Meissner (1996) 
have shown voltage-dependant activation of RyRs by luminal Ca2+ in the absence of 
ATP. The observed RyR activity increase is consistent with an increased Ca2+ release 
rate from SR observed by Ikemoto et al. (1989) and Donoso et al. (1995). 
Increasing luminal Ca2+ (from pM to mM) has been reported to activate RyRs 
Sitsapesan and Williams, 1995; Herrmann-Frank: and Lehmann-Hom, 1996; Tripathy 
and Meissner, 1996; Gyorke and Gyorke, 1998; Ching et al., 2000. It appears that 
probably only one of these studies would have had RyRs with CSQ attached (Gycfrke 
and Gyorke, 1998), due to the use of either purified RyRs or exposure of CSQ to <nM 
Ca2+, which is thought to inhibit CSQ folding, polymerisation and interactions with the 
RyR complex (Wang et al., 1998 and Chapter 5). Tripathy and Meissner (1996) and 
Herrmann-Frank and Lehmann-Hom (1996) sh~w RyR activation by lu1ninal Ca2+ in 
purified channels (no CSQ), whilst Ikemoto et al. (1989) and Donoso et al. (1995) 
report an enhanced release rate from SR vesicles containing CSQ upon increasing 
luminal Ca2+. The differences observed between luminal Ca2+-dependence ofRyR 
activity and SR Ca2+ release cannot be attributed entirely to the presence or absence of 
CSQ. Only a detailed study which takes account of the differences between the 
methods used in the different studies (i.e. presence or absence of ATP, co-proteins and 
cytoplasmic Ca2+), will be able to resolve the exact effects of luminal Ca2+ 
concentration on RyR activity. 
6.6 Physiological relevance of CSQ mutation or altered 
• expression 
To date, two physiological conditions have reported alternations in CSQ expression or a 
CSQ mutation. Firstly, catecholamine-induced polymorphic ventricular tachycardia is a 
disease that can deteriorate to ventricular fibrillation and induce sudden death upon 
exercise stress or catecholamine infusion. The autosomal dominant form of this 
' 
disease have been shown to be due - in part at least - to mutations in the RyR gene in 
cardiac muscle (Priori et al. , 2002). Recently, a missense mutation in the cardiac CSQ 
gene has been described, which gives rise to an autoso1nal recessive form of this disease 
Lahat et al., 2001. This mutation leads to a single amino acid change from an 
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aspartic acid to a histidine at residue 307 ( d307h). This occurs close to the highly 
charged Ca2+ binding domain (Glu354-Asp367) of CSQ. It is proposed that mutated CSQ 
may serve to increase the free Ca2+ in the SR, resulting in Ca2+ overload. 
It is very important to discover what effects this single amino acid mutation has on the 
formation (or lack of it) of the RyR/T/J/CSQ complex, and effects on RyR activation 
and calcium release, as well as the RyR response to small luminal Ca
2
+ changes (that 
occur within the contraction/relaxation cycle. For example, does replacing a negatively 
charged residues (Asp) to a positively charged amino acid (His) alter the structure of 
CSQ in such a way that either the Ca2+ binding domain becomes partially buried and 
unavailable for Ca2+ binding? Or, does a structural change inhibit the interaction of 
CSQ with its co-proteins (triadin and junctin) or the RyR? How much of a role does the 
up-regulation of other luminal Ca2+ binding proteins play in Ca
2
+ sequestration in the 
SR lumen? As yet, a CSQ knockout model has not been generated, and hence the 
importance of CSQ in regular muscle function has not been elucidated. Both the CSQ 
mutation (Labat et al., 2001) and the overexpresion studies (Jones et al, 1998, 
Knollman et al, 2000, Wang et al, 20009) suggest that CSQ (at normal expression 
levels) is required for fully functioning muscle, but do not really elucidate its role. It 
would be interesting to see whether the total absence of expressed CSQ would result in 
non-functioning muscle (particularly in the heart), and death. 
Secondly, an increased expression of skeletal muscle CSQ and CSQ-like proteins has 
been found in mice with streptozotocin-induced diabetes (Howarth et al, 2002). These 
mice had a 2.5 times greater skeletal muscle Ca2+ -binding capacity, but showed no such 
alteration in binding capacity and not alteration in CSQ expression in cardiac muscle. 
Diabetics present with an elevated cytosolic Ca
2
+ level in muscle, and the authors 
suggest that up-regulation of the SR Ca2+ homeostasis proteins may be a compensatory 
mechanism, enabling extra luminal Ca2+ buffering, thereby reducing the cytosolic Ca
2
+ 
levels (Howarth et al, 2002). This is the first report of altered CSQ expression apparent 
in a skeletal muscle disorder. 
These two disorders illustrate the importance of the understanding of the RyR/T/J/CSQ 
complex, and in particular, how CSQ regulates Ca2+ release through the SR, which 
eventually leads to muscle contraction. Whilst this thesis presents the first study that has 
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systematically studied the interactions of CSQ with native RyRs and the resultant 
channel modulation, the results illustrate the need for more investigation into the 
mechanisms of RyR/CSQ interaction and SR Ca2+ sequestration and release. 
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